Table A.1 Incident counts of reported ESRD: all patients by age, gender, race, ethnicity, & primary diagnosis
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+ Unknown
1985 140 103 214 441 2,084 3,309 3,689 5,501 3,950 3,929 5,785 1,025 360 *
1990 150 152 246 545 2,635 4,888 6,277 8,362 6,138 7,244 10,875 2,397 962 *
1995 166 147 283 569 2,692 5,750 8,988 11,956 8,003 9,313 16,584 4,157 1,785 *
2000 193 153 308 575 2,711 5,819 10,993 16,881 10,076 11,509 23,967 7,455 3,900 .
2001 203 151 309 586 2,712 5,754 11,058 17,774 10,481 11,875 24,841 7,770 4,288 .
2002 179 182 338 584 2,579 5,802 11,324 18,229 10,579 11,805 24,941 8,751 4,684 .
2003 198 147 338 624 2,549 5,736 11,625 19,162 11,268 12,169 24,949 8,911 5,005 .
2004 232 148 322 649 2,634 5,800 11,946 19,852 11,650 12,307 24,947 9,249 5,241 .
2005 209 146 336 624 2,737 5,904 12,120 20,674 11,953 12,231 25,083 9,737 5,523 .
2006 199 128 298 672 2,760 6,023 12,654 21,974 12,433 12,721 25,563 9,870 5,812 *
2007 237 130 313 627 2,836 5,898 12,354 22,058 12,964 12,811 24,927 9,904 6,133 *
2008 224 146 282 692 2,806 5,995 12,246 22,472 13,464 13,189 24,850 9,876 6,418 *
2009 293 154 294 659 2,900 6,218 12,690 22,917 14,274 14,007 25,207 9,963 6,791 28
0-19 20-44 45-64 65-74 75+ Unknown
898 7,133 11,400 7,412 3,687 *
1,093 10,641 17,659 13,509 7,969 *
1,165 12,539 24,850 18,686 13,153 *
1,229 13,269 33,211 23,902 22,929 .
1,249 13,173 34,606 24,760 24,014 .
1,283 13,123 35,390 24,512 25,669 .
1,307 13,139 37,201 24,620 26,414 .
1,351 13,401 38,481 24,875 26,869 .
1,315 13,755 39,633 24,779 27,795 .
1,297 14,013 41,831 25,567 28,399 *
1,307 13,849 42,261 25,501 28,274 *
1,344 13,784 43,199 25,914 28,419 *
1,400 14,300 44,699 26,998 28,970 28
Male Female Unknown
16,561 13,974 *
27,310 23,562 .
37,139 33,254 *
50,600 43,940 .
52,607 45,195 .
54,325 45,652 .
55,633 47,041 *
57,984 46,993 .
59,576 47,697 *
62,083 49,026 *
62,351 48,841 *
63,599 49,061 *
65,996 50,393 *
White African American Native American Asian Other/unknown
20,794 8,723 307 602 111
33,828 14,997 602 1,295 150
44,666 21,612 885 2,289 942
61,827 26,761 1,200 3,250 1,502
63,931 27,804 1,175 3,449 1,443
65,013 28,697 1,149 3,602 1,516
66,416 29,578 1,137 3,763 1,787
68,504 29,386 1,203 3,893 1,991
70,172 30,490 1,224 4,158 1,233
73,236 31,491 1,236 4,775 372
72,841 31,653 1,279 5,116 304
73,744 31,957 1,312 5,212 439
76,377 32,314 1,442 5,647 615
12,546 81,994
11,791 86,011
12,529 87,448
13,323 89,358
13,694 91,283
13,893 93,384
14,811 96,299
15,129 96,064
15,673 96,991
16,240 100,155
45,656 28,574 8,447 2,305 2,819 10,195 4,048 637
46,743 28,750 8,607 2,342 2,865 10,824 4,112 734
47,435 29,065 8,209 2,522 2,169 12,347 4,654 876
49,437 29,853 8,028 2,662 1,680 13,754 4,827 869
†Hispanic †Non-Hispanic Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing disease
8,706 8,265 5,108 1,227 1,177 3,555 1,549 950
18,151 15,387 7,091 1,579 1,309 4,873 1,921 561
29,325 18,837 8,305 1,931 2,046 7,154 2,481 315
42,441 25,087 8,694 2,195 2,735 9,122 3,760 506
44,155 26,321 8,640 2,268 2,771 9,323 3,997 327
44,466 27,298 8,741 2,251 2,932 9,940 3,942 407
49,071 30,791 7,615 2,643 1,551 14,154 4,636 732
49,683 31,503 7,519 2,687 1,575 14,287 4,415 995
50,970 32,688 7,612 2,662 1,590 14,810 4,245 1,818
U.S. U.S. territories Puerto Rico Foreign Unknown
29,950 31 392 20 144
49,875 62 611 41 283
69,377 104 838 35 40
93,230 136 1,099 41 34
96,433 145 1,173 28 23
98,525 101,010 103,241 105,559 109,269 109,360 173 165 169 172 202 207 1,218 1,286 1,294 1,232 1,329 1,365 35 34 23 26 32 23 26 186 250 288 278 238
110,703 232 1,382 19 328
114,215 236 1,403 14 527
All
30,537
50,872
70,394
94,540
97,802
99,977 102,681 104,977 107,277 111,110 111,193
112,664
116,395
Table A.1 (continued) Incident counts of reported ESRD: all patients: U.S. only, with unknowns dropped by age, gender, race, ethnicity, & primary diagnosis
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1985 133 101 207 429 2,030 3,233 3,591 5,357 3,859 3,856 5,701 1,012 351
1990 144 146 239 526 2,564 4,763 6,085 8,109 5,986 7,152 10,736 2,370 949
1995 159 145 268 550 2,618 5,616 8,736 11,568 7,781 9,072 16,331 4,097 1,758
2000 186 149 296 542 2,575 5,638 10,668 16,316 9,729 11,207 23,536 7,353 3,860
2001 184 143 297 563 2,595 5,549 10,775 17,187 10,163 11,572 24,375 7,673 4,242
2002 163 175 326 547 2,429 5,603 10,978 17,655 10,248 11,500 24,480 8,631 4,622
2003 185 133 313 581 2,400 5,473 11,221 18,465 10,870 11,820 24,428 8,770 4,928
2004 209 135 292 610 2,461 5,500 11,488 19,139 11,245 11,975 24,466 9,111 5,169
2005 195 136 315 591 2,601 5,743 11,777 20,082 11,654 11,933 24,660 9,605 5,468
2006 191 121 281 652 2,686 5,899 12,384 21,531 12,165 12,486 25,222 9,757 5,751
2007 225 122 301 608 2,774 5,766 12,120 21,604 12,668 12,572 24,548 9,811 6,078
2008 213 137 274 664 2,736 5,854 11,976 21,981 13,160 12,925 24,447 9,791 6,347
2009 269 139 276 630 2,805 6,046 12,369 22,384 13,936 13,721 24,756 9,859 6,718
0-19 20-44 45-64 65-74 75+
870 6,946 11,124 7,289 3,631
1,055 10,352 17,155 13,338 7,869
1,122 12,225 24,094 18,303 12,955
1,173 12,804 32,122 23,345 22,611
1,187 12,732 33,537 24,200 23,662
1,211 12,629 34,284 23,940 25,293
1,212 12,561 35,868 23,981 25,965
1,246 12,726 37,107 24,287 26,434
1,237 13,311 38,546 24,246 27,420
1,245 13,703 40,962 25,147 28,069
1,256 13,556 41,376 25,055 27,954
1,288 13,463 42,244 25,421 28,089
1,314 13,894 43,646 26,459 28,595
Male Female
16,177 13,683
26,676 23,093
36,168 32,531
49,154 42,901
51,109 44,209
52,765 44,592
53,838 45,749
56,143 45,657
58,095 46,665
60,922 48,204
61,179 48,018
62,320 48,185
64,534 49,374
White African American Native American Asian
20,369 8,615 304 572
33,142 14,831 599 1,197
44,100 21,502 884 2,213
61,052 26,658 1,200 3,145
63,125 27,677 1,175 3,341
64,191 28,547 1,149 3,470
65,396 29,428 1,135 3,628
67,590 29,244 1,203 3,763
69,184 30,326 1,220 4,030
72,054 31,268 1,216 4,588
71,611 31,446 1,262 4,878
72,523 31,731 1,296 4,955
75,077 32,116 1,404 5,311
10,724 81,331
9,918 85,400
10,545 86,812
11,091 88,496
11,486 90,314
12,147 92,613
13,446 95,680
13,728 95,469
14,230 96,275
14,766 99,142
45,158 28,221 8,308 2,285 2,808 10,590 3,972 458
46,169 28,674 8,023 2,478 2,120 12,160 4,591 545
48,388 29,607 7,897 2,632 1,644 13,608 4,790 560
†Hispanic †Non-Hispanic Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing disease All Patients dropped
8,512 8,142 4,992 1,206 1,149 3,504 1,486 869
17,708 15,196 6,920 1,550 1,260 4,809 1,850 476
28,459 18,536 8,116 1,899 1,980 7,030 2,407 272
41,114 24,697 8,436 2,140 2,667 8,912 3,650 439
42,766 25,900 8,398 2,214 2,713 9,145 3,888 294
43,021 26,860 8,471 2,197 2,867 9,732 3,850 359
44,053 28,022 8,169 2,249 2,766 9,981 3,908 439
47,970 30,532 7,486 2,617 1,516 14,006 4,599 471
48,517 31,243 7,393 2,664 1,540 14,140 4,371 637
49,786 32,373 7,505 2,634 1,553 14,658 4,214 1,185
29,860
49,769
68,699
92,055
95,318
97,357
99,587 101,800 104,760 109,126 109,197
110,505
113,908
677
1,103
1,695
2,485
2,484
2,620
2,159
2,487
3,094
3,177
2,517
1,984
1,996
Table A.2 Incident rates of reported ESRD per million population, by age, gender, race, ethnicity, & primary diagnosis UNADJUSTED 0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1985 7.5 6.1 12.2 22.9 47.3 85.9 139.8 242.6 353.8 412.7 437.7 299.5 131.6
1990 1995 2000 2001 2002 2003 2004 7.6 8.1 9.7 9.5 8.3 9.3 10.3 8.1 7.5 7.3 7.1 8.8 6.7 6.9 13.9 14.0 14.4 14.2 15.4 14.8 13.8 29.6 29.9 26.7 27.6 26.7 28.2 29.3 63.4 68.9 67.0 67.1 62.1 60.5 61.0 113.6 125.2 130.6 129.3 131.9 130.8 133.6 192.4 230.9 249.6 247.6 248.7 251.5 255.3 371.0 462.0 520.8 527.5 523.2 532.0 533.0 563.5 767.5 896.2 915.5 891.5 898.3 894.4 709.6 909.3 1,177.6 1,214.5 1,200.9 1,214.0 1,204.1 757.6 1,047.0 1,444.1 1,497.2 1,508.9 1,510.9 1,524.6 602.0 907.5 1,474.1 1,487.8 1,620.1 1,610.7 1,631.0 310.2 477.6 903.9 974.2 1,040.1 1,077.3 1,103.4
0-19 20-44 45-64 65-74 75+
12.4 73.4 249.5 432.4 314.2
Male Female White African American Native American Asian
2007 10.8 6.1 14.8 28.2 65.7 142.9 271.5 551.5 876.2 1,169.9 1,526.4 1,699.1 1,154.6
2008 10.1 6.7 13.6 30.7 64.0 145.0 271.0 549.9 872.6 1,140.5 1,509.9 1,680.6 1,164.6
2009 12.6 6.7 13.8 29.3 64.9 149.6 282.3 549.5 881.4 1,164.3 1,515.7 1,693.3 1,193.1
14.7 103.4 370.5 736.7 598.7
14.6 14.6 14.7 14.9 14.9 15.2 15.1 15.1 15.2 118.6 123.0 121.9 120.8 120.3 121.9 127.6 131.3 129.8 456.3 514.8 521.0 515.7 523.4 526.1 530.7 549.0 541.5 970.2 1,270.5 1,319.4 1,307.5 1,304.7 1,312.7 1,299.0 1,328.0 1,292.2 869.3 1,354.0 1,393.7 1,465.4 1,480.2 1,488.3 1,520.1 1,536.4 1,512.8
15.5 128.8 542.6 1,262.3 1,505.2
15.8 132.8 549.8 1,272.6 1,522.8
139.8 112.0
219.2 180.5
277.8 239.1
355.0 298.5
365.1 304.7
373.1 304.6
377.3 309.9
389.5 306.6
399.1 310.7
414.3 318.1
411.7 313.9
415.3 312.3
426.1 317.4
100.8 301.6 177.0 102.0
158.3 483.9 291.0 158.6
200.1 635.3 362.0 230.4
264.8 726.0 403.6 264.9
271.5 744.2 388.0 271.4
273.9 758.6 372.9 272.5
277.1 773.8 362.1 276.2
284.2 759.8 377.2 278.2
288.7 778.5 375.6 289.2
298.4 792.5 367.5 319.9
294.1 786.3 374.0 330.8
295.7 783.3 377.0 327.3
304.0 783.3 401.1 342.0
300.9 329.9
267.7 344.3
274.3 348.1
278.8 353.2
279.2 358.5
285.5 365.8
305.5 375.8
301.7 372.8
302.9 374.0
305.0 383.4
†Hispanic †Non-Hispanic Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing disease All
2005 9.5 6.9 15.1 28.0 63.5 141.2 261.0 539.0 897.8 1,179.5 1,536.8 1,691.4 1,124.7
2006 9.3 6.1 13.7 30.5 64.5 146.0 275.1 558.1 911.9 1,205.4 1,570.6 1,704.3 1,135.9
35.8 34.2 21.0 5.1 4.8 14.7 6.3 3.7
70.9 60.9 27.7 6.2 5.1 19.3 7.4 1.9
106.9 69.6 30.5 7.1 7.4 26.4 9.0 1.0
145.7 87.5 29.9 7.6 9.5 31.6 12.9 1.6
150.0 90.9 29.5 7.8 9.5 32.1 13.6 1.0
149.5 93.3 29.4 7.6 10.0 33.8 13.4 1.3
151.7 96.5 28.1 7.8 9.5 34.4 13.5 1.5
154.1 96.3 28.4 7.8 9.6 36.1 13.6 1.6
156.1 97.0 27.1 8.4 7.2 41.1 15.5 1.8
162.1 99.2 26.5 8.8 5.5 45.6 16.0 1.9
159.1 101.2 24.8 8.7 5.0 46.4 15.3 1.6
159.4 102.7 24.3 8.8 5.1 46.5 14.4 2.1
162.2 105.5 24.5 8.6 5.1 47.7 13.7 3.9
125.5
199.4
258.0
326.2
334.4
338.3
343.0
347.4
354.2
365.5
362.1
363.1
371.0
Table A.2 (continued) Incident rates of reported ESRD per million population, by age, gender, race, ethnicity, & primary diagnosis ADJUSTED 0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1985 7.3 6.1 12.2 22.7 47.5 90.9 153.2 270.9 408.8 469.9 502.8 388.1 195.9
1990 1995 2000 2001 2002 7.5 7.9 9.5 9.4 8.2 7.9 7.3 7.1 7.0 8.7 13.7 13.7 14.0 13.8 15.0 28.8 28.8 26.0 26.7 26.0 62.6 67.0 65.3 65.6 60.6 117.7 127.1 129.7 128.1 130.7 213.0 250.6 261.1 257.8 257.9 412.5 519.9 581.6 587.8 576.5 635.0 847.6 967.9 997.2 970.7 814.9 1,015.9 1,286.0 1,319.3 1,302.5 883.4 1,229.4 1,638.4 1,686.3 1,705.3 750.5 1,126.1 1,771.9 1,757.2 1,911.4 439.7 665.2 1,199.0 1,288.4 1,379.2
2007 10.3 5.9 14.8 27.3 63.2 139.7 273.9 588.9 957.8 1,274.1 1,682.7 1,949.6 1,527.2
2008 10.0 6.7 13.4 29.9 61.6 141.8 272.2 585.5 949.2 1,246.8 1,660.3 1,913.4 1,531.7
2009 12.5 6.7 13.7 29.0 62.4 146.0 282.6 580.9 953.2 1,275.0 1,670.9 1,930.7 1,552.2
0-19 20-44 45-64 65-74 75+
12.1 81.2 281.9 496.9 355.2
14.5 14.4 14.1 14.2 14.5 14.4 14.7 14.5 14.5 14.6 108.7 119.0 119.6 118.4 117.3 117.0 118.7 124.5 128.4 127.1 425.8 545.5 611.3 620.9 608.9 614.4 612.9 614.5 629.9 613.4 850.8 1,110.2 1,406.5 1,452.2 1,443.6 1,436.5 1,437.3 1,422.7 1,451.3 1,421.8 690.1 1,015.2 1,573.6 1,611.0 1,705.5 1,718.2 1,719.1 1,757.8 1,768.4 1,757.6
15.0 126.8 609.3 1,391.6 1,743.2
15.5 131.3 610.2 1,407.0 1,761.9
Male Female
169.6 117.8
264.1 185.2
330.2 240.9
411.8 287.7
White African American Native American Asian
104.4 418.4 288.5 152.1
161.0 665.1 494.4 241.1
200.3 875.8 605.9 353.5
†Hispanic †Non-Hispanic Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing disease All
420.7 291.4
427.3 288.3
2003 9.2 6.6 14.5 27.2 59.3 129.3 259.2 582.6 981.5 1,318.3 1,695.9 1,882.6 1,434.7
427.8 290.6
2004 10.2 6.8 13.6 28.1 59.8 132.0 261.9 580.2 977.3 1,306.1 1,688.3 1,901.1 1,448.0
437.1 285.3
2005 9.4 6.9 14.7 26.9 61.7 139.4 265.9 581.8 982.9 1,280.9 1,700.1 1,959.6 1,478.0
443.0 286.3
2006 9.1 6.1 13.4 29.4 62.4 143.4 278.8 598.2 995.8 1,305.7 1,726.2 1,965.6 1,484.1
454.6 290.9
447.0 284.4
445.2 279.8
451.5 281.9
258.7 263.9 264.3 265.3 990.7 1,009.6 1,019.4 1,027.8 658.3 600.3 574.4 544.5 378.6 378.8 379.2 373.9
270.2 272.5 279.8 997.2 1,008.4 1,015.3 558.6 532.3 501.2 367.4 374.5 401.1
273.1 998.5 506.2 405.8
271.8 983.8 506.1 391.4
277.2 976.0 522.5 402.7
593.3 321.7
511.9 333.7
519.5 334.2
518.6 336.0
509.0 338.4
508.9 342.1
530.5 348.6
514.7 342.2
508.5 339.7
500.6 344.9
40.9 39.7 23.2 5.9 5.2 15.6 6.9 4.0
79.7 67.8 29.9 7.1 5.4 20.2 8.2 2.1
118.1 75.6 32.6 7.8 7.9 27.7 9.7 1.1
154.0 91.5 30.9 7.9 9.8 32.5 13.4 1.6
157.3 94.2 30.3 8.0 9.8 32.8 14.1 1.1
155.0 96.0 30.1 7.8 10.2 34.5 13.7 1.3
155.3 98.4 28.5 7.9 9.7 34.8 13.7 1.5
156.0 97.3 28.6 7.9 9.7 36.4 13.7 1.6
156.1 97.0 27.1 8.4 7.2 41.1 15.5 1.8
160.3 98.3 26.3 8.8 5.5 45.3 15.9 1.9
155.2 99.2 24.5 8.6 4.9 45.8 15.0 1.5
153.4 99.4 23.8 8.6 4.9 45.4 14.0 2.0
154.1 101.1 23.8 8.4 4.9 46.3 13.3 3.7
141.4
220.4
280.5
341.6
347.6
348.5
349.8
351.0
354.2
362.1
354.7
351.5
355.4
Table A.3 Incident rates of reported diabetic ESRD per million population, by age, gender, race, & ethnicity UNADJUSTED 0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1980 . . . 0.5 5.3 16.4 17.8 27.0 32.2 29.4 18.0 * *
1985 * . * * 12.6 30.1 46.4 89.4 119.6 121.9 82.8 34.9 6.4
1990 * * * 0.8 15.6 37.3 74.8 176.4 262.7 283.5 220.2 100.6 35.6
1995 * . * * 13.8 40.8 93.6 246.4 420.4 456.7 405.3 212.6 77.4
2000 * . . * 12.8 42.3 102.4 291.3 520.8 646.3 642.1 442.5 187.8
2001 * * * * 12.2 40.6 100.8 292.5 542.4 674.9 664.6 472.7 210.4
2002 * * * * 10.3 41.3 101.6 286.2 514.8 650.1 667.7 513.7 223.0
2003 * . . * 10.5 41.5 102.3 288.7 510.5 659.5 676.4 492.4 238.9
2004 * . * * 10.4 44.5 103.7 287.9 504.4 656.5 681.5 525.1 246.8
2005 * . * * 10.6 43.6 107.1 288.8 508.6 633.2 689.5 547.5 241.7
2006 * . * 0.6 10.5 47.8 116.9 292.8 512.4 646.9 702.3 569.8 270.0
2007 * . . 0.6 11.8 48.1 111.6 282.5 489.2 613.0 685.1 582.2 271.8
2008 * . * 0.5 11.6 47.9 114.5 283.3 484.6 600.8 664.9 559.1 284.4
2009 1.3 * * * 11.3 51.1 121.3 281.7 479.4 597.8 669.1 555.6 286.1
0-19 20-44 45-64 65-74 75+
0.2 11.0 26.3 25.7 7.7
0.2 23.4 88.2 109.6 43.6
0.3 32.8 171.1 269.3 122.2
0.2 36.8 237.3 452.7 240.4
0.2 38.5 279.8 654.2 455.4
* 37.6 283.1 680.8 478.2
0.2 36.2 277.2 666.1 497.6
* 37.3 277.5 670.1 502.4
* 38.1 278.1 671.3 514.3
0.2 39.1 279.7 662.7 520.3
0.2 42.6 285.7 677.8 535.0
0.2 41.8 277.3 651.5 528.5
0.2 41.7 279.5 630.9 518.4
0.5 43.7 281.6 627.5 520.4
Male Female
12.3 10.6
36.0 35.5
67.8 74.0
102.5 111.1
146.6 144.9
152.6 147.6
154.9 144.2
157.9 145.8
164.8 143.8
168.3 144.3
175.8 148.7
174.1 144.4
176.0 143.3
180.7 144.1
White African American Native American Asian
9.6 24.6 35.7 *
28.6 84.0 109.4 28.0
56.1 167.9 193.3 55.4
82.9 253.7 261.3 99.9
118.4 311.6 298.3 125.1
121.0 327.7 278.1 130.0
120.1 330.4 270.3 126.0
122.2 333.7 267.1 128.4
125.5 328.5 274.0 132.8
126.6 336.1 254.3 138.1
131.5 344.6 243.6 156.1
129.3 334.7 251.9 153.6
128.8 337.1 257.4 157.1
131.7 336.2 273.4 161.8
178.6 141.0
162.0 148.2
163.9 147.3
169.1 149.0
169.5 151.6
168.8 154.0
179.0 159.1
177.2 155.9
180.3 155.6
179.9 158.9
†Hispanic †Non-Hispanic All
11.4
35.8
70.9
106.9
145.7
150.0
149.5
151.7
154.1
156.1
162.1
159.1
159.4
162.2
ADJUSTED 0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
. . . 0.5 5.3 16.1 18.9 30.6 36.9 34.2 19.2 * *
* . * * 12.3 30.2 50.2 101.1 141.7 144.8 100.1 52.2 11.1
* * * 0.8 15.0 37.5 81.9 196.3 298.8 333.0 257.8 128.9 54.6
* . * * 13.4 40.7 100.5 278.0 466.7 516.2 480.8 276.3 111.1
* . . * 12.7 42.0 106.8 325.4 561.8 708.0 729.5 540.3 259.4
* * * * 12.2 40.2 104.6 326.7 590.7 736.2 751.4 565.2 284.3
* * * * 10.4 41.1 105.2 316.1 561.3 706.2 757.3 625.1 299.2
* . . * 10.6 41.3 105.1 316.3 557.9 717.0 762.3 584.6 317.2
* . * * 10.5 44.2 106.0 312.8 550.9 714.3 757.2 625.8 340.7
* . * * 10.5 43.2 108.8 311.3 556.6 688.1 765.0 644.0 328.9
* . * 0.5 10.3 47.3 118.0 313.0 559.1 701.5 771.2 668.8 360.4
* . . 0.5 11.4 47.2 112.3 300.6 532.6 666.7 755.2 674.1 370.8
* . * 0.5 11.2 46.9 114.7 301.1 525.5 658.3 730.1 646.1 381.1
1.3 * * * 10.9 50.2 121.2 297.8 515.2 655.9 735.8 646.2 387.3
0-19 20-44 45-64 65-74 75+
0.1 11.9 29.8 28.8 6.1
0.2 25.0 101.1 129.9 49.5
0.3 33.7 197.8 314.7 134.2
0.2 36.3 287.6 521.8 273.9
0.2 37.1 337.5 725.9 504.9
* 36.2 344.3 751.7 528.4
0.2 35.0 333.0 736.8 557.1
* 36.1 330.9 738.0 555.8
* 37.1 328.1 735.2 575.0
0.2 38.1 328.4 724.5 580.7
0.2 41.7 331.9 739.0 598.4
0.2 41.1 317.5 715.3 597.2
0.2 41.3 316.7 692.5 586.9
0.5 43.7 314.2 692.2 592.2
Male Female
14.3 11.6
43.2 38.5
81.3 77.8
121.7 114.8
168.3 142.1
174.1 143.4
175.1 138.5
176.2 138.4
182.0 135.0
183.5 133.9
189.4 136.5
185.4 131.0
184.5 128.3
186.9 127.7
White African American Native American Asian
10.3 34.0 60.7 *
29.6 118.9 187.6 48.0
57.5 240.1 336.7 89.3
83.8 365.1 451.1 159.9
116.6 438.3 484.3 184.4
118.6 457.4 438.3 187.1
116.7 456.1 419.9 178.4
117.5 452.6 404.8 176.2
119.7 439.5 405.7 179.2
119.7 442.8 361.0 179.9
123.4 447.5 332.3 198.5
119.9 429.2 341.2 191.5
118.0 425.6 343.2 190.7
119.6 419.6 357.6 193.5
364.0 138.0
324.5 144.2
326.7 141.7
328.4 141.7
323.4 142.8
315.4 143.5
325.2 146.9
315.7 142.1
315.3 140.0
306.4 141.5
154.0
157.3
155.0
155.3
156.0
156.1
160.3
155.2
153.4
154.1
†Hispanic †Non-Hispanic All
12.9
40.9
79.7
118.1
Table A.3 Incident rates of reported diabetic ESRD:CDC diabetic population per million population, by age, gender, race, & ethnicity UNADJUSTED 0-44 45-64 65-74 75+
1980 988 482 285 97
1985 2,208 1,579 1,090 485
1990 2,600 3,083 2,736 1,596
1995 2,719 3,934 4,205 2,574
2000 1,874 3,368 4,380 3,928
2001 1,764 3,234 4,260 3,892
2002 1,718 3,054 3,994 3,792
2003 1,762 2,966 3,848 3,602
2004 1,650 2,829 3,727 3,598
2005 1,498 2,732 3,608 3,479
2006 1,582 2,728 3,588 3,491
2007 1,565 2,536 3,369 3,326
2008 1,494 2,330 3,196 3,175
2009 1,508 2,339 3,242 3,154
Male Female
556 392
1,547 1,227
2,848 2,535
3,669 3,458
3,465 3,382
3,323 3,315
3,229 3,113
3,141 3,030
3,151 2,786
3,078 2,599
3,142 2,566
3,014 2,386
2,829 2,220
2,798 2,251
White African American Other
406 753 588
1,130 2,309 3,750
2,198 4,744 4,080
2,974 5,919 3,867
2,972 5,868 2,705
2,850 5,927 2,558
2,661 5,932 2,733
2,575 5,729 2,927
2,475 5,360 3,321
2,385 5,010 2,838
2,426 4,905 2,640
2,306 4,692 2,315
2,170 4,549 1,883
2,121 4,517 2,575
4,606 3,269
4,077 3,221
4,071 3,055
4,025 2,961
3,890 2,844
3,599 2,726
3,667 2,725
3,416 2,578
3,267 2,398
3,205 2,413
†Hispanic †Non-Hispanic All
. . 464
1,365
2,672
3,554
3,422
3,319
3,171
3,086
2,967
2,833
2,844
2,688
2,515
2,522
1,014 478 326 104
2,276 1,669 1,208 515
2,762 3,143 2,865 1,947
2,858 3,761 4,469 2,702
1,911 3,315 4,487 4,148
1,776 3,207 4,352 4,207
1,702 3,063 4,107 4,156
1,743 2,953 3,955 3,969
1,632 2,790 3,862 3,867
1,451 2,696 3,649 3,775
1,528 2,691 3,627 3,681
1,504 2,515 3,404 3,552
1,478 2,332 3,243 3,331
1,483 2,324 3,272 3,336
Male Female
536 408
1,624 1,356
2,925 2,699
3,739 3,379
3,595 3,307
3,469 3,238
3,380 3,050
3,256 2,960
3,241 2,737
3,172 2,542
3,217 2,497
3,108 2,312
2,934 2,181
2,932 2,190
White African American Other
420 709 496
1,180 2,332 3,066
2,214 4,901 4,926
3,012 5,852 4,816
2,941 6,145 3,075
2,802 6,340 2,905
2,606 6,388 3,031
2,522 6,024 3,231
2,430 5,509 3,589
2,353 5,275 3,010
2,394 5,103 2,817
2,268 4,916 2,460
2,133 4,718 2,159
2,097 4,738 2,713
4,846 3,262
4,169 3,210
4,296 3,030
4,227 2,925
4,182 2,811
3,882 2,710
3,890 2,709
3,641 2,555
3,511 2,383
3,511 2,396
3,436
3,341
3,197
3,090
2,970
2,833
2,838
2,685
2,539
2,541
ADJUSTED 0-44 45-64 65-74 75+
†Hispanic †Non-Hispanic All
472
1,484
2,808
3,554
Table A.5 Incident rates of reported ESRD, 2007-2009 combined per million population, by age & primary diagnosis
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+ 0-19 20-44 45-64 65-74 75+
Unadjusted rates Male White Af Am N Am 13 16 22 6 7 * 13 16 * 29 43 24 50 160 66 109 552 244 221 1,070 568 471 2,116 958 784 3,007 1,523 1,116 3,710 1,849 1,657 4,180 2,058 2,199 4,230 1,834 1,894 3,939 1,507
Asian 25 24 35 53 91 148 329 704 1,255 1,625 2,110 2,867 2,532
Hisp. 13 7 22 53 80 151 385 1,045 1,742 2,227 2,636 2,655 1,918
15 21 18 34 22 100 444 207 147 145 470 1,963 948 704 945 1,270 3,900 1,895 1,756 2,364 1,988 4,171 1,943 2,556 2,532
Female White Af Am 8 6 6 4 13 12 22 40 40 162 75 370 143 661 308 1,340 568 2,255 728 2,987 975 3,319 1,056 3,218 638 2,404
N Am * * 30 35 64 232 392 789 1,298 1,836 1,938 1,742 607
Asian 9 15 29 53 72 106 193 430 737 975 1,377 1,832 1,405
Hisp. 7 9 20 47 70 116 257 685 1,329 1,562 1,852 1,773 1,054
12 16 18 25 19 70 321 177 104 112 321 1,311 763 423 663 813 3,114 1,931 1,075 1,670 911 3,063 1,426 1,616 1,626
Rates adjusted for: Gender White Af Am N Am 11 11 12 6 6 * 13 14 26 25 42 29 45 163 66 91 459 239 180 862 478 393 1,755 886 674 2,627 1,406 919 3,342 1,848 1,324 3,749 2,001 1,619 3,716 1,781 1,256 3,162 1,037
Asian 17 20 32 53 81 126 262 574 993 1,293 1,769 2,341 1,964
Hisp. 10 8 21 50 75 134 326 892 1,536 1,889 2,250 2,210 1,472
Race Gender Male Female & race 14 8 11 7 6 6 14 14 14 32 26 29 67 58 62 170 117 142 341 215 276 715 462 585 1,107 807 953 1,489 1,050 1,265 2,036 1,318 1,671 2,494 1,385 1,931 2,188 907 1,537
14 18 18 30 22 17 13 84 397 207 125 133 152 106 418 1,779 927 614 931 733 495 1,055 3,524 1,932 1,427 2,032 1,671 1,152 1,444 3,557 1,602 2,094 2,002 2,301 1,225
15 128 611 1,407 1,754
Diabetes Hypertension GN
149 91 26
341 324 53
261 51 31
188 94 41
192 69 22
111 61 15
331 244 36
261 41 22
129 65 31
165 50 16
119 69 19
425 364 50
347 69 31
192 101 38
312 107 24
306 274 42
213 151 23
258 211 32
Other cause
84
133
54
68
49
59
112
47
54
41
67
147
64
69
65
156
89
122
351 852 355 1,168
397 558
391 505
332 611
246 213
723 831
371 474
279 315
272 423
298 274
784 986
384 512
333 400
303 508
418 448
315 282
365 354
All All (age adjusted)
Table A.7 Incidence of reported ESRD, by primary diagnosis, 2005-2009 combined by detailed primary diagnosis
ROW PERCENT All ESRD, (reference) Diabetes Diabetes with renal manifestations, Type 2 Diabetes with renal manifestations, Type 1 Glomerulonephritis Glomerulonephritis (GN; histologically not examined) Focal glomerulosclerosis, focal sclerosing GN Membranous nephropathy Membranoproliferative GN type 1, diffuse MPGN Dense deposit disease, MPGN type 2 IgA nephropathy, Berger's (by immunofluorescence) IgM nephropathy (by immunofluorescence) With lesion of rapidly progressive GN Post-infectious GN, SBE Other proliferative GN Secondary GN/vasculitis Lupus erythematosus (SLE nephritis) Henoch-Schonlein syndrome Scleroderma Hemolytic uremic syndrome Polyarteritis Wegener's granulomatosis Nephropathy due to heroin abuse and related drugs Other vasculitis and its derivatives Goodpasture's syndrome Secondary GN, other Interstitial nephritis/pyelonephritis Analgesic abuse Radiation nephritis Lead nephropathy Nephropathy caused by other agents Gouty nephropathy Nephrolithiasis Acquired obstructive uropathy Chronic pyelonephritis, reflux nephropathy Chronic interstitial nephritis Acute interstitial nephritis Urolithiasis Other disorders of calcium metabolism Hypertensive/large vessel disease Unspecified with renal failure Renal artery stenosis Renal artery occlusion Cholesterol emboli, renal emboli Cystic/heriditary/congenital diseases Polycystic kidneys, adult type (dominant) Polycystic, infantile (recessive) Medullary cystic disease, including nephronophthisis Tuberous sclerosis Hereditary nephritis, Alport's syndrome Cystinosis Primary oxalosis Fabry's disease Congenital nephrotic syndrome Drash syndrome, mesangial sclerosis Congenital obstruction of ureterpelvic junction Congenital obstruction of uretrovesical junction Other congenital obstructive uropathy Renal hypoplasia, dysplasia, oligonephronia Prune belly syndrome Other (congenital malformation syndromes)
Total % patients inc . 558,639 100.0 246,596 44.6 223,273 40.3 23,323 4.2 38,206 6.9 13,716 2.5 12,105 2.2 2,389 0.4 1,603 0.3 147 0.0 4,627 0.8 331 0.1 1,194 0.2 571 0.1 1,523 0.3 11,737 2.1 5,613 1.0 118 0.0 620 0.1 705 0.1 287 0.1 1,723 0.3 206 0.0 1,237 0.2 634 0.1 594 0.1 17,218 3.1 906 0.2 242 0.0 24 0.0 2,650 0.5 216 0.0 926 0.2 5,130 0.9 1,661 0.3 3,740 0.7 1,329 0.2 223 0.0 171 0.0 153,897 27.8 144,101 26.0 6,288 1.1 1,177 0.2 2,331 0.4 17,937 3.2 12,652 2.3 256 0.0 268 0.0 193 0.0 811 0.1 95 0.0 55 0.0 95 0.0 312 0.1 83 0.0 200 0.0 141 0.0 1,094 0.2 1,025 0.2 123 0.0 534 0.1
Median age 64 63 64 51 54 58 51 58 54 46 44 45 63 59 57 48 38 43 56 45 68 64 46 65 58 57 65 66 67 62 63 63 64 70 46 65 65 61 61 70 69 76 74 75 51 54 17 29 60 35 15 41 45 32 59 33 26 24 13 11 29
Age 0-19 20-64 65+ 1.2 50.4 48.4 0.0 53.5 46.4 0.0 51.0 49.0 0.1 78.0 21.8 3.9 66.2 29.9 2.0 59.9 38.1 6.5 69.9 23.6 1.6 61.2 37.2 4.6 70.0 25.4 15.6 64.0 20.4 2.9 83.4 13.8 3.9 74.3 21.8 3.7 49.6 46.7 3.3 59.7 37.0 5.3 59.8 34.9 6.2 69.5 24.3 7.0 86.0 7.0 19.5 55.9 24.6 0.8 68.9 30.3 20.0 60.6 19.4 5.2 38.3 56.4 3.0 47.8 49.2 0.0 95.6 4.4 4.4 43.6 52.1 4.4 58.7 36.9 3.0 61.5 35.5 2.1 47.3 50.6 0.3 46.3 53.4 0.8 44.2 55.0 0.0 62.5 37.5 1.3 53.3 45.4 0.5 53.2 46.3 1.3 49.9 48.8 0.8 36.9 62.3 11.9 63.9 24.1 1.7 47.8 50.4 0.2 47.9 51.9 0.4 58.3 41.3 1.8 56.7 41.5 0.2 39.1 60.7 0.2 40.6 59.2 0.1 15.5 84.4 0.5 23.7 75.8 0.1 14.6 85.3 12.5 68.0 19.5 0.3 76.6 23.1 54.7 40.6 4.7 36.6 50.4 13.1 4.1 53.4 42.5 17.4 74.2 8.4 68.4 23.2 8.4 32.7 54.6 12.7 0.0 90.5 9.5 38.8 49.0 12.2 24.1 36.1 39.8 30.5 56.0 13.5 33.3 58.2 8.5 43.3 43.6 13.1 74.0 21.1 4.9 74.8 22.8 2.4 29.2 61.2 9.6
% Percent male White Af Am 56.1 65.6 28.3 54.1 65.5 27.6 54.0 65.0 27.9 55.1 69.9 25.1 61.4 66.9 24.5 61.2 67.5 22.8 61.1 58.4 36.5 64.5 67.0 28.8 59.8 73.7 18.7 52.4 82.3 10.2 67.5 75.0 6.3 60.1 72.5 12.7 51.2 82.4 12.8 65.5 79.9 13.7 52.3 77.3 17.2 33.6 63.4 30.5 18.2 42.0 49.5 65.3 87.3 5.1 23.1 76.9 19.7 37.9 78.0 18.2 43.6 84.7 8.4 54.4 91.2 5.5 74.3 52.9 44.7 45.9 84.2 11.1 46.2 89.1 7.6 59.4 71.0 24.6 58.3 82.5 13.0 44.7 84.1 11.8 48.8 87.2 10.7 75.0 45.8 45.8 55.5 83.1 13.5 72.2 53.7 19.4 53.8 82.6 9.1 77.0 83.1 14.0 42.3 85.9 7.6 48.9 81.5 13.8 49.8 82.2 15.0 60.5 79.4 11.7 52.0 80.1 15.8 57.6 59.5 36.2 57.8 57.3 38.1 51.5 89.8 8.0 55.6 88.4 9.3 64.0 93.0 4.9 57.0 80.0 13.6 54.2 80.8 13.5 53.5 75.8 15.6 46.6 81.7 8.2 42.5 82.4 16.1 65.7 84.1 9.5 46.3 90.5 3.2 60.0 74.5 12.7 84.2 83.2 10.5 56.1 68.9 23.7 65.1 84.3 13.3 65.0 78.5 16.0 74.5 77.3 14.2 75.1 76.7 15.5 61.3 73.5 14.6 96.7 75.6 13.8 56.9 81.1 12.0
N Am 1.2 1.8 1.8 1.3 1.2 1.2 0.9 0.7 1.3 1.4 1.9 1.8 1.3 2.5 1.3 1.2 1.2 0.0 1.0 0.6 2.4 1.2 1.5 1.6 0.8 1.0 0.6 0.8 0.4 0.0 0.5 0.5 0.5 0.8 0.9 0.4 0.4 0.0 0.0 0.5 0.5 0.4 0.7 0.3 0.7 0.5 0.8 1.1 0.0 0.6 1.1 1.8 0.0 1.0 0.0 1.5 2.1 1.7 1.9 1.6 1.5
% Tx % Died Asian 1st yr 1st yr 4.5 4.9 22.8 4.8 2.6 21.2 5.0 1.7 21.8 3.5 11.6 16.0 7.0 14.6 10.9 7.9 8.8 14.2 3.9 16.7 7.7 3.1 10.1 11.6 5.9 17.0 12.5 5.4 24.5 9.5 16.4 30.8 4.3 12.4 30.2 5.1 2.9 4.4 19.5 3.7 7.0 21.0 4.0 10.4 15.7 4.7 7.4 16.9 6.9 9.2 11.2 7.6 27.1 11.9 2.3 1.9 36.6 2.8 9.8 16.6 4.2 4.5 22.0 2.0 6.3 20.9 0.5 0.5 19.4 2.7 4.8 23.6 2.5 4.3 18.1 3.4 5.7 21.2 3.6 7.6 23.3 3.1 5.6 21.1 1.7 4.1 33.1 8.3 8.3 12.5 2.6 7.6 26.2 24.1 8.8 21.8 7.5 7.5 18.3 1.9 2.1 28.4 5.1 25.3 10.6 4.1 9.6 20.6 2.2 2.0 26.6 8.1 7.2 15.7 4.1 13.5 20.5 3.7 2.2 25.1 3.8 2.3 24.7 1.7 1.3 31.9 1.7 1.2 34.1 1.8 0.6 31.4 5.3 29.1 5.8 5.0 26.1 5.3 7.0 43.8 9.4 9.0 53.7 5.2 1.6 6.7 22.3 5.3 37.7 2.1 5.3 65.3 3.2 9.1 34.5 9.1 6.3 34.7 3.2 5.4 33.0 11.2 1.2 13.3 22.9 2.5 22.5 8.5 5.7 39.7 5.0 5.2 29.7 9.0 8.4 42.0 4.4 8.1 47.2 4.9 5.2 36.1 6.4
Table A.7 Incidence of reported ESRD, by primary diagnosis, 2005-2009 combined by detailed primary diagnosis
ROW PERCENT Neoplasms/tumors Renal tumor (malignant) Urinary tract tumor (malignant) Renal tumor (benign) Urinary tract tumor (benign) Renal tumor (unspecified) Urinary tract tumor (unspecified) Lymphoma of kidneys Multiple myeloma Other immuno prolif. neoplasms (inc. light chain neph.) Amyloidosis Complications of transplanted organ, unspecified Complications of transplanted kidney Complications of transplanted liver Complications of transplanted heart Complications of transplanted lung Complications of transplanted bone marrow Complications of transplanted pancreas Complications of transplanted intestine Complications of other specified transplanted organ Miscellaneous conditions Sickle cell disease/anemia Sickle cell trait and other sickle cell (HbS/Hb other) Post-partum renal failure AIDS nephropathy Traumatic or surgical loss of kidney(s) Hepatorenal syndrome Tubular necrosis (no recovery) Other renal disorders Etiology uncertain Missing
Total patients 13,522 2,191 727 83 46 259 151 190 5,700 710 1,336 41 135 882 712 197 102 21 * 30 31,456 495 27 110 4,009 608 2,676 15,886 7,645 22,778 5,292
% inc . 2.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.0 0.7 0.1 0.5 2.9 1.4 4.1 1.0
Median age 67 69 73 71 69 71 72 66 69 68 66 57 51 58 62 57 45 58 55 55 62 43 51 30 44 65 56 68 66 66 61
Age 0-19 20-64 65+ 1.0 41.8 57.2 1.4 34.1 64.5 0.0 25.5 74.6 2.4 26.5 71.1 0.0 41.3 58.7 1.2 30.9 68.0 0.0 29.1 70.9 1.1 45.8 53.2 0.1 37.3 62.6 0.3 40.7 59.0 0.2 46.9 52.8 9.8 58.5 31.7 6.7 74.8 18.5 2.3 73.5 24.3 4.2 55.5 40.3 1.0 76.1 22.8 18.6 69.6 11.8 4.8 76.2 19.0 0.0 66.7 33.3 23.3 50.0 26.7 1.4 53.2 45.5 3.4 92.7 3.8 3.7 85.2 11.1 10.0 89.1 0.9 0.9 95.7 3.4 2.5 45.6 52.0 0.2 77.8 22.0 0.8 41.4 57.8 2.7 44.2 53.1 2.8 44.5 52.7 4.3 54.0 41.6
% Percent male White Af Am 63.5 80.1 16.9 72.1 82.8 14.9 84.6 84.5 13.1 61.4 88.0 9.6 84.8 87.0 13.0 66.4 77.6 18.5 74.8 84.8 12.6 71.6 85.3 12.1 57.4 76.1 21.3 61.3 81.8 15.2 57.9 82.0 14.8 61.0 82.9 7.3 58.5 69.6 12.6 61.2 87.3 8.4 76.4 80.8 15.4 52.8 90.9 6.6 62.7 84.3 12.7 47.6 71.4 14.3 44.4 100.0 0.0 80.0 76.7 6.7 60.3 70.6 26.1 54.5 4.0 95.4 44.4 3.7 96.3 3.6 61.8 33.6 66.2 12.0 86.8 65.8 82.1 14.8 66.0 82.7 11.8 58.0 81.8 15.5 77.7 17.5 61.0 58.5 72.7 21.3 57.7 41.2 21.8
N Am 0.7 0.9 0.7 0.0 0.0 0.8 0.7 0.5 0.6 1.0 0.5 0.0 1.5 1.0 1.0 0.0 0.0 4.8 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.5 2.1 0.6 0.6 0.8 1.9
% Tx % Died Asian 1st yr 1st yr 2.2 3.5 43.8 1.3 1.4 30.4 1.8 0.4 51.3 2.4 4.8 18.1 0.0 2.2 19.6 2.7 5.0 30.5 1.3 0.7 43.0 1.1 0.5 51.1 1.8 0.1 56.6 1.8 1.0 39.9 2.5 3.2 40.3 9.8 22.0 7.3 16.3 28.9 13.3 3.2 18.1 26.1 2.8 13.2 28.9 2.5 16.8 32.0 2.9 14.7 39.2 9.5 9.5 28.6 0.0 22.2 33.3 16.7 26.7 30.0 2.3 4.4 35.8 0.4 2.2 28.7 0.0 0.0 18.5 4.5 8.2 5.5 0.4 0.3 27.9 2.1 4.8 23.2 3.3 19.0 59.6 1.9 0.7 36.9 4.0 9.2 31.5 5.0 5.7 28.3 8.0 28.2 28.5
Table A.7 (continued) Incidence of reported ESRD, by primary diagnosis, 2005-2009 combined by detailed primary diagnosis
COLUMN PERCENT All ESRD, (reference) Diabetes Diabetes with renal manifestations, Type 2 Diabetes with renal manifestations, Type 1 Glomerulonephritis Glomerulonephritis (GN; histologically not examined) Focal glomerulosclerosis, focal sclerosing GN Membranous nephropathy Membranoproliferative GN type 1, diffuse MPGN Dense deposit disease, MPGN type 2 IgA nephropathy, Berger's (by immunofluorescence) IgM nephropathy (by immunofluorescence) With lesion of rapidly progressive GN Post-infectious GN, SBE Other proliferative GN Secondary GN/vasculitis Lupus erythematosus (SLE nephritis) Henoch-Schonlein syndrome Scleroderma Hemolytic uremic syndrome Polyarteritis Wegener's granulomatosis Nephropathy due to heroin abuse and related drugs Other vasculitis and its derivatives Goodpasture's syndrome Secondary GN, other Interstitial nephritis/pyelonephritis Analgesic abuse Radiation nephritis Lead nephropathy Nephropathy caused by other agents Gouty nephropathy Nephrolithiasis Acquired obstructive uropathy Chronic pyelonephritis, reflux nephropathy Chronic interstitial nephritis Acute interstitial nephritis Urolithiasis Other disorders of calcium metabolism Hypertensive/large vessel disease Unspecified with renal failure Renal artery stenosis Renal artery occlusion Cholesterol emboli, renal emboli Cystic/heriditary/congenital diseases Polycystic kidneys, adult type (dominant) Polycystic, infantile (recessive) Medullary cystic disease, including nephronophthisis Tuberous sclerosis Hereditary nephritis, Alport's syndrome Cystinosis Primary oxalosis Fabry's disease Congenital nephrotic syndrome Drash syndrome, mesangial sclerosis Congenital obstruction of ureterpelvic junction Congenital obstruction of uretrovesical junction Other congenital obstructive uropathy Renal hypoplasia, dysplasia, oligonephronia Prune belly syndrome Other (congenital malformation syndromes)
Total Counts patients White 558,639 366,370 246,596 161,532 223,273 145,219 23,323 16,313 38,206 25,558 13,716 9,261 12,105 7,066 2,389 1,601 1,603 1,182 147 121 4,627 3,470 331 240 1,194 984 571 456 1,523 1,177 11,737 7,438 5,613 2,356 118 103 620 477 705 550 287 243 1,723 1,571 206 109 1,237 1,042 634 565 594 422 17,218 14,209 906 762 242 211 24 11 2,650 2,203 216 116 926 765 5,130 4,261 1,661 1,426 3,740 3,047 1,329 1,093 223 177 171 137 153,897 91,495 144,101 82,640 6,288 5,648 1,177 1,040 2,331 2,167 17,937 14,353 12,652 10,224 256 194 268 219 193 159 811 682 95 86 55 41 95 79 312 215 83 70 200 157 141 109 1,094 839 1,025 753 123 93 534 433
Af Am 157,905 68,130 62,284 5,846 9,368 3,125 4,413 687 300 15 293 42 153 78 262 3,578 2,780 * 122 128 24 95 92 137 48 146 2,240 107 26 11 358 42 84 717 126 516 200 26 27 55,662 54,935 503 109 115 2,431 1,703 40 22 31 77 * * * 74 11 32 20 170 150 17 64
N Am 6,493 4,333 4,025 308 451 160 108 17 21 * 87 * 16 14 20 136 65 . * * * 20 * 20 * * 103 * * . 14 * * 39 15 16 * . . 753 714 25 * * 134 65 * * . * * * . * . * * 19 19 * *
Asian 24,908 11,877 11,067 810 2,658 1,089 476 75 95 * 757 41 35 21 61 549 388 * 14 20 12 35 * 34 16 20 613 28 * * 68 52 69 97 85 154 29 18 * 5,672 5,502 108 20 42 953 637 18 24 * 43 * * * 17 * * * 57 86 * 28
Percent White 100.0 44.4 39.9 4.5 7.0 2.5 1.9 0.4 0.3 0.0 1.0 0.1 0.3 0.1 0.3 2.0 0.6 0.0 0.1 0.2 0.1 0.4 0.0 0.3 0.2 0.1 3.9 0.2 0.1 0.0 0.6 0.0 0.2 1.2 0.4 0.8 0.3 0.0 0.0 25.1 22.7 1.6 0.3 0.6 3.9 2.8 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.1
Af Am 100.0 43.5 39.7 3.7 6.0 2.0 2.8 0.4 0.2 0.0 0.2 0.0 0.1 0.0 0.2 2.3 1.8 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 1.4 0.1 0.0 0.0 0.2 0.0 0.1 0.5 0.1 0.3 0.1 0.0 0.0 35.5 35.0 0.3 0.1 0.1 1.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0
N Am 100.0 67.8 63.0 4.8 7.1 2.5 1.7 0.3 0.3 0.0 1.4 0.1 0.3 0.2 0.3 2.1 1.0 0.0 0.1 0.1 0.1 0.3 0.0 0.3 0.1 0.1 1.6 0.1 0.0 0.0 0.2 0.0 0.1 0.6 0.2 0.3 0.1 0.0 0.0 11.8 11.2 0.4 0.1 0.1 2.1 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1
Asian 100.0 48.5 45.2 3.3 10.9 4.4 1.9 0.3 0.4 0.0 3.1 0.2 0.1 0.1 0.2 2.2 1.6 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 2.5 0.1 0.0 0.0 0.3 0.2 0.3 0.4 0.3 0.6 0.1 0.1 0.0 23.2 22.5 0.4 0.1 0.2 3.9 2.6 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.1
Table A.7 (continued) Incidence of reported ESRD, by primary diagnosis, 2005-2009 combined by detailed primary diagnosis
COLUMN PERCENT Neoplasms/tumors Renal tumor (malignant) Urinary tract tumor (malignant) Renal tumor (benign) Urinary tract tumor (benign) Renal tumor (unspecified) Urinary tract tumor (unspecified) Lymphoma of kidneys Multiple myeloma Other immuno prolif. neoplasms (inc. light chain neph.) Amyloidosis Complications of transplanted organ, unspecified Complications of transplanted kidney Complications of transplanted liver Complications of transplanted heart Complications of transplanted lung Complications of transplanted bone marrow Complications of transplanted pancreas Complications of transplanted intestine Complications of other specified transplanted organ Miscellaneous conditions Sickle cell disease/anemia Sickle cell trait and other sickle cell (HbS/Hb other) Post-partum renal failure AIDS nephropathy Traumatic or surgical loss of kidney(s) Hepatorenal syndrome Tubular necrosis (no recovery) Other renal disorders Etiology uncertain Missing
Total Counts patients White 13,522 10,834 2,191 1,815 727 614 83 73 46 40 259 201 151 128 190 162 5,700 4,339 710 581 1,336 1,096 41 34 135 94 882 770 712 575 197 179 102 86 21 15 * * 30 23 31,456 22,217 495 20 27 * 110 68 4,009 482 608 499 2,676 2,212 15,886 12,994 7,645 5,941 22,778 16,556 5,292 2,178
Af Am 2,280 326 95 * * 48 19 23 1,214 108 198 * 17 74 110 13 13 * . * 8,219 472 26 37 3,479 90 315 2,463 1,337 4,845 1,152
N Am 93 19 * . . * * * 32 * * . * * * . . * . . 213 . . . 12 * 56 94 48 177 100
Asian 293 28 13 * . * * * 104 13 33 * 22 28 20 * * * . * 727 * . * 15 13 87 300 305 1,141 425
Percent White 3.0 0.5 0.2 0.0 0.0 0.1 0.0 0.0 1.2 0.2 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.1 0.1 0.6 3.6 1.6 4.5 0.6
Af Am 1.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.2 0.3 0.0 0.0 2.2 0.1 0.2 1.6 0.9 3.1 0.7
N Am 1.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.2 0.0 0.9 1.5 0.8 2.8 1.6
Asian 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.1 0.1 0.4 1.2 1.2 4.7 1.7
7DEOH% Point prevalent counts of reported ESRD: all patients patients alive on December 31 of each year, by age, gender, race, ethnicity, & primary diagnosis
8QNQRZQ 8QNQRZQ 0DOH )HPDOH 8QNQRZQ :KLWH $IULFDQ$PHULFDQ 1DWLYH$PHULFDQ $VLDQ 2WKHUXQNQRZQ +LVSDQLF 1RQ+LVSDQLF 'LDEHWHV +\SHUWHQVLRQ *ORPHUXORQHSKULWLV &\VWLFNLGQH\ 2WKHUXURORJLF 2WKHUFDXVH 8QNQRZQFDXVH 0LVVLQJGLVHDVH 86 86WHUULWRULHV 3XHUWR5LFR )RUHLJQ 8QNQRZQ $OO 7RWDOORVWWRIROORZXS 5HFRYHU\RIUHQDOIXQFWLRQ
$OOZLWKORVWWRIROORZXS UHFRYHU\RIUHQDOIXQFWLRQ
7DEOH%FRQWLQXHG Point prevalent counts of reported ESRD patients: U.S. only, with unknowns dropped patients alive on December 31 of each year, by age, gender, race, ethnicity, & primary diagnosis
0DOH )HPDOH :KLWH $IULFDQ$PHULFDQ 1DWLYH$PHULFDQ $VLDQ +LVSDQLF 1RQ+LVSDQLF 'LDEHWHV +\SHUWHQVLRQ *ORPHUXORQHSKULWLV &\VWLFNLGQH\ 2WKHUXURORJLF 2WKHUFDXVH 8QNQRZQFDXVH 0LVVLQJGLVHDVH $OO 3DWLHQWVGURSSHG
Table B.2 Point prevalent rates of reported ESRD patients alive on December 31 of each year, per million population, by age, gender, race, ethnicity, & primary diagnosis UNADJUSTED 0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1985 15.3 24.7 50.3 103.8 244.0 471.4 677.6 960.1 1,135.6 1,145.2 1,049.0 643.5 264.7
0-19 20-44 45-64 65-74 75+
49.5 62.2 70.9 77.9 79.2 80.9 82.1 83.9 85.2 86.0 87.0 86.9 87.8 389.5 566.4 738.9 842.6 853.1 860.6 867.6 875.7 886.7 900.2 910.5 918.8 927.1 951.4 1,441.2 2,007.6 2,473.1 2,549.9 2,618.3 2,683.5 2,746.0 2,814.5 2,892.4 2,967.4 3,048.1 3,130.5 1,130.9 1,956.9 3,075.6 4,155.8 4,360.5 4,522.8 4,665.9 4,811.5 4,925.8 5,095.8 5,209.5 5,301.4 5,401.9 707.9 1,374.0 2,303.8 3,375.8 3,550.0 3,746.1 3,903.2 4,040.6 4,182.0 4,297.4 4,417.7 4,549.3 4,718.8
Male Female White African American Native American Asian
520.2 408.2
1990 17.6 38.1 65.2 132.8 332.5 648.9 973.9 1,483.1 1,827.2 1,968.1 1,853.8 1,368.1 659.7
1995 20.3 40.3 77.3 149.6 404.0 814.3 1,332.0 2,060.0 2,804.0 3,039.2 3,007.5 2,346.5 1,228.8
2000 23.8 42.5 84.3 158.3 422.9 945.8 1,568.4 2,523.4 3,583.5 4,139.2 4,123.7 3,506.3 2,032.0
2001 23.7 44.1 84.7 161.5 419.2 962.0 1,598.3 2,617.9 3,692.0 4,350.3 4,305.0 3,713.8 2,204.1
2002 23.0 45.8 88.3 163.0 412.0 981.5 1,627.5 2,690.1 3,791.1 4,478.1 4,504.8 3,952.7 2,367.0
2003 22.3 47.3 86.0 169.5 406.4 998.5 1,657.2 2,758.7 3,876.1 4,591.5 4,668.5 4,134.9 2,539.9
2004 24.1 48.4 85.8 173.4 404.2 1,009.9 1,693.8 2,826.5 3,953.9 4,704.8 4,834.2 4,271.5 2,705.7
2005 24.7 49.0 85.8 176.8 404.6 1,027.6 1,726.4 2,910.7 4,043.8 4,798.8 4,984.6 4,425.8 2,851.2
2006 24.0 48.3 88.2 178.8 407.1 1,042.8 1,783.6 2,986.6 4,113.4 4,946.1 5,162.4 4,532.0 2,981.4
2007 26.2 47.1 87.7 182.8 411.5 1,049.7 1,829.4 3,053.2 4,204.2 5,039.9 5,319.4 4,659.4 3,078.9
2008 26.7 46.9 90.5 180.7 418.0 1,054.3 1,881.0 3,111.3 4,326.4 5,104.8 5,464.4 4,806.2 3,212.3
2009 30.9 47.6 90.8 180.2 421.4 1,059.6 1,939.0 3,162.6 4,457.9 5,207.0 5,622.2 4,987.2 3,352.2
803.8 1,157.9 1,505.6 1,569.0 1,632.6 1,687.9 1,747.0 1,808.2 1,877.2 1,940.5 2,005.1 2,072.3 654.4 952.8 1,208.1 1,251.1 1,288.8 1,326.9 1,361.0 1,396.9 1,435.8 1,473.9 1,512.4 1,555.6
367.4 563.7 794.9 1,024.6 1,155.2 1,853.2 2,714.6 3,413.8 619.6 1,038.8 1,523.1 1,798.1 314.5 585.6 981.5 1,260.5
†Hispanic †Non-Hispanic
1,067.8 3,519.0 1,863.3 1,315.1
1,106.6 3,635.2 1,894.3 1,368.3
1,142.3 3,743.3 1,913.7 1,418.0
1,181.8 3,822.1 1,959.8 1,467.3
1,220.6 3,919.3 1,990.8 1,519.5
1,262.5 4,027.3 2,025.9 1,598.1
1,299.8 4,134.9 2,076.7 1,680.4
1,337.4 4,246.6 2,099.9 1,766.8
1,378.8 4,357.2 2,147.1 1,859.8
1,167.1 1,209.8 1,256.6 1,300.8 1,343.7 1,387.6 1,446.8 1,508.8 1,567.1 1,622.5 1,381.6 1,437.2 1,489.2 1,537.2 1,585.3 1,635.5 1,689.4 1,739.0 1,790.2 1,846.2
Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing disease
85.9 105.8 110.3 28.5 17.2 59.6 29.9 25.5
186.9 188.2 158.1 39.7 24.3 85.5 32.6 12.0
330.6 276.3 204.0 51.8 31.0 113.7 37.6 8.2
479.7 334.4 238.7 63.0 41.1 139.3 48.5 9.4
505.6 346.5 243.4 65.1 42.6 143.5 50.9 9.7
528.3 358.8 248.0 67.3 44.1 148.2 53.0 10.1
548.8 372.1 251.3 69.6 45.2 152.2 54.8 10.4
570.1 383.2 255.6 71.8 45.9 157.2 56.3 10.7
590.9 393.7 258.8 74.7 44.8 166.1 59.4 11.2
614.7 404.9 261.7 77.9 43.7 176.1 62.8 11.6
636.8 418.3 263.7 80.8 42.4 184.8 65.3 11.8
659.3 432.6 266.4 84.2 41.9 192.1 66.9 12.1
682.7 449.2 268.9 87.2 41.6 199.2 67.9 14.0
All
462.7
727.2 1,053.1 1,354.1 1,407.2 1,457.7 1,504.4 1,550.9 1,599.4 1,653.3 1,703.9 1,755.4 1,810.6
Table B.2 (continued) Point prevalent rates of reported ESRD patients alive on December 31 of each year, per million population, by age, gender, race, ethnicity, & primary diagnosis ADJUSTED 0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1985 14.9 24.5 49.9 102.3 242.6 490.1 736.2 1,067.3 1,316.5 1,327.4 1,223.4 825.8 374.0
0-19 20-44 45-64 65-74 75+
47.9 62.4 70.7 75.9 77.1 78.6 79.9 81.5 82.5 83.3 84.4 84.9 86.2 423.3 585.9 732.4 818.0 829.1 838.0 846.5 856.3 869.5 885.3 898.7 910.9 924.1 1,068.2 1,645.2 2,340.5 2,861.4 2,943.9 3,009.9 3,069.7 3,123.3 3,184.4 3,247.7 3,305.6 3,368.9 3,432.9 1,313.2 2,314.8 3,643.1 4,743.5 4,941.9 5,108.7 5,253.3 5,397.8 5,507.0 5,690.9 5,828.3 5,945.0 6,066.0 782.5 1,604.8 2,773.6 4,035.6 4,232.8 4,460.8 4,647.5 4,779.9 4,933.2 5,062.6 5,203.0 5,352.8 5,545.4
Male Female White African American Native American Asian
618.8 436.1
1990 17.3 37.3 64.5 130.7 326.9 665.4 1,061.3 1,651.7 2,099.4 2,305.1 2,219.1 1,756.8 943.8
1995 19.9 39.9 76.2 146.8 394.7 820.1 1,417.0 2,304.2 3,152.0 3,505.9 3,652.4 3,043.5 1,752.9
2000 23.5 41.9 83.1 155.0 416.1 938.5 1,625.5 2,803.8 3,967.9 4,645.1 4,858.4 4,410.5 2,821.5
2001 23.5 43.6 83.1 158.3 414.6 954.5 1,649.3 2,894.0 4,096.1 4,852.9 5,025.8 4,611.4 3,066.2
2002 22.8 45.5 86.5 159.8 408.3 973.6 1,672.6 2,949.9 4,220.9 4,979.1 5,225.2 4,897.5 3,272.8
2003 22.0 46.9 84.7 166.0 402.1 989.6 1,696.0 3,004.2 4,327.7 5,100.8 5,377.5 5,098.0 3,495.2
2004 23.8 48.0 84.5 169.5 398.4 999.2 1,725.9 3,061.1 4,405.7 5,223.8 5,523.8 5,190.0 3,674.0
2005 24.4 48.6 84.7 172.5 397.0 1,014.3 1,751.0 3,131.4 4,498.1 5,330.3 5,654.9 5,317.6 3,855.9
2006 23.7 48.0 87.0 174.3 397.6 1,025.9 1,802.1 3,195.8 4,574.5 5,502.5 5,817.9 5,408.3 4,022.8
2007 25.6 46.5 87.0 178.5 400.3 1,030.5 1,842.1 3,252.3 4,665.2 5,624.1 5,976.3 5,533.1 4,155.9
2008 26.4 46.0 89.7 177.3 405.9 1,034.2 1,888.6 3,300.8 4,770.9 5,709.7 6,124.2 5,681.2 4,309.1
2009 30.6 46.8 90.0 177.5 409.0 1,039.4 1,942.5 3,341.4 4,887.4 5,828.8 6,296.5 5,873.4 4,472.9
949.4 1,343.8 1,691.1 1,750.0 1,805.7 1,850.7 1,897.5 1,945.2 1,999.7 2,045.5 2,091.4 2,140.3 685.7 975.6 1,190.7 1,222.7 1,247.4 1,272.2 1,292.8 1,314.6 1,338.7 1,360.4 1,381.8 1,407.5
383.8 579.1 803.6 1,013.4 1,594.7 2,546.1 3,704.9 4,512.9 960.8 1,661.1 2,447.3 2,748.6 417.2 808.6 1,349.5 1,648.4
†Hispanic †Non-Hispanic
1,050.7 4,613.5 2,787.5 1,694.0
1,081.6 4,720.3 2,771.1 1,740.1
1,109.2 4,813.0 2,747.4 1,776.2
1,139.9 4,860.6 2,755.0 1,805.1
1,169.1 4,929.7 2,732.1 1,840.1
1,200.3 5,015.8 2,725.8 1,900.8
1,225.3 5,103.8 2,738.2 1,962.4
1,250.2 5,193.8 2,724.2 2,029.1
1,278.7 5,283.7 2,735.5 2,101.1
2,069.8 2,121.7 2,179.2 2,224.0 2,265.6 2,306.4 2,367.9 2,432.5 2,488.8 2,538.5 1,359.7 1,404.5 1,443.1 1,477.7 1,511.7 1,546.8 1,584.2 1,615.9 1,648.5 1,685.3
Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing disease
98.2 127.0 120.9 33.0 18.4 62.0 33.6 28.8
210.5 217.5 170.8 45.6 25.7 88.5 36.1 13.1
365.1 306.7 216.5 57.9 32.3 117.1 40.4 8.7
508.3 353.0 246.1 66.9 42.1 141.7 50.3 9.7
530.6 362.1 249.4 68.3 43.4 145.6 52.4 9.9
547.9 370.8 252.7 69.7 44.8 149.8 54.2 10.3
562.3 380.5 254.6 71.2 45.6 153.4 55.6 10.6
577.1 387.5 257.3 72.7 46.1 157.9 56.8 10.8
590.9 393.7 258.8 74.7 44.8 166.1 59.4 11.2
606.9 400.4 260.2 77.0 43.5 175.4 62.3 11.5
620.0 408.9 260.6 79.0 42.0 183.1 64.3 11.6
633.0 418.0 261.8 81.5 41.3 189.4 65.4 11.8
646.8 429.3 262.7 83.4 40.8 195.4 66.0 13.5
All
521.8
807.9 1,144.7 1,417.9 1,461.7 1,500.1 1,533.8 1,566.1 1,599.4 1,637.1 1,669.6 1,702.0 1,737.8
Table B.3 Point prevalent rates of reported diabetic ESRD patients alive on December 31 of each year, per million population, by demographic characteristics UNADJUSTED 0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1980 0.1 0.1 0.1 0.8 11.1 37.8 42.7 56.2 66.9 56.9 31.2 9.0 2.2
1985 0.5 0.2 0.2 1.2 28.2 100.6 128.7 208.9 261.9 243.2 161.0 59.5 12.2
1990 0.8 0.2 0.3 1.4 41.0 155.4 248.1 452.9 625.1 625.5 469.9 207.7 67.5
1995 0.3 0.1 0.5 1.6 40.2 198.1 382.9 762.0 1,192.5 1,277.2 1,035.4 498.8 183.8
2000 0.4 0.2 0.2 1.4 33.8 212.5 459.9 1,018.3 1,715.0 2,020.5 1,726.6 1,028.9 412.1
2001 0.2 0.2 0.2 1.2 32.9 209.4 471.6 1,057.5 1,798.2 2,152.7 1,841.9 1,141.8 459.4
2002 0.1 0.4 0.2 1.0 30.0 208.2 480.4 1,092.1 1,850.5 2,221.4 1,951.4 1,259.9 517.4
2003 . 0.2 0.2 1.0 27.9 208.4 491.4 1,119.2 1,876.2 2,294.3 2,051.6 1,338.2 562.7
2004 . 0.1 0.2 0.8 26.8 210.6 502.2 1,146.1 1,908.6 2,357.9 2,151.2 1,418.6 633.1
2005 0.1 0.1 0.1 0.8 25.8 210.2 511.2 1,186.4 1,953.1 2,390.4 2,241.3 1,481.1 679.3
2006 0.2 0.1 0.2 0.9 25.2 212.3 532.9 1,213.0 1,980.3 2,464.2 2,333.1 1,554.7 732.8
2007 0.3 . 0.2 0.9 26.5 213.5 546.5 1,234.4 2,017.3 2,502.1 2,411.9 1,636.5 786.8
2008 0.4 . 0.3 0.9 27.8 214.3 566.6 1,253.8 2,075.7 2,517.8 2,479.3 1,718.5 834.8
2009 2.0 . 0.4 0.8 27.6 216.5 591.5 1,270.3 2,127.2 2,561.7 2,549.2 1,780.9 881.3
0-19 20-44 45-64 65-74 75+
0.3 25.4 55.7 48.0 14.4
0.5 70.7 204.2 218.0 80.4
0.7 121.9 440.8 591.6 248.4
0.6 165.2 737.6 1,227.6 582.4
0.5 180.5 991.3 1,947.3 1,105.3
0.4 181.2 1,029.3 2,074.5 1,196.7
0.4 179.8 1,062.3 2,166.0 1,289.4
0.3 179.8 1,088.3 2,255.6 1,360.4
0.3 181.6 1,113.1 2,344.0 1,431.5
0.3 182.2 1,145.0 2,407.4 1,487.6
0.4 184.6 1,177.5 2,496.9 1,544.2
0.4 186.7 1,207.7 2,546.0 1,611.8
0.4 188.7 1,242.8 2,578.0 1,671.8
0.8 190.4 1,278.7 2,612.1 1,742.7
Male Female
26.5 22.5
87.8 84.2
182.5 191.1
322.9 338.0
486.4 473.3
517.7 493.9
547.1 510.1
573.5 525.0
602.6 538.7
631.7 551.4
663.5 567.3
693.4 581.8
723.5 596.8
753.8 613.3
White African American Native American Asian
20.2 56.2 69.7 3.2
67.2 213.9 278.7 47.8
143.5 471.2 572.4 126.7
247.5 843.0 918.7 274.5
362.5 1,183.8 1,148.7 406.5
383.7 1,232.9 1,194.8 437.3
401.1 1,286.3 1,216.0 457.9
417.3 1,330.7 1,236.3 479.5
435.5 1,366.3 1,268.5 502.9
452.0 1,407.4 1,281.8 530.3
470.2 1,455.3 1,290.8 571.3
487.6 1,497.5 1,313.6 604.6
503.9 1,545.7 1,325.4 646.5
521.5 1,592.5 1,351.4 685.1
556.1 468.5
582.6 493.9
609.6 515.5
635.0 534.9
659.7 555.3
678.9 575.9
709.2 598.1
741.4 618.0
774.9 637.9
806.2 659.2
†Hispanic †Non-Hispanic All
24.4
85.9
186.9
330.6
479.7
505.6
528.3
548.8
570.1
590.9
614.7
636.8
659.3
682.7
ADJUSTED 0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
0.1 0.1 0.1 0.8 11.2 37.2 45.0 64.0 78.7 68.0 35.8 9.9 3.3
0.5 0.2 0.2 1.2 27.4 100.3 136.6 238.6 317.1 300.8 200.0 91.0 18.0
0.8 0.2 0.3 1.4 39.5 155.7 264.0 513.0 737.6 757.4 574.0 286.0 98.0
0.3 0.1 0.5 1.6 38.7 196.9 400.9 863.2 1,358.6 1,498.5 1,275.8 684.6 268.7
0.3 0.2 0.2 1.4 33.7 209.9 472.7 1,144.3 1,911.5 2,286.7 2,056.1 1,335.7 588.4
0.2 0.2 0.2 1.2 33.3 207.5 482.7 1,180.9 2,009.1 2,416.6 2,173.9 1,456.7 664.6
0.1 0.3 0.2 1.0 30.4 207.0 490.3 1,207.0 2,072.8 2,483.2 2,289.4 1,600.2 734.3
. 0.1 0.3 0.9 28.2 207.6 499.8 1,225.0 2,107.3 2,563.6 2,385.5 1,691.9 791.7
. 0.1 0.2 0.7 26.8 209.5 509.0 1,244.6 2,136.5 2,635.6 2,478.1 1,768.0 886.1
0.1 0.1 0.1 0.7 25.6 208.5 516.0 1,277.9 2,181.2 2,672.3 2,561.1 1,827.0 949.5
0.3 0.1 0.2 0.8 24.7 209.8 536.1 1,299.5 2,207.7 2,759.3 2,640.6 1,904.5 1,019.2
0.3 . 0.2 0.8 25.8 210.5 548.4 1,316.2 2,239.9 2,809.8 2,723.2 1,982.3 1,092.8
0.4 . 0.2 0.9 26.9 211.3 567.0 1,331.1 2,287.8 2,833.8 2,787.6 2,075.0 1,157.0
2.0 . 0.3 0.8 26.6 214.0 590.6 1,343.7 2,326.3 2,884.7 2,863.8 2,139.1 1,211.5
0-19 20-44 45-64 65-74 75+
0.2 27.8 63.7 55.4 14.0
0.5 75.5 236.4 265.9 92.7
0.7 123.4 516.2 719.5 283.5
0.6 159.8 889.7 1,475.8 683.9
0.5 171.5 1,193.8 2,244.9 1,277.7
0.4 172.8 1,238.6 2,369.1 1,382.5
0.4 172.4 1,270.1 2,464.6 1,489.1
0.3 173.3 1,290.6 2,554.6 1,569.7
0.3 175.9 1,309.2 2,644.0 1,652.6
0.2 177.6 1,337.3 2,705.9 1,719.7
0.3 181.4 1,360.3 2,802.1 1,786.6
0.3 184.9 1,379.2 2,862.3 1,868.9
0.4 188.6 1,404.3 2,904.7 1,943.9
0.8 192.4 1,428.5 2,946.5 2,023.3
Male Female
31.2 24.8
104.6 91.3
217.0 202.8
378.9 350.3
552.1 468.5
582.9 483.9
609.6 493.5
631.5 501.7
656.2 508.7
679.7 514.6
704.9 522.8
727.0 529.1
748.3 535.3
769.3 543.4
21.8 79.2 121.4 4.1
70.3 304.1 480.3 78.5
147.4 677.8 991.8 202.0
251.0 1,213.4 1,582.4 424.2
359.5 1,659.6 1,859.9 583.6
378.2 1,712.0 1,885.6 617.1
392.1 1,763.8 1,868.8 634.6
404.4 1,800.1 1,859.7 649.0
418.3 1,822.5 1,863.3 665.6
430.4 1,851.9 1,832.8 686.3
443.4 1,887.8 1,800.7 722.3
454.5 1,917.0 1,791.6 745.3
464.4 1,951.2 1,770.9 778.4
475.4 1,983.2 1,765.5 808.5
1,108.1 461.1
1,147.2 481.9
1,187.0 497.5
1,214.3 510.7
1,241.6 524.7
1,256.1 538.6
1,287.2 553.0
1,319.7 564.3
1,352.0 575.4
1,380.0 587.8
508.3
530.6
547.9
562.3
577.1
590.9
606.9
620.0
633.0
646.8
White African American Native American Asian †Hispanic †Non-Hispanic All
28.0
98.2
210.5
365.1
Table B.3 (continued) Point prevalent rates of reported diabetic ESRD: CDC diabetic population patients alive on December 31 of each year, per million population, by demographic characteristics UNADJUSTED 0-44 45-64 65-74 75+
1980 2,301 1,023 538 185
1985 6,723 3,659 2,185 906
1990 1995 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 9,721 12,204 8,778 8,494 8,504 8,482 7,850 6,964 6,842 6,974 6,745 6,535 7,993 12,412 12,121 11,952 11,882 11,803 11,495 11,336 11,381 11,148 10,461 10,726 6,042 11,390 13,028 12,971 13,011 12,995 13,073 13,203 13,377 13,418 13,270 13,709 3,291 6,323 9,614 9,821 9,906 9,813 10,092 10,010 10,133 10,194 10,271 10,593
Male Female
1,205 840
3,790 2,918
7,724 11,628 11,563 11,334 11,455 11,470 11,581 11,611 11,916 12,060 11,685 11,727 6,591 10,584 11,101 11,145 11,055 10,955 10,485 9,978 9,835 9,656 9,284 9,619
White African American Other
856 1,736 1,186
2,669 5,651 8,920 9,139 9,071 8,917 8,829 8,621 8,552 8,712 8,733 8,519 8,426 5,920 13,449 19,828 22,434 22,435 23,217 22,985 22,429 21,117 20,855 21,127 20,983 21,522 8,315 10,900 12,058 9,535 9,556 10,877 11,949 13,667 12,072 10,946 10,043 8,373 11,539
†Hispanic †Non-Hispanic All
. .
. .
999
3,294
. .
. 14,627 14,942 15,404 15,367 15,395 14,722 14,773 14,528 14,260 14,581 . 10,897 10,762 10,721 10,662 10,444 10,225 10,274 10,247 9,854 10,038
7,086 11,058 11,326 11,239 11,255 11,213 11,028 10,776 10,842 10,813 10,445 10,663
ADJUSTED 20-44 45-64 65-74 75+
2,337 1,011 633 221
6,919 10,200 12,840 9,070 8,768 8,672 8,616 7,845 6,869 6,727 6,850 6,769 6,490 3,858 8,160 11,787 11,824 11,790 11,891 11,719 11,317 11,159 11,209 11,037 10,452 10,649 2,397 6,369 12,281 13,580 13,405 13,578 13,549 13,845 13,460 13,602 13,563 13,516 13,862 978 4,162 6,694 10,475 11,135 11,319 11,350 11,204 11,213 10,924 11,151 10,971 11,483
Male Female
1,167 865
3,996 3,197
White African American Other
889 1,655 965
2,824 5,671 9,219 9,167 9,076 8,926 8,847 8,588 8,519 8,671 8,666 8,419 8,341 5,948 13,916 19,623 23,377 23,815 24,739 24,010 22,960 22,108 21,694 22,046 21,718 22,483 6,923 12,970 14,658 10,664 10,757 11,951 13,113 14,640 12,788 11,679 10,561 9,516 12,128
†Hispanic †Non-Hispanic All
. .
. .
1,013
3,585
7,855 12,006 12,067 11,923 12,125 12,024 11,958 11,939 12,164 12,371 12,036 12,236 7,004 10,219 10,754 10,859 10,857 10,750 10,324 9,739 9,548 9,322 9,064 9,297
. .
. 15,123 15,112 15,952 15,924 16,266 15,633 15,588 15,489 15,251 16,055 . 10,934 10,788 10,748 10,671 10,414 10,209 10,252 10,200 9,809 9,966
7,419 11,106 11,379 11,351 11,448 11,343 11,097 10,776 10,802 10,780 10,499 10,703
Table B.7 Prevalence of reported ESRD, by primary diagnosis, 2009 patients alive on December 31 of each year, by detailed primary diagnosis
ROW PERCENT All ESRD, (reference) Diabetes Diabetes with renal manifestations, Type 2 Diabetes with renal manifestations, Type 1 Glomerulonephritis Glomerulonephritis (GN; histologically not examined) Focal glomerulosclerosis, focal sclerosing GN Membranous nephropathy Membranoproliferative GN type 1, diffuse MPGN Dense deposit disease, MPGN type 2 IgA nephropathy, Berger's (by immunofluorescence) IgM nephropathy (by immunofluorescence) With lesion of rapidly progressive GN Post-infectious GN, SBE Other proliferative GN Secondary GN/vasculitis Lupus erythematosus (SLE nephritis) Henoch-Schonlein syndrome Scleroderma Hemolytic uremic syndrome Polyarteritis Wegener's granulomatosis Nephropathy due to heroin abuse and related drugs Other vasculitis and its derivatives Goodpasture's syndrome Secondary GN, other Interstitial nephritis/pyelonephritis Analgesic abuse Radiation nephritis Lead nephropathy Nephropathy caused by other agents Gouty nephropathy Nephrolithiasis Acquired obstructive uropathy Chronic pyelonephritis, reflux nephropathy Chronic interstitial nephritis Acute interstitial nephritis Urolithiasis Other disorders of calcium metabolism Hypertensive/large vessel disease Unspecified with renal failure Renal artery stenosis Renal artery occlusion Cholesterol emboli, renal emboli Cystic/heriditary/congenital diseases Polycystic kidneys, adult type (dominant) Polycystic, infantile (recessive) Medullary cystic disease, including nephronophthisis Tuberous sclerosis Hereditary nephritis, Alport's syndrome Cystinosis Primary oxalosis Fabry's disease Congenital nephrotic syndrome Drash syndrome, mesangial sclerosis Congenital obstruction of ureterpelvic junction Congenital obstruction of uretrovesical junction Other congenital obstructive uropathy Renal hypoplasia, dysplasia, oligonephronia Prune belly syndrome Other (congenital malformation syndromes)
Total Percent Median Age patients prevalent age 0-19 20-64 571,414 100.0 59.0 1.4 62.5 214,909 38.4 62.0 0.0 58.2 183,537 32.8 63.0 0.0 53.4 31,372 5.6 50.0 0.1 85.8 81,506 14.6 51.0 1.8 78.5 35,483 6.3 53.0 0.5 77.3 23,068 4.1 49.0 3.7 79.5 4,018 0.7 57.0 0.8 68.3 3,419 0.6 51.0 2.3 81.3 251 0.0 41.0 10.8 76.1 9,061 1.6 46.0 0.9 87.8 768 0.1 48.0 1.4 82.9 2,213 0.4 54.0 2.9 66.7 570 0.1 53.0 2.3 75.4 2,655 0.5 52.0 3.2 75.9 17,785 3.2 47.0 3.4 81.4 10,345 1.8 43.0 1.7 92.1 376 0.1 36.0 8.8 83.5 542 0.1 56.0 0.4 72.9 1,126 0.2 37.0 19.2 71.2 310 0.1 57.0 4.5 60.3 1,834 0.3 60.0 2.7 58.7 334 0.1 52.0 0.9 88.9 1,271 0.2 59.0 4.6 56.5 1,018 0.2 53.0 2.3 69.1 629 0.1 54.0 3.7 71.1 20,860 3.7 58.0 2.1 62.8 848 0.2 64.0 0.0 52.4 138 0.0 64.0 2.2 52.9 47 0.0 62.0 0.0 57.5 2,123 0.4 61.0 1.3 58.2 263 0.0 60.0 0.4 63.5 1,037 0.2 62.0 1.0 57.6 5,063 0.9 64.0 1.7 50.1 4,141 0.7 44.0 5.3 82.5 6,036 1.1 58.0 1.4 65.1 685 0.1 63.0 0.7 54.6 248 0.0 60.0 0.4 65.7 231 0.0 59.0 0.9 62.3 139,910 25.0 62.0 0.1 54.5 134,185 24.0 62.0 0.1 55.9 3,611 0.6 75.0 0.2 23.3 740 0.1 72.0 1.2 29.1 1,374 0.2 76.0 0.2 12.2 39,270 7.0 53.0 8.7 70.8 25,984 4.6 58.0 0.3 71.6 548 0.1 23.0 40.1 53.7 643 0.1 30.0 20.7 73.1 205 0.0 51.0 2.9 74.6 2,506 0.4 42.0 4.3 87.1 260 0.0 23.0 33.1 62.3 127 0.0 39.0 22.8 66.1 182 0.0 49.0 0.0 94.5 614 0.1 26.0 41.4 54.9 91 0.0 30.0 42.9 37.4 234 0.0 30.0 29.1 62.4 133 0.0 26.0 32.3 63.2 3,266 0.6 31.0 24.9 70.9 3,225 0.6 23.0 38.8 59.2 356 0.1 19.0 52.0 47.2 896 0.2 39.0 13.3 77.6
65+ 36.2 41.8 46.5 14.2 19.7 22.1 16.8 30.9 16.4 13.1 11.3 15.6 30.4 22.3 20.9 15.3 6.1 7.7 26.8 9.6 35.2 38.6 10.2 38.9 28.7 25.3 35.1 47.6 44.9 42.6 40.6 36.1 41.5 48.2 12.2 33.4 44.7 33.9 36.8 45.4 44.0 76.5 69.7 87.6 20.4 28.1 6.2 6.2 22.4 8.7 4.6 11.0 5.5 3.7 19.8 8.5 4.5 4.2 2.1 0.8 9.2
Percent Percent male White Af Am N Am Asian 56.6 60.8 31.6 1.3 5.3 54.6 61.3 30.7 2.2 5.2 54.4 59.1 32.3 2.4 5.6 56.2 74.0 21.6 1.2 2.9 60.7 64.0 26.0 1.2 7.8 60.5 65.0 23.7 1.3 8.8 60.5 54.3 40.3 0.8 3.9 66.3 65.8 29.2 0.8 3.4 58.3 73.8 17.6 1.3 6.6 49.0 79.3 13.9 1.6 4.4 66.3 73.5 6.6 2.0 16.8 62.0 71.7 10.7 1.3 15.5 48.8 75.5 16.4 1.9 5.6 58.9 76.1 17.0 2.3 4.2 53.0 72.2 20.2 1.2 5.3 30.3 60.8 32.2 1.0 5.2 17.9 46.2 45.3 0.9 6.7 54.8 85.1 7.2 1.1 6.1 22.1 77.5 18.1 0.9 2.8 40.2 78.2 17.8 0.5 2.8 42.3 80.3 12.6 2.6 3.5 56.1 90.4 6.2 0.8 2.3 64.4 45.5 47.9 2.1 4.2 40.8 81.1 12.3 1.7 4.1 50.1 90.5 6.6 1.0 1.7 58.3 63.3 30.2 1.4 4.8 54.7 80.8 13.5 0.7 4.3 42.3 78.7 16.2 0.7 4.0 47.8 84.8 12.3 0.7 2.2 76.6 36.2 59.6 0.0 4.3 54.7 81.2 14.3 0.3 3.7 76.0 56.7 19.0 0.4 22.4 50.2 77.7 11.0 0.8 9.3 79.0 80.6 15.4 0.8 2.6 39.2 87.2 7.0 1.0 4.0 47.0 79.5 14.7 0.8 4.5 52.0 75.8 19.7 0.3 3.8 58.1 74.6 13.3 0.0 10.9 47.2 81.0 12.6 0.0 5.6 59.5 47.2 47.0 0.5 4.7 59.7 45.5 48.6 0.5 4.7 52.0 86.1 10.4 0.5 2.8 57.7 84.3 11.6 0.9 2.6 66.7 92.0 5.2 0.6 2.2 57.9 82.4 12.4 0.7 3.8 53.2 82.9 12.2 0.5 3.8 50.4 79.0 13.7 1.5 4.0 48.7 84.6 7.2 1.1 6.2 45.4 77.6 19.5 0.0 2.0 73.0 86.8 8.7 1.0 3.0 53.5 90.4 5.8 1.2 2.3 54.3 82.7 6.3 2.4 5.5 89.0 87.4 7.7 0.5 3.8 57.7 72.5 18.7 1.1 6.0 59.3 74.7 18.7 0.0 3.3 72.6 77.4 16.7 1.3 3.0 77.4 77.4 13.5 2.3 6.8 77.2 79.6 14.6 1.1 3.4 61.4 79.6 14.0 1.1 3.9 98.0 75.3 20.2 0.8 3.1 58.4 84.2 9.6 1.2 4.6
Table B.7 Prevalence of reported ESRD, by primary diagnosis, 2009 patients alive on December 31 of each year, by detailed primary diagnosis
ROW PERCENT Neoplasms/tumors Renal tumor (malignant) Urinary tract tumor (malignant) Renal tumor (benign) Urinary tract tumor (benign) Renal tumor (unspecified) Urinary tract tumor (unspecified) Lymphoma of kidneys Multiple myeloma Other immuno prolif. neoplasms (inc. light chain neph Amyloidosis Complications of transplanted organ, unspecified Complications of transplanted kidney Complications of transplanted liver Complications of transplanted heart Complications of transplanted lung Complications of transplanted bone marrow Complications of transplanted pancreas Complications of transplanted intestine Complications of other specified transplanted organ Miscellaneous conditions Sickle cell disease/anemia Sickle cell trait and other sickle cell (HbS/Hb other) Post-partum renal failure AIDS nephropathy Traumatic or surgical loss of kidney(s) Hepatorenal syndrome Tubular necrosis (no recovery) Other renal disorders Etiology uncertain Missing
Total Percent Median Age patients prevalent age 0-19 20-64 7,709 1.4 63.0 1.7 53.2 1,595 0.3 68.0 3.4 36.1 286 0.1 72.0 0.3 28.0 81 0.0 67.0 2.5 42.0 39 0.0 65.0 0.0 43.6 175 0.0 69.0 0.6 39.4 67 0.0 72.0 0.0 28.4 68 0.0 63.0 1.5 52.9 1,606 0.3 67.0 0.1 43.5 321 0.1 66.0 0.3 46.1 821 0.1 65.0 0.2 48.7 154 0.0 53.0 1.3 85.7 974 0.2 49.0 1.3 87.6 950 0.2 57.0 2.1 74.5 378 0.1 63.0 5.3 50.5 92 0.0 56.0 1.1 75.0 48 0.0 41.0 12.5 68.8 30 0.0 60.0 3.3 73.3 * 0.0 50.0 0.0 85.7 17 0.0 40.0 17.6 64.7 17,162 3.1 57.0 2.8 62.8 380 0.1 42.0 1.6 94.0 32 0.0 48.0 0.0 90.6 175 0.0 38.0 3.4 95.4 3,201 0.6 47.0 0.6 95.9 492 0.1 62.0 3.3 52.4 1,076 0.2 58.0 0.2 76.7 5,986 1.1 66.0 2.6 44.4 5,820 1.0 58.0 4.8 58.7 20,808 3.7 56.0 2.8 62.9 11,495 2.1 54.0 3.4 71.9
65+ 45.1 60.5 71.7 55.6 56.4 60.0 71.6 45.6 56.4 53.6 51.0 13.0 11.1 23.4 44.2 23.9 18.8 23.3 14.3 17.6 34.4 4.5 9.4 1.1 3.5 44.3 23.1 53.0 36.5 34.3 24.7
Percent Percent male White Af Am N Am Asian 62.6 77.5 18.5 0.7 3.0 70.3 77.9 19.7 0.9 1.1 81.1 81.8 15.4 0.7 2.1 51.9 79.0 18.5 0.0 1.2 89.7 79.5 20.5 0.0 0.0 67.4 73.7 22.9 0.6 2.9 70.1 70.1 22.4 0.0 4.5 72.1 88.2 11.8 0.0 0.0 55.4 72.1 24.6 0.6 2.4 61.4 80.4 15.3 1.2 2.8 56.4 82.2 14.4 0.7 2.6 58.4 82.5 14.3 0.0 3.2 59.0 71.4 20.7 0.5 7.1 59.7 82.4 12.3 1.1 3.7 75.7 80.4 15.3 1.1 3.2 52.2 90.2 5.4 0.0 4.3 66.7 87.5 10.4 0.0 2.1 56.7 76.7 10.0 0.0 10.0 42.9 71.4 28.6 0.0 0.0 82.4 58.8 23.5 0.0 17.6 59.0 62.3 33.2 0.7 3.3 55.0 6.6 92.6 0.0 0.5 40.6 9.4 90.6 0.0 0.0 2.9 56.6 33.1 0.6 6.9 69.4 9.4 89.1 0.2 0.4 65.2 77.0 18.7 0.4 2.6 67.4 79.9 12.7 2.0 5.0 54.6 78.8 17.4 0.8 2.7 57.6 74.0 19.5 0.7 5.3 57.8 66.0 24.9 1.0 6.7 57.3 61.2 17.5 1.3 6.9
Table B.7 (continued) Prevalence of reported ESRD, by primary diagnosis, 2009 patients alive on December 31 of each year, by detailed primary diagnosis
COLUMN PERCENT All ESRD, (reference) Diabetes Diabetes with renal manifestations, Type 2 Diabetes with renal manifestations, Type 1 Glomerulonephritis Glomerulonephritis (GN; histologically not examined) Focal glomerulosclerosis, focal sclerosing GN Membranous nephropathy Membranoproliferative GN type 1, diffuse MPGN Dense deposit disease, MPGN type 2 IgA nephropathy, Berger's (by immunofluorescence) IgM nephropathy (by immunofluorescence) With lesion of rapidly progressive GN Post-infectious GN, SBE Other proliferative GN Secondary GN/vasculitis Lupus erythematosus (SLE nephritis) Henoch-Schonlein syndrome Scleroderma Hemolytic uremic syndrome Polyarteritis Wegener's granulomatosis Nephropathy due to heroin abuse and related drugs Other vasculitis and its derivatives Goodpasture's syndrome Secondary GN, other Interstitial nephritis/pyelonephritis Analgesic abuse Radiation nephritis Lead nephropathy Nephropathy caused by other agents Gouty nephropathy Nephrolithiasis Acquired obstructive uropathy Chronic pyelonephritis, reflux nephropathy Chronic interstitial nephritis Acute interstitial nephritis Urolithiasis Other disorders of calcium metabolism Hypertensive/large vessel disease Unspecified with renal failure Renal artery stenosis Renal artery occlusion Cholesterol emboli, renal emboli Cystic/heriditary/congenital diseases Polycystic kidneys, adult type (dominant) Polycystic, infantile (recessive) Medullary cystic disease, including nephronophthisis Tuberous sclerosis Hereditary nephritis, Alport's syndrome Cystinosis Primary oxalosis Fabry's disease Congenital nephrotic syndrome Drash syndrome, mesangial sclerosis Congenital obstruction of ureterpelvic junction Congenital obstruction of uretrovesical junction Other congenital obstructive uropathy Renal hypoplasia, dysplasia, oligonephronia Prune belly syndrome Other (congenital malformation syndromes)
Total patients 571,414 214,909 183,537 31,372 81,506 35,483 23,068 4,018 3,419 251 9,061 768 2,213 570 2,655 17,785 10,345 376 542 1,126 310 1,834 334 1,271 1,018 629 20,860 848 138 47 2,123 263 1,037 5,063 4,141 6,036 685 248 231 139,910 134,185 3,611 740 1,374 39,270 25,984 548 643 205 2,506 260 127 182 614 91 234 133 3,266 3,225 356 896
Counts White Af Am 347,268 180,685 131,645 66,026 108,437 59,245 23,208 6,781 52,175 21,166 23,052 8,395 12,521 9,289 2,644 1,173 2,523 603 199 35 6,662 594 551 82 1,671 362 434 97 1,918 536 10,808 5,732 4,778 4,682 320 27 420 98 881 200 249 39 1,658 113 152 160 1,031 156 921 67 398 190 16,860 2,806 667 137 117 17 17 28 1,724 303 149 50 806 114 4,080 782 3,609 288 4,800 890 519 135 185 33 187 29 66,021 65,763 61,023 65,232 3,110 374 624 86 1,264 71 32,346 4,876 21,552 3,183 433 75 544 46 159 40 2,174 219 235 15 105 * 159 14 445 115 68 17 181 39 103 18 2,600 478 2,566 451 268 72 754 86
N Am 7,682 4,770 4,399 371 1,002 452 192 32 45 * 180 * 42 13 32 183 97 * * * * 15 * 22 * * 155 * * . * * * 43 41 46 * . . 759 727 17 * * 275 130 * * . 24 * * * * . * * 36 36 * 11
Asian 30,365 11,191 10,286 905 6,336 3,139 892 135 225 11 1,526 119 124 24 141 932 696 23 15 31 11 43 14 52 17 30 905 34 * * 78 59 96 130 165 272 26 27 13 6,521 6,372 100 19 30 1,486 981 22 40 * 74 * * * 37 * * * 112 125 11 41
Percent White 100.0 38.7 31.9 6.8 15.3 6.8 3.7 0.8 0.7 0.1 2.0 0.2 0.5 0.1 0.6 3.2 1.4 0.1 0.1 0.3 0.1 0.5 0.0 0.3 0.3 0.1 5.0 0.2 0.0 0.0 0.5 0.0 0.2 1.2 1.1 1.4 0.2 0.1 0.1 19.4 17.9 0.9 0.2 0.4 9.5 6.3 0.1 0.2 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.8 0.1 0.2
Af Am 100.0 37.0 33.2 3.8 11.8 4.7 5.2 0.7 0.3 0.0 0.3 0.0 0.2 0.1 0.3 3.2 2.6 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 1.6 0.1 0.0 0.0 0.2 0.0 0.1 0.4 0.2 0.5 0.1 0.0 0.0 36.8 36.5 0.2 0.0 0.0 2.7 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0
N Am 100.0 63.3 58.4 4.9 13.3 6.0 2.5 0.4 0.6 0.1 2.4 0.1 0.6 0.2 0.4 2.4 1.3 0.1 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 2.1 0.1 0.0 0.0 0.1 0.0 0.1 0.6 0.5 0.6 0.0 0.0 0.0 10.1 9.7 0.2 0.1 0.1 3.7 1.7 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.5 0.0 0.1
Asian 100.0 37.8 34.8 3.1 21.4 10.6 3.0 0.5 0.8 0.0 5.2 0.4 0.4 0.1 0.5 3.2 2.4 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 3.1 0.1 0.0 0.0 0.3 0.2 0.3 0.4 0.6 0.9 0.1 0.1 0.0 22.0 21.5 0.3 0.1 0.1 5.0 3.3 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.4 0.0 0.1
Table B.7 (continued) Prevalence of reported ESRD, by primary diagnosis, 2009 patients alive on December 31 of each year, by detailed primary diagnosis
COLUMN PERCENT Neoplasms/tumors Renal tumor (malignant) Urinary tract tumor (malignant) Renal tumor (benign) Urinary tract tumor (benign) Renal tumor (unspecified) Urinary tract tumor (unspecified) Lymphoma of kidneys Multiple myeloma Other immuno prolif. neoplasms (inc. light chain neph Amyloidosis Complications of transplanted organ, unspecified Complications of transplanted kidney Complications of transplanted liver Complications of transplanted heart Complications of transplanted lung Complications of transplanted bone marrow Complications of transplanted pancreas Complications of transplanted intestine Complications of other specified transplanted organ Miscellaneous conditions Sickle cell disease/anemia Sickle cell trait and other sickle cell (HbS/Hb other) Post-partum renal failure AIDS nephropathy Traumatic or surgical loss of kidney(s) Hepatorenal syndrome Tubular necrosis (no recovery) Other renal disorders Etiology uncertain Missing
Total Counts patients White 7,709 5,971 1,595 1,243 286 234 81 64 39 31 175 129 67 47 68 60 1,606 1,158 321 258 821 675 154 127 974 695 950 783 378 304 92 83 48 42 30 23 * * 17 * 17,162 10,684 380 25 32 * 175 99 3,201 300 492 379 1,076 860 5,986 4,714 5,820 4,304 20,808 13,727 11,495 7,031
Af Am 1,425 315 44 15 * 40 15 * 395 49 118 22 202 117 58 * * * * * 5,698 352 29 58 2,853 92 137 1,044 1,133 5,178 2,015
N Am 57 15 * . . * . . * * * . * * * . . . . . 125 . . * * * 21 50 43 204 152
Asian 234 18 * * . * * . 39 * 21 * 69 35 12 * * * . * 565 * . 12 13 13 54 160 311 1,404 791
Percent White 1.8 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.1 0.1 0.3 1.4 1.3 4.0 2.1
Af Am 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 1.6 0.1 0.1 0.6 0.6 2.9 1.1
N Am 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.3 0.7 0.6 2.7 2.0
Asian 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.5 1.1 4.7 2.7
Table C.2 Percent distribution of patients, by prior or current employment status incident patients with completed Medical Evidence forms; 2001-2003 Full-time current * . * 2.2 19.6 23.5 21.5 14.9 7.1 2.8 0.9 0.3 0.3
prior . * . 4.3 6.7 4.3 3.5 2.7 2.1 1.7 1.1 0.6 0.3
Part-time current * . . 2.9 4.6 3.3 2.7 2.2 1.8 1.5 0.9 0.5 0.3
Homemaker prior current * * * * . . * * 2.5 2.7 3.1 3.4 3.0 3.1 4.3 4.4 6.0 6.2 5.7 5.7 5.5 5.5 4.9 4.9 4.9 4.9
Retired (age/prf) prior current 4.7 5.3 * * * * * * 0.3 0.4 0.4 0.5 0.9 1.1 4.7 5.6 19.9 22.5 52.9 57.6 68.4 73.7 74.4 79.9 74.9 80.5
Retired (disab.) prior current * 2.1 * * * * 0.9 1.3 6.0 8.5 13.3 16.6 19.7 24.1 29.9 35.2 30.8 35.2 14.4 16.2 6.0 7.1 4.0 4.7 3.4 4.2
Medical leave prior current * * . * . . * 1.9 0.9 8.9 1.1 8.7 1.2 7.7 1.0 5.9 0.5 2.9 0.1 0.8 0.0 0.3 * 0.1 * *
prior 15.7 76.0 87.0 61.9 6.3 0.5 0.1 0.0 * * * * *
Student current 16.9 84.3 93.6 62.8 6.0 0.5 0.1 0.0 * * * * .
Unemployed prior current 29.3 32.4 4.1 5.1 2.7 3.0 16.7 23.9 31.4 45.4 28.3 39.1 26.0 34.8 21.2 27.0 16.0 19.5 9.0 11.1 6.5 8.0 5.4 6.5 5.6 6.9
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
prior * . * 5.2 34.5 36.7 32.5 23.3 12.0 4.7 1.9 1.0 0.8
0-19 20-44 45-64 65-74 75+
2.6 35.5 21.3 3.5 1.2
1.1 22.2 13.7 2.0 0.5
2.0 4.6 2.7 1.5 0.6
1.4 3.4 2.2 1.3 0.5
* 2.9 4.6 5.6 5.1
0.3 3.1 4.8 5.6 5.1
1.0 0.4 8.7 59.6 72.8
1.2 0.5 9.9 64.6 78.2
0.7 13.4 28.6 10.6 4.3
1.0 16.8 33.5 12.2 5.2
* 1.1 0.9 0.1 0.0
1.0 8.5 5.3 0.6 0.1
62.6 1.5 0.0 * *
65.9 1.5 0.0 * *
13.7 28.4 20.4 7.8 5.8
17.7 39.3 25.9 9.7 7.1
Male Female
16.4 9.9
10.5 5.9
2.2 2.0
1.9 1.4
0.1 10.1
0.1 10.4
38.2 34.1
41.4 37.1
17.0 14.1
20.0 16.6
0.5 0.4
3.5 2.8
1.0 1.0
1.0 1.0
12.9 16.5
17.3 20.5
White African American N Am/Alas Native Asian Pacific Islander Mid.-east./Arabian Ind. Subcont. Other/multiracial Unknown
12.4 14.9 14.7 18.2 19.4 13.6 20.7 13.3 11.3
8.0 8.9 8.6 11.6 11.9 9.7 13.8 8.1 7.4
2.2 2.0 2.7 1.9 2.0 2.3 2.7 1.9 2.2
1.8 1.4 2.0 1.8 1.5 1.8 2.5 1.5 1.9
5.4 2.6 6.6 6.0 8.6 7.1 7.5 7.2 4.0
5.5 2.6 6.8 6.2 9.0 7.6 7.8 7.3 4.3
42.3 25.4 19.5 34.4 31.7 29.5 23.9 22.5 23.8
45.6 28.5 20.8 36.0 33.7 30.6 25.7 24.1 27.8
14.8 18.2 19.7 9.5 11.2 10.7 10.4 16.8 14.4
17.2 21.9 22.9 12.3 13.2 12.6 13.6 18.9 17.1
0.5 0.6 0.4 0.4 0.6 * * 0.4 *
2.9 3.9 3.1 3.7 5.0 1.5 3.1 3.0 3.0
0.9 0.9 1.3 1.6 1.2 3.3 2.3 1.8 *
1.0 1.0 1.3 1.6 1.2 3.8 2.2 1.8 *
11.1 20.4 25.3 19.0 18.9 22.0 19.9 23.4 19.4
14.1 27.1 29.8 23.7 22.8 28.2 27.7 30.8 25.0
Hispanic, Mexican Hispanic, other Hispanic, non-spec. Non-Hispanic Unknown
13.7 12.5 10.5 13.5 9.4
6.7 7.2 6.0 8.6 6.1
1.9 1.7 * 2.2 2.5
1.2 1.3 * 1.8 *
9.0 6.8 * 4.2 3.1
9.0 6.8 * 4.3 3.8
24.4 27.9 25.0 37.9 34.4
24.9 29.3 26.5 41.3 42.2
18.7 18.2 12.0 15.3 11.6
22.1 20.3 11.5 18.1 15.1
0.4 0.4 * 0.5 *
3.3 2.8 * 3.2 2.0
2.0 1.4 * 0.9 *
2.0 1.3 * 0.9 *
24.2 20.7 32.0 13.4 9.8
28.0 26.3 36.5 17.6 15.6
Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing
10.4 11.0 28.4 36.1 14.6 15.5 14.0 .
6.4 6.4 19.2 29.3 9.2 8.8 8.3 .
1.6 1.8 3.8 4.7 2.9 2.7 2.4 .
1.3 1.4 3.3 4.2 2.2 1.9 2.0 .
5.7 3.9 3.6 4.4 3.7 4.0 3.9 .
5.7 4.0 3.8 4.7 3.9 4.1 4.1 .
34.4 45.6 24.8 19.9 39.5 31.8 40.2 .
37.3 49.5 26.9 21.6 42.5 34.5 43.5 .
21.0 10.8 10.3 10.2 12.3 13.9 10.4 *
24.1 13.2 12.8 12.9 14.5 16.6 12.6 *
0.5 0.3 0.6 1.0 0.5 0.7 0.4 .
2.4 2.6 6.2 6.3 3.6 4.7 3.1 .
0.1 0.2 3.6 1.5 3.6 3.7 2.1 .
0.1 0.2 3.7 1.8 3.6 3.9 2.3 .
15.0 14.0 14.0 10.6 12.4 15.3 15.0 *
18.5 18.5 20.0 14.6 16.6 20.6 19.8 *
All
13.4
8.4
2.1
1.7
4.7
4.8
36.4
39.4
15.7
18.5
0.5
3.2
1.0
1.0
14.5
18.8
Total N (in 1,000s)
39.8
24.9
6.3
5.0
14.0
14.3
108.0
117.1
46.6
54.9
1.5
9.4
2.9
3.0
43.2
55.8
Table C.2 (continued) Percent distribution of patients, by prior or current employment status incident patients with completed Medical Evidence forms; 2004-2006
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
Full-time prior current 2.4 * * * * * 5.4 2.7 33.4 18.7 38.5 23.2 33.8 21.4 25.4 15.7 14.4 8.2 5.8 3.2 2.3 1.1 1.3 0.4 1.1 0.3
Part-time prior current * * * . * . 4.1 2.6 7.0 4.8 4.9 3.6 3.8 2.9 2.9 2.4 2.4 2.0 2.1 1.9 1.2 1.0 0.6 0.5 0.4 0.4
Homemaker Retired (age/prf) Retired (disab.) Medical leave Student prior current prior current prior current prior current prior * * 7.1 7.1 2.7 3.4 . * 19.6 . . * * * * * * 82.7 * . * * * * . * 90.8 * * * * 1.0 1.5 * 2.4 65.2 2.3 2.5 0.5 0.6 7.5 9.5 0.9 7.7 6.9 3.0 3.2 0.4 0.5 13.3 16.1 1.3 8.9 0.7 2.8 2.9 1.0 1.2 21.1 24.6 1.2 7.5 0.2 3.7 3.7 5.0 5.5 31.9 35.8 1.0 6.1 0.0 5.0 5.1 19.6 21.0 34.4 37.9 0.7 3.4 * 4.9 4.9 54.2 57.2 16.5 17.8 0.2 1.0 * 5.2 5.1 71.8 74.7 7.1 7.9 0.1 0.3 * 4.9 4.7 78.2 81.1 4.5 5.1 * 0.1 . 4.5 4.3 79.7 82.6 3.6 4.2 . * *
0-19 20-44 45-64 65-74 75+
3.2 36.7 23.3 4.3 1.5
1.6 22.1 14.3 2.3 0.5
2.2 5.1 2.9 1.8 0.7
1.3 3.7 2.3 1.6 0.6
0.4 2.7 4.0 5.1 4.9
0.3 2.9 4.0 5.0 4.8
1.6 0.6 8.7 61.7 76.9
1.7 0.7 9.4 64.6 79.8
1.1 14.0 31.1 12.4 4.9
1.5 16.8 34.8 13.5 5.5
* 1.2 1.0 0.1 0.0
1.5 8.4 5.5 0.7 0.1
64.9 1.7 0.1 * *
65.9 1.6 0.0 * *
16.5 32.5 23.3 9.3 6.3
18.9 42.0 27.5 10.3 7.0
Male Female
17.6 11.2
10.7 6.3
2.4 2.3
2.0 1.7
0.1 9.4
0.1 9.4
39.1 35.5
40.9 37.1
18.8 15.9
21.1 17.8
0.6 0.5
3.6 2.9
1.0 1.1
1.0 1.1
15.1 18.8
18.6 21.7
White African American N Am/Alas Native Asian Pacific Islander Mid.-east./Arabian Ind. Subcont. Other/multiracial Unknown
13.7 16.5 14.9 18.9 19.5 15.5 21.3 14.3 11.0
8.4 9.3 8.7 11.8 11.7 8.5 15.6 8.6 6.6
2.3 2.4 2.9 2.7 2.5 2.3 2.0 2.2 2.9
1.9 1.7 1.7 2.3 2.1 2.3 * 1.5 2.8
4.8 2.4 6.1 6.1 7.9 5.2 6.9 7.3 4.0
4.8 2.3 6.1 5.9 8.1 5.6 6.9 7.3 3.7
43.5 25.7 20.5 34.5 27.7 30.6 22.8 22.8 27.9
45.3 27.2 21.0 36.0 29.0 33.3 23.9 24.2 30.5
16.5 20.5 20.2 10.8 13.9 9.9 10.2 17.3 12.7
18.4 23.3 22.8 12.8 16.1 11.4 13.5 19.7 15.0
0.5 0.6 0.4 0.7 0.5 * * 0.6 *
3.0 3.9 3.1 4.2 4.5 5.0 4.8 3.0 2.8
1.0 1.0 1.5 1.4 0.9 * * 1.9 *
1.0 1.0 1.4 1.4 0.9 * 2.6 2.0 *
12.9 24.4 27.7 20.8 23.4 23.0 20.8 22.1 24.2
15.3 29.2 32.9 23.9 26.3 28.0 27.6 29.8 30.5
Hispanic, Mexican Hispanic, other Hispanic, non-spec. Non-Hispanic Unknown
13.2 13.5 15.6 14.7 11.6
6.7 7.8 7.9 9.0 7.6
2.0 1.9 2.2 2.4 3.5
1.2 1.5 1.5 1.9 3.0
8.1 7.0 7.5 3.8 4.2
8.2 6.9 7.3 3.8 3.5
24.0 26.0 26.5 39.3 35.4
24.6 27.9 27.0 41.1 39.8
19.6 18.1 21.0 17.1 12.0
22.3 20.7 23.3 19.2 14.8
0.6 0.5 0.5 0.5 .
3.1 2.7 3.1 3.4 3.0
1.9 1.7 2.0 0.9 *
1.9 1.7 2.0 0.9 *
25.0 20.1 24.1 15.7 14.1
29.4 26.8 27.7 18.7 18.8
Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing
11.7 12.3 30.2 39.7 15.9 16.8 14.5 *
6.8 6.7 20.4 30.5 10.8 9.3 8.1 .
1.8 2.1 4.1 5.2 3.3 3.0 2.5 .
1.4 1.6 3.6 5.1 2.7 2.1 2.0 .
5.0 3.8 3.2 3.8 3.0 3.7 3.9 .
4.9 3.8 3.4 3.9 2.8 3.7 3.8 .
35.6 46.9 25.1 19.8 41.9 33.4 40.0 *
37.1 49.1 26.3 20.9 43.7 35.0 42.2 *
23.0 12.6 11.1 11.4 13.0 15.5 12.5 .
25.3 14.6 13.2 13.5 14.5 17.7 14.4 .
0.5 0.4 0.8 0.7 0.4 0.8 0.4 .
2.6 2.7 6.2 6.4 3.2 5.0 3.2 *
0.1 0.2 3.8 1.6 3.2 3.7 2.5 .
0.1 0.2 3.9 1.6 3.1 3.7 2.4 .
17.2 16.1 16.2 12.3 14.5 17.4 18.1 *
19.8 19.5 21.0 15.9 17.5 21.3 21.9 *
All
14.7
8.8
2.3
1.9
4.3
4.2
37.5
39.2
17.5
19.6
0.5
3.3
1.0
1.0
16.8
20.0
Total N (in 1,000s)
47.0
28.1
7.5
5.9
13.6
13.6
119.8
125.3
55.8
62.7
1.7
10.6
3.3
3.3
53.5
63.8
current 19.9 85.5 93.9 65.1 6.3 0.7 0.2 0.0 * * * . *
Unemployed prior current 32.0 34.6 7.6 7.8 3.2 3.3 19.2 23.2 35.7 48.0 32.5 42.0 30.5 37.4 24.3 28.8 17.6 20.2 11.8 10.6 7.3 8.1 6.0 6.5 6.2 6.7
Table C.2 (continued) Percent distribution of patients, by prior or current employment status incident patients with completed Medical Evidence forms; 2007-2009
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
Full-time prior current 3.7 2.4 * * * . 5.4 2.3 34.8 18.7 39.4 23.5 36.0 21.9 27.4 16.5 17.0 9.7 7.4 3.8 2.9 1.2 1.7 0.5 1.4 0.3
Part-time prior current * * . . . . 4.6 3.4 8.4 5.3 5.7 4.0 4.2 3.2 3.3 2.5 2.7 2.2 2.3 1.9 1.5 1.2 0.7 0.5 0.5 0.4
Homemaker Retired (age/pref) Retired (disability) Medical leave Student prior current prior current prior current prior current prior * * 6.5 6.6 3.2 4.0 . * 27.8 * * * * * * * * 88.5 . . * * * * . * 94.7 * * * * 0.7 0.9 * 1.5 70.6 2.1 2.2 0.5 0.6 7.3 9.2 0.9 7.9 6.6 2.7 2.8 0.4 0.5 13.9 16.3 1.2 8.5 0.7 2.6 2.7 0.8 0.8 22.3 25.0 1.2 7.7 0.2 3.4 3.3 4.8 5.0 33.2 36.4 1.1 6.3 0.1 4.4 4.3 19.6 20.2 36.4 39.1 0.7 3.7 * 4.1 3.9 54.4 55.9 19.7 20.7 0.2 1.3 * 4.3 4.2 74.6 75.5 8.5 9.2 0.1 0.4 * 4.6 4.3 81.5 82.5 5.0 5.4 * 0.1 * 4.3 3.9 83.2 84.1 4.6 5.0 * 0.1 *
0-19 20-44 45-64 65-74 75+
3.5 38.0 25.3 5.5 1.9
1.6 22.4 15.1 2.7 0.6
2.3 5.7 3.3 2.1 0.8
1.7 4.0 2.5 1.7 0.6
0.3 2.5 3.6 4.2 4.4
0.3 2.6 3.5 4.1 4.1
1.7 0.5 8.8 62.8 80.3
1.7 0.5 9.1 64.0 81.2
1.1 14.6 32.7 14.9 5.8
1.5 17.1 35.6 15.8 6.2
* 1.2 1.0 0.1 0.0
0.9 8.2 5.7 0.9 0.2
69.6 1.7 0.1 * *
68.3 1.6 0.1 * *
18.3 35.8 25.3 10.3 6.9
20.8 43.6 28.4 10.7 7.0
Male Female
18.9 12.5
11.1 7.0
2.7 2.7
2.2 1.8
0.1 8.5
0.1 8.2
39.7 36.2
40.3 36.9
20.0 18.1
21.9 19.7
0.6 0.5
3.7 3.1
1.0 1.1
1.0 1.1
16.9 20.3
19.6 22.1
White African American N Am/Alas Native Asian Pacific Islander Mid.-east./Arabian Ind. Subcont. Other/multiracial Unknown
14.9 18.3 18.4 21.2 21.0 . . 17.9 .
8.8 10.0 9.6 12.8 12.3 . . 11.3 .
2.7 2.7 2.5 2.8 2.7 . . 3.2 .
2.1 1.8 2.0 2.2 1.8 . . 2.3 .
4.4 1.9 5.3 5.6 5.7 . . 6.8 .
4.2 1.9 5.3 5.5 5.5 . . 6.7 .
43.4 27.1 21.7 36.9 25.1 . . 29.6 *
44.1 27.7 22.3 37.6 25.8 . . 30.4 *
18.3 22.5 20.5 11.1 14.2 . . 18.1 .
19.9 24.6 22.8 13.0 16.2 . . 19.3 .
0.5 0.6 0.5 0.5 1.3 . . * .
3.1 4.0 3.6 4.2 4.7 . . 3.5 .
1.1 1.0 1.3 1.4 1.3 . . 3.2 .
1.0 0.9 1.3 1.3 1.2 . . 3.3 .
14.8 25.9 29.9 20.5 28.8 . . 20.2 .
16.6 29.1 33.1 23.3 32.3 . . 22.9 .
Hispanic, Mexican Hispanic, other Hispanic, non-spec. Non-Hispanic Unknown
. . 16.1 16.1 .
. . 8.0 9.5 .
. . 2.6 2.7 .
. . 1.7 2.1 .
. . 6.8 3.3 .
. . 6.6 3.2 .
. . 25.1 40.3 .
. . 25.4 41.0 .
. . 21.2 18.9 .
. . 23.5 20.5 .
. . 0.6 0.6 .
. . 3.5 3.4 .
. . 1.9 0.9 .
. . 1.9 0.9 .
. . 25.7 17.2 .
. . 29.2 19.3 .
Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing
13.1 13.9 33.2 42.7 16.6 17.7 15.9 .
7.4 7.5 21.8 32.4 10.0 9.3 8.7 .
2.1 2.5 4.7 5.4 3.5 3.2 2.9 .
1.6 1.9 3.8 4.5 2.5 2.3 2.2 .
4.3 3.4 3.1 3.5 2.8 3.2 3.4 .
4.2 3.3 3.1 3.6 2.8 3.2 3.2 .
35.9 47.3 24.9 20.2 43.3 35.1 41.1 .
36.4 48.1 25.5 20.8 43.7 35.6 41.7 .
24.9 14.3 12.3 11.4 15.6 17.0 13.9 .
26.8 15.9 14.3 13.1 17.1 18.9 15.6 .
0.5 0.4 0.8 0.9 0.7 0.8 0.6 .
2.7 2.8 6.5 6.6 4.3 5.1 3.4 .
0.1 0.2 3.9 1.7 3.0 3.9 2.5 .
0.1 0.2 3.8 1.7 3.0 3.8 2.5 .
19.0 17.9 17.0 14.1 14.5 18.7 19.8 .
20.8 20.3 21.2 17.2 16.5 21.5 22.6 .
All
16.1
9.3
2.7
2.0
3.8
3.7
38.2
38.8
19.2
21.0
0.6
3.4
1.1
1.0
18.4
20.7
Total N (in 1,000s)
54.2
31.3
9.0
6.8
12.6
12.3
128.2
130.4
64.5
70.4
1.9
11.6
3.5
3.4
61.8
69.6
current 27.7 88.5 94.5 68.0 6.1 0.6 0.2 0.1 * * * * *
Unemployed prior current 42.0 42.2 8.1 8.3 3.7 3.7 17.8 22.9 49.9 39.4 35.9 43.8 32.8 38.5 26.7 30.0 19.2 20.7 11.8 12.4 8.2 8.4 6.6 6.7 6.1 6.1
Table C.3 Insurance coverage in the incident population (%) incident patients with completed Medical Evidence forms; 2001-2003
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
Medicaid 49.8 54.6 45.7 38.6 32.8 31.9 29.7 27.6 27.0 23.5 18.8 16.2 18.0
Medicare 10.9 2.8 2.4 3.2 8.2 14.1 18.2 26.1 34.6 84.9 88.6 90.3 91.4
DVA . * * * 0.3 0.5 1.1 2.0 1.6 1.3 1.3 1.0 0.5
EGHP 34.0 32.5 35.0 31.4 27.9 32.9 34.2 33.9 29.1 16.0 13.6 11.8 10.1
Other 24.0 20.0 24.2 24.7 16.1 13.6 15.2 19.2 24.2 37.2 46.2 52.0 52.6
None 3.3 7.8 6.6 13.5 24.3 20.0 16.7 11.4 9.3 2.0 1.5 1.3 1.1
Medicare Advantage . . . . . . . . . . . . .
Applying for Medicare 84.5 88.5 89.5 88.5 88.5 87.6 87.0 85.3 83.8 70.7 68.7 67.6 67.0
0-19 20-44 45-64 65-74 75+
44.1 31.4 27.8 21.7 17.2
4.1 14.0 27.4 86.5 90.0
* 0.5 1.8 1.3 1.1
32.9 32.1 32.6 14.9 12.2
23.9 14.6 20.0 40.7 50.4
9.5 20.2 11.5 1.8 1.3
. * * * .
88.1 87.6 85.2 70.0 67.7
Male Female
18.7 30.7
54.7 57.2
2.3 0.2
24.9 20.8
32.9 31.3
8.8 6.3
* *
77.6 77.1
White African American N Am/Alas Native Asian Pacific Islander Mid.-east./Arabian Ind. Subcont. Other/multiracial Unknown
18.6 34.2 39.7 36.9 32.0 44.5 32.6 29.6 32.4
61.4 47.2 41.9 45.3 40.2 36.2 29.7 41.0 44.1
1.2 1.6 1.3 0.5 1.6 . . 1.2 *
24.0 21.7 14.7 24.4 29.8 17.4 26.3 13.4 15.3
38.9 18.2 33.6 24.7 25.0 18.8 22.8 32.4 28.1
5.7 11.3 8.3 8.7 7.6 14.9 14.8 12.3 13.6
* * . * . . . . .
76.6 78.7 90.2 75.8 76.8 70.2 75.4 79.9 77.4
Hispanic, Mexican Hispanic, other Hispanic, non-spec. Non-Hispanic Unknown
39.9 34.2 40.0 22.3 17.2
40.3 46.5 37.5 57.7 54.3
0.7 1.5 * 1.3 *
16.7 12.8 13.5 24.2 15.4
17.5 29.9 16.0 33.6 42.1
16.7 9.6 24.5 6.7 10.3
. . . * .
82.8 78.8 69.5 76.8 78.8
Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing
28.3 21.9 18.4 12.6 22.1 22.2 21.2 *
57.8 63.2 36.8 29.7 56.2 49.4 56.5 *
1.4 1.2 1.1 1.4 1.4 1.2 1.4 .
21.7 18.7 34.5 46.6 23.6 26.5 19.6 *
30.1 35.5 29.8 28.4 31.9 33.5 35.6 .
6.4 8.5 10.3 7.1 7.6 7.6 10.8 .
* * * . . * . .
77.9 74.6 81.4 82.4 77.9 78.2 76.4 *
All
24.3
55.8
1.3
23.0
32.2
7.7
.
77.4
72,050
165,878
3,874
68,373
95,573
22,715
*
229,773
Total N
Table C.3 (continued) Insurance coverage in the incident population (%) incident patients with completed Medical Evidence forms; 2004-2006
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
Medicaid 51.5 50.4 46.2 43.6 35.6 33.3 32.1 28.6 26.9 24.2 19.7 16.0 17.4
Medicare 10.2 2.6 3.2 1.8 7.9 13.5 18.3 26.0 34.4 83.7 86.7 88.4 88.8
DVA * . * * 0.3 0.4 1.0 2.5 2.3 1.5 1.5 1.4 1.0
EGHP 33.7 36.6 35.3 32.2 27.5 33.2 33.9 35.3 32.7 18.8 16.2 14.9 13.1
Other 18.3 20.9 22.3 17.9 12.2 11.1 12.0 14.8 19.1 30.9 39.4 45.3 46.4
None 2.8 5.2 7.1 12.4 25.2 20.2 17.2 11.7 9.0 2.0 1.4 1.0 1.1
Medicare Advantage * * . * * 0.2 0.3 0.6 1.0 2.7 3.4 3.4 3.2
Applying for Medicare 88.1 87.4 88.4 86.5 87.0 86.9 86.1 83.7 81.7 68.0 66.1 64.0 64.3
0-19 20-44 45-64 65-74 75+
46.3 33.3 28.7 22.5 17.4
3.7 13.5 27.4 84.7 88.2
* 0.5 2.2 1.6 1.3
33.7 32.3 34.3 17.6 15.1
19.3 11.5 15.6 34.1 43.8
8.6 20.5 11.8 1.7 1.1
* 0.3 0.7 3.0 3.3
87.3 86.8 83.5 67.3 64.8
Male Female
20.0 31.6
53.2 55.8
2.6 0.3
27.0 22.9
27.2 26.1
8.8 6.5
1.8 1.9
75.5 75.2
White African American N Am/Alas Native Asian Pacific Islander Mid.-east./Arabian Ind. Subcont. Other/multiracial Unknown
20.1 34.6 40.3 36.6 32.9 42.2 33.4 32.2 27.9
59.3 45.9 42.1 43.8 37.9 41.4 28.2 41.8 46.2
1.5 1.8 2.1 0.5 1.5 * . 1.9 *
26.2 23.7 15.0 26.8 26.7 16.8 28.0 15.0 13.9
32.1 14.5 32.8 20.7 23.3 21.7 20.0 31.3 23.3
6.0 11.5 7.2 8.0 9.0 12.4 13.9 12.1 19.6
2.2 1.2 0.6 1.7 1.1 . . 1.1 .
74.4 77.3 89.8 72.5 77.6 65.4 75.1 75.6 73.9
Hispanic, Mexican Hispanic, other Hispanic, non-spec. Non-Hispanic Unknown
40.5 35.3 39.0 23.1 24.5
39.8 45.1 39.2 56.5 49.5
0.9 1.7 1.1 1.6 *
15.7 12.4 18.1 26.5 18.3
17.2 29.3 15.3 28.0 27.1
17.1 10.3 12.9 6.9 15.0
. . 4.1 1.8 .
79.9 74.8 77.6 75.0 74.8
Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing
28.9 22.8 19.5 13.3 21.7 23.3 24.0 .
56.2 61.6 34.6 28.4 53.9 49.1 53.3 *
1.8 1.4 1.5 1.4 1.8 1.3 1.9 .
23.8 20.9 37.1 49.9 25.2 29.1 21.3 .
24.6 29.9 24.6 22.3 28.8 28.3 29.0 *
6.6 8.8 10.5 7.5 8.1 7.1 10.6 .
1.9 2.1 1.2 1.0 1.8 1.6 1.9 .
75.8 73.1 80.0 81.0 75.7 75.7 73.1 *
All
25.2
54.4
1.6
25.2
26.7
7.8
1.9
75.4
80,372
173,598
5,052
80,485
85,327
24,767
5,902
240,744
Total N
Table C.3 (continued) Insurance coverage in the incident population (%) incident patients with completed Medical Evidence forms; 2007-2009
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
Medicaid 53.9 57.4 52.4 42.8 36.4 33.6 32.5 29.1 25.6 22.9 19.4 15.9 16.4
Medicare 10.8 4.4 2.2 2.1 7.8 13.2 17.7 24.9 32.2 76.5 80.1 82.8 83.7
DVA * * * * 0.3 0.4 0.9 2.5 3.5 1.8 1.8 1.6 1.3
EGHP 35.9 33.8 34.3 33.1 27.3 32.9 34.6 35.3 33.9 19.4 16.3 15.2 13.6
Other 14.4 14.5 15.6 18.8 10.9 9.6 10.0 12.2 16.1 24.5 31.4 37.7 39.8
None 2.1 3.9 5.4 12.2 25.5 20.7 16.9 12.0 8.6 1.4 0.9 0.5 0.5
Medicare Advantage * * * * 0.4 0.7 1.2 2.2 3.6 10.0 11.4 10.6 9.9
Applying for Medicare 86.4 82.4 85.5 84.3 86.4 86.5 85.6 83.8 81.9 69.5 67.6 66.2 65.2
0-19 20-44 45-64 65-74 75+
48.5 33.8 28.6 21.8 16.9
4.0 13.2 26.1 77.9 82.2
* 0.5 2.5 1.8 1.6
34.0 32.4 34.7 18.0 15.1
16.8 9.9 13.1 26.8 36.5
7.9 20.7 11.6 1.2 0.6
0.3 0.8 2.5 10.7 10.8
84.7 86.2 83.5 68.7 66.4
Male Female
20.2 31.1
49.3 51.7
3.0 0.4
27.3 23.5
22.2 21.3
8.4 6.4
6.3 6.2
76.1 76.1
White African American N Am/Alas Native Asian Pacific Islander Mid.-east./Arabian Ind. Subcont. Other/multiracial Unknown
20.5 33.2 35.4 36.9 30.5 . . 34.4 .
54.2 43.2 42.0 42.1 32.0 . . 41.3 *
1.8 2.1 1.7 0.7 2.0 . . 1.2 .
26.2 24.4 16.1 26.2 27.2 . . 28.2 .
25.9 12.2 31.9 18.5 20.4 . . 23.5 *
5.9 11.2 8.2 6.8 10.2 . . 9.6 .
7.1 4.7 1.6 4.5 2.5 . . 11.0 .
75.0 78.4 88.3 73.7 81.1 . . 80.7 *
Hispanic, Mexican Hispanic, other Hispanic, non-spec. Non-Hispanic Unknown
. . 38.6 22.7 .
. . 35.6 52.8 .
. . 1.2 2.0 .
. . 17.1 27.0 .
. . 14.4 23.0 .
. . 12.8 6.7 .
. . 7.9 6.0 .
. . 77.7 75.9 .
Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing
28.7 22.9 18.9 13.8 21.1 22.9 23 .
51.7 56.6 31.8 25.6 51.6 46.2 50 .
2.1 1.7 1.8 1.4 1.9 1.5 2 .
23.8 21.5 38.7 52.6 25.5 29.8 23 .
19.8 24.4 19.9 18.3 23.3 23.8 24 .
6.6 8.5 10.0 6.9 7.3 6.9 9 .
6.7 6.9 4.1 2.8 7.1 5.3 5 .
76.5 74.4 80.0 81.1 76.9 76.4 74 .
All
25.0
50.4
1.9
25.6
21.8
7.5
6.3
76.1
83,857
169,174
6,236
86,120
73,299
25,261
20,992
255,727
Total N
Table C.4 Incident patient comorbidity (%) incident patients with completed Medical Evidence forms (old form); percent with comorbidity in each year; 2001-2005
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
CHF 6.0 1.7 2.1 3.4 8.0 11.9 18.3 27.0 33.0 36.4 40.4 44.0 46.0
ASHD * * * * 0.1 0.4 1.1 2.2 3.0 3.4 4.0 4.6 4.9
Other cardiac disease * * * 0.4 0.5 0.6 1.0 1.6 2.0 2.2 2.5 3.0 3.4
0-19 20-44 45-64 65-74 75+
3.3 12.6 27.6 37.8 43.3
* 0.5 2.3 3.6 4.4
0.5 0.7 1.6 2.3 2.9
0.8 2.8 8.0 11.9 12.3
0.6 4.1 12.4 18.1 18.2
41.2 76.8 81.2 81.0 80.1
* 0.3 0.6 0.5 0.3
1.6 20.8 29.7 25.9 16.3
0.2 0.8 2.0 2.2 2.0
* 0.4 0.8 0.9 0.9
* 1.3 1.7 1.1 0.6
0.5 1.4 6.2 10.8 11.4
1.0 7.6 7.2 4.3 2.1
1.1 1.4 4.3 8.0 10.3
Male Female
30.7 33.2
3.1 2.6
2.1 1.8
9.1 9.6
15.1 12.8
79.0 80.8
0.5 0.3
22.3 25.7
1.9 1.8
0.8 0.8
1.2 1.3
8.6 7.2
6.0 4.1
7.0 5.5
White African American N Am/Alas Native Asian Pacific Islander Mid.-east./Arabian Ind. Subcont. Other/multiracial Unknown
34.1 28.0 31.9 23.2 28.2 28.9 25.3 26.7 31.7
3.5 1.8 2.6 2.8 2.3 . * 0.7 .
2.3 1.5 1.4 1.5 1.2 . * 0.4 .
9.5 9.4 8.0 7.5 8.4 6.7 6.7 6.5 8.2
16.4 9.6 17.8 6.2 9.4 8.7 8.1 13.6 12.5
77.8 84.4 83.2 79.2 84.1 72.8 77.7 79.0 74.9
0.5 0.4 0.8 0.2 0.3 . . 0.1 .
24.2 23.4 36.9 17.4 22.6 17.3 22.5 23.5 21.7
1.9 1.7 2.5 2.9 2.4 . * 0.4 .
0.8 0.8 1.2 1.1 0.8 . * 0.2 .
1.3 1.0 2.5 1.3 1.7 . * 0.3 .
9.8 4.9 4.9 2.5 3.2 4.5 2.4 2.9 7.0
5.1 5.9 5.7 1.5 2.9 3.1 0.9 2.3 3.2
7.5 4.5 3.0 3.4 2.3 2.5 1.7 2.9 3.6
Hispanic, Mexican Hispanic, other Hispanic, non-spec. Non-Hispanic Unknown
26.5 28.0 29.3 32.5 34.9
* * 17.0 3.0 .
* * 9.2 2.1 .
6.2 6.6 7.5 9.7 8.5
10.7 13.6 13.2 14.3 19.0
80.0 79.0 82.7 79.8 75.2
. . 3.9 0.4 .
23.4 24.2 36.7 23.6 22.5
* . 16.9 1.8 .
* * 6.2 0.8 .
. . 13.8 1.1 .
2.5 3.8 3.8 8.6 9.9
1.9 2.1 2.7 5.6 4.9
2.3 3.4 3.5 6.8 7.6
Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing
38.8 32.6 16.3 8.1 16.0 21.9 28.1 *
3.4 3.0 1.4 1.2 1.7 2.3 2.6 *
2.1 2.1 1.2 0.9 1.5 2.0 2.3 .
10.7 10.7 4.8 4.5 5.5 5.8 7.6 *
18.4 14.1 5.5 3.5 6.9 7.8 9.0 *
82.1 88.2 77.8 80.9 61.4 61.2 62.0 *
0.8 0.2 0.1 * 0.2 0.2 0.3 *
45.7 6.8 3.5 2.0 4.0 7.0 7.1 *
3.0 1.0 0.6 0.4 0.7 1.0 1.3 *
1.0 0.7 0.5 0.2 0.4 0.6 0.7 .
2.5 0.2 0.1 * * 0.1 0.3 .
7.4 9.9 5.9 3.5 7.8 7.4 9.5 .
4.2 6.0 6.3 5.5 6.3 5.6 5.4 .
3.8 6.0 4.9 3.5 19.5 15.8 8.7 .
All
31.8
2.9
2.0
9.3
14.0
79.8
0.4
23.9
1.8
0.8
1.2
7.9
5.2
6.3
161,219
14,690
10,057
47,104 71,135
404,270
2,210 120,985
9,277
4,005
6,212
40,207
26,100
32,027
Total N
CVA/TIA 1.3 * 0.7 0.6 1.2 2.4 4.8 7.9 9.9 11.6 12.3 12.6 11.7
PVD 2.3 * * * 1.5 3.8 7.2 12.2 15.4 17.7 18.7 18.3 16.2
History of HTN 27.7 29.6 37.1 51.1 71.5 77.1 80.0 81.5 81.1 81.2 80.6 80.3 78.9
Amputation * . . * 0.1 0.3 0.5 0.6 0.6 0.5 0.4 0.3 0.2
DM on insulin 3.1 * 0.8 1.7 13.2 22.1 25.2 30.5 30.3 27.8 22.2 14.7 9.7
DM oral med. * * * * 0.2 0.7 1.3 2.0 2.3 2.2 2.1 2.0 1.7
DM w/o meds * . . * 0.2 0.4 0.6 0.8 0.9 0.9 0.9 0.8 0.8
Diabetic retinopathy * * . * 0.7 1.3 1.6 1.8 1.6 1.4 0.9 0.5 0.3
COPD 1.1 * * * 0.5 1.2 3.0 5.7 8.5 10.1 11.8 11.1 10.0
Current smoker * * * 1.7 5.3 7.3 9.1 7.3 5.8 4.7 3.3 1.8 1.0
Malig. neoplasm 2.2 1.7 1.2 0.6 0.6 1.2 2.2 4.1 5.9 7.3 9.4 10.6 10.4
Table C.4 Incident patient c incident patients with
Alcohol Drug depend. depend. * . * * * * * 0.7 0.8 1.9 1.8 3.5 3.1 3.8 2.1 1.5 1.4 0.4 1.0 0.1 0.7 0.1 0.3 0.0 0.2 *
Inability to ambulate 4.8 2.6 2.3 1.5 1.1 1.5 2.4 3.8 4.3 5.0 5.7 6.5 7.8
Inabilitiy Needs to assist. Institutransfer daily act. tionalized 2.8 2.1 * 1.7 * . 1.1 0.8 . 0.9 0.5 * 0.4 0.4 0.2 0.5 0.5 0.3 0.8 0.7 0.4 1.3 1.1 0.7 1.7 1.3 0.8 2.0 1.4 0.9 2.3 1.7 1.2 2.6 2.3 1.6 3.4 2.7 2.3
Instit. assist. living * . . * * * 0.0 0.0 0.1 0.1 0.1 0.2 0.4
Instit. Instit. nursing other home inst. * . . . . . * * 0.1 0.1 0.2 0.1 0.4 0.1 0.6 0.1 0.7 0.1 0.8 0.1 1.2 0.1 1.6 0.1 2.1 0.1
Non-renal congen. abnormality * * * 0.5 0.2 0.1 0.1 0.0 0.0 * 0.0 * *
None 4.2 5.6 4.5 4.2 1.5 0.8 0.5 0.3 0.3 0.2 0.2 0.2 0.2
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
Toxic neph. . * . * 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 *
0-19 20-44 45-64 65-74 75+
* 0.1 0.1 0.1 0.0
* 2.1 2.1 0.9 0.4
0.4 3.5 1.5 0.1 0.0
2.4 1.6 3.7 5.2 6.5
1.3 0.5 1.3 2.0 2.7
0.8 0.6 1.1 1.5 2.2
* 0.3 0.7 1.0 1.6
* 0.0 0.0 0.1 0.2
* 0.2 0.6 1.0 1.5
* 0.1 0.1 0.1 0.1
0.5 0.1 0.0 0.0 0.0
4.5 0.8 0.3 0.2 0.2
Male Female
0.1 0.1
2.0 0.6
1.4 0.6
4.0 5.1
1.5 2.1
1.3 1.6
0.9 1.0
0.1 0.1
0.8 1.0
0.1 0.1
0.0 0.0
0.4 0.4
White African American N Am/Alas Native Asian Pacific Islander Mid.-east./Arabian Ind. Subcont. Other/multiracial Unknown
0.1 0.0 * * * . . * .
1.1 2.0 3.6 0.3 0.6 * * 1.0 1.2
0.5 2.5 0.8 * 0.2 * * 0.8 1.2
4.6 4.4 3.8 3.2 3.5 4.0 3.0 4.2 3.6
1.8 1.8 1.2 1.4 1.4 1.5 1.1 1.4 1.5
1.5 1.3 1.2 1.3 0.8 . . 0.4 .
1.0 0.9 0.5 0.5 0.3 . . 0.2 .
0.1 0.0 * * . . . * .
0.9 0.9 0.5 0.5 0.3 . . 0.2 .
0.1 0.1 * * * . . * .
0.0 0.0 * * * . . * .
0.4 0.3 * 0.7 0.4 . . * .
Hispanic, Mexican Hispanic, other Hispanic, non-spec. Non-Hispanic Unknown
* . 0.3 0.1 .
1.1 0.9 1.3 1.4 1.5
0.6 0.8 0.8 1.1 *
3.2 4.0 6.9 4.6 4.7
1.1 1.5 3.1 1.8 2.6
. . 10.1 1.4 .
. . 3.6 1.0 .
. . 0.3 0.1 .
. . 3.8 0.9 .
. . 0.4 0.1 .
. . 0.2 0.0 .
. . 3.8 0.3 .
Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing
0.0 0.0 0.0 * * 0.3 0.1 .
0.7 1.6 1.5 0.6 1.2 2.8 2.5 .
0.5 1.3 1.6 0.5 0.4 2.1 1.6 .
5.4 3.7 1.8 0.9 6.5 5.2 5.6 .
2.0 1.5 0.6 0.3 2.4 2.4 2.5 .
1.6 1.3 0.5 0.2 1.4 1.7 1.7 .
1.0 1.0 0.3 0.2 0.9 1.1 1.3 .
0.1 0.1 0.0 * * 0.1 0.2 .
0.9 0.9 0.3 0.1 0.8 1.0 1.3 .
0.1 0.1 0.0 * * 0.1 0.1 .
0.0 0.0 0.1 * 0.2 0.1 0.1 .
0.1 0.2 0.7 0.9 1.0 1.1 1.4 .
All
0.1
1.4
1.0
4.5
1.8
1.4
0.9
0.1
0.9
0.1
0.0
0.4
Total N
325
6,866
5,233
22,850
8,947
7,136
4,652
408
4,424
369
197
1,859
Table C.4 (continued) Incident patient comorbidity (%) incident patients with completed Medical Evidence forms (new form); percent with comorbidity in each year; 2006-2009
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
CHF 5.6 3.4 1.5 3.1 7.6 12.5 19.2 27.0 32.9 36.1 40.4 44.4 47.2
ASHD 3.0 * * * 1.3 3.5 8.5 15.6 21.9 25.3 29.7 32.6 31.0
Other cardiac disease 5.4 4.3 3.6 3.7 4.1 5.6 8.3 12.2 15.8 18.4 21.9 25.0 26.1
0-19 20-44 45-64 65-74 75+
3.2 13.2 27.7 37.5 44.0
1.0 4.2 16.6 26.8 31.5
4.1 5.9 12.8 19.6 24.4
1.2 3.0 8.4 11.8 12.0
1.1 4.5 12.3 17.5 17.9
46.0 81.8 85.1 85.3 84.7
0.3 2.3 4.1 3.3 1.7
3.0 29.0 41.8 39.5 26.2
0.8 5.4 13.5 16.2 14.0
0.4 2.8 5.0 5.8 5.9
0.5 9.4 11.5 8.6 4.0
0.6 1.7 7.0 12.0 12.7
1.1 8.3 8.8 5.2 2.4
1.5 1.6 5.0 9.3 11.8
Male Female
31.4 32.8
22.6 19.0
17.3 15.2
9.1 9.6
14.8 12.6
83.6 84.9
3.6 2.4
33.5 37.5
13.2 12.9
5.0 5.1
8.3 8.9
9.1 8.6
7.1 5.1
8.1 6.2
White African American N Am/Alas Native Asian Pacific Islander Mid.-east./Arabian Ind. Subcont. Other/multiracial Unknown
33.4 29.7 30.2 24.9 28.5 . . 30.6 .
24.3 13.9 19.1 17.3 16.1 . . 24.0 *
18.4 12.3 11.6 12.2 13.4 . . 13.7 .
9.2 10.0 8.0 8.3 8.0 . . 8.6 .
15.8 10.0 16.5 7.3 9.5 . . 15.6 .
82.3 88.3 86.7 85.6 85.2 . . 84.6 *
3.1 3.0 7.5 1.0 3.8 . . 3.5 .
35.0 35.6 49.7 30.1 40.1 . . 40.2 .
13.0 12.2 18.3 18.5 20.3 . . 12.7 .
4.7 5.7 8.0 5.7 6.5 . . 4.6 .
8.8 7.3 19.3 8.6 12.9 . . 13.3 .
10.5 6.0 5.2 3.3 4.1 . . 5.6 .
5.9 7.3 6.9 2.1 4.8 . . 4.9 .
8.4 5.2 4.0 3.8 3.1 . . 6.2 .
Hispanic, Mexican Hispanic, other Hispanic, non-spec. Non-Hispanic Unknown
. . 27.8 32.7 .
. . 17.9 21.5 .
. . 10.5 17.3 .
. . 7.3 9.7 .
. . 13.5 13.9 .
. . 84.8 84.0 *
. . 3.8 2.9 .
. * 41.1 34.3 *
. . 17.2 12.4 .
. . 5.1 5.0 .
. . 13.5 7.8 .
. . 3.5 9.7 *
. . 2.7 6.7 .
. . 3.5 7.9 .
Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing
38.8 33.1 15.4 7.6 16.4 22.6 27.7 .
25.2 21.1 11.5 8.1 14.5 15.8 16.9 .
17.0 18.2 9.7 7.8 10.7 15.7 16.7 .
10.8 10.5 4.5 4.3 5.3 6.0 7.9 .
18.4 13.2 5.5 3.2 7.5 8.2 8.5 .
86.5 90.5 83.7 85.8 68.9 68.7 67.8 *
5.5 1.3 0.5 0.3 1.2 1.2 1.2 .
64.5 13.0 6.7 3.4 7.3 13.3 13.7 *
21.1 7.6 4.9 3.4 5.2 6.2 7.1 .
6.1 4.9 3.4 2.2 3.8 3.7 4.5 .
17.6 1.5 0.8 0.3 0.8 1.3 1.4 .
8.7 10.3 6.2 3.5 8.7 8.6 10.0 *
5.3 7.0 7.5 6.0 7.7 6.7 6.1 .
4.5 7.0 5.5 3.9 21.2 17.0 9.2 .
All
32.0
21.0
16.4
9.3
13.8
84.1
3.1
35.3
13.1
5.1
8.6
8.9
6.2
7.3
142,729
93,684
72,917
41,642 61,690
375,104
58,343 22,541
38,136
39,565
27,561
32,423
Total N
CVA/TIA 2.4 2.4 * 0.8 1.5 2.6 5.2 8.3 10.0 11.3 12.1 12.2 11.6
PVD 2.8 2.0 * * 1.6 4.2 7.8 11.8 15.1 16.9 18.5 18.2 15.8
History of HTN 33.3 39.1 41.6 54.3 76.4 82.5 84.5 84.9 85.5 85.3 85.0 84.5 84.6
Amputation * * * * 0.8 2.3 3.5 4.3 4.1 3.5 2.6 1.5 1.2
DM on insulin 5.7 2.0 1.5 2.9 17.0 30.2 35.8 42.0 44.2 41.4 34.4 25.0 18.1
DM oral med. 2.8 * * * 1.9 4.9 9.4 13.3 15.5 16.3 15.8 14.1 10.9
DM w/o meds * * * 0.5 1.2 2.7 4.0 5.0 5.3 5.7 6.0 5.9 5.3
Diabetic retinopathy 1.4 . * * 5.2 10.1 10.9 11.8 11.4 9.6 6.5 3.5 2.3
COPD 2.2 * * * 0.7 1.3 3.5 6.5 9.6 11.4 12.9 12.9 11.3
Current smoker * . * 1.7 6.8 7.9 10.4 9.1 7.1 5.8 3.9 2.0 1.1
Malig. neoplasm 3.0 2.6 1.1 0.8 1.0 1.4 2.6 4.8 6.7 8.6 10.8 12.1 11.8
13,650 157,196
Table C.4 (continue Incident patient c incident patients with Inabilitiy Needs to assist. Institutransfer daily act. tionalized 4.2 11.0 1.8 * 7.6 * 1.0 5.3 * 0.6 3.8 0.6 0.9 4.0 1.2 1.0 4.3 1.6 1.4 5.8 3.0 2.3 8.4 4.6 3.0 10.4 5.6 3.8 12.0 7.2 4.7 14.7 9.5 5.5 17.7 13.0 7.0 21.3 16.2
Instit. assist. living * . . * 0.2 0.2 0.3 0.3 0.4 0.5 0.7 1.3 2.2
Instit. Instit. nursing other home inst. 1.1 * * . * * * * 0.8 0.4 1.2 0.5 2.5 0.6 4.2 0.5 5.5 0.4 7.1 0.4 9.4 0.5 12.7 0.6 15.3 0.6
Non-renal congen. abnormality 7.6 8.8 6.0 4.1 1.8 0.8 0.4 0.3 0.1 0.1 0.1 0.1 0.1
None 35.8 35.4 38.6 29.4 10.8 5.3 3.2 2.2 1.7 1.4 1.3 1.1 1.2
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+ 0-19 20-44 45-64 65-74 75+
0.3 0.5 0.5 0.4 0.3
* 2.1 2.6 1.1 0.4
0.3 3.7 2.2 0.2 0.1
2.8 2.3 5.4 8.1 10.3
1.5 1.0 2.4 4.1 5.6
5.9 4.6 8.6 12.9 17.6
0.7 1.8 4.7 7.9 12.6
* 0.2 0.4 0.5 1.3
0.4 1.4 4.3 7.8 12.3
0.3 0.4 0.5 0.5 0.6
5.7 0.9 0.2 0.1 0.1
33.2 5.8 2.2 1.4 1.2
Male Female
0.5 0.4
2.2 0.8
1.7 0.9
6.0 8.0
2.9 4.1
9.9 13.2
6.2 8.1
0.5 0.7
5.8 7.9
0.6 0.5
0.3 0.3
2.5 2.6
White African American N Am/Alas Native Asian Pacific Islander Mid.-east./Arabian Ind. Subcont. Other/multiracial Unknown
0.5 0.3 0.3 0.4 0.3 . . * .
1.4 2.0 4.4 0.3 0.7 . . 1.2 .
0.7 3.1 1.5 0.1 0.5 . . 1.5 .
7.1 6.5 5.7 4.9 5.0 . . 6.4 .
3.5 3.5 2.2 2.6 2.9 . . 2.6 .
11.9 10.5 9.8 8.6 9.3 . . 10.5 .
7.5 6.7 4.4 3.9 2.8 . . 5.4 .
0.7 0.3 0.3 0.4 0.3 . . * .
7.1 6.5 4.3 4.1 2.7 . . 5.0 .
0.5 0.5 * 0.3 0.3 . . * .
0.3 0.2 * 0.1 0.4 . . * .
2.8 1.9 1.4 3.7 3.2 . . 3.1 .
Hispanic, Mexican Hispanic, other Hispanic, non-spec. Non-Hispanic Unknown
. . 0.3 0.5 .
. . 1.4 1.6 .
. . 1.0 1.4 .
. . 6.2 7.0 *
. . 3.1 3.5 *
. . 10.7 11.5 .
. . 3.6 7.6 .
. . 0.3 0.7 .
. . 3.6 7.2 .
. . 0.3 0.6 .
. . 0.2 0.3 .
. . 3.5 2.4 .
Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing
0.2 0.2 0.3 0.1 0.4 2.0 0.6 .
0.9 1.7 1.6 0.7 1.9 3.6 2.6 .
0.8 1.7 1.8 0.7 0.9 2.6 2.0 .
8.0 6.0 2.5 1.1 8.5 7.8 7.4 *
3.7 3.2 1.1 0.5 4.1 4.3 4.2 *
12.6 10.9 5.0 2.4 12.2 12.6 12.2 .
7.3 7.5 2.7 1.2 7.4 8.0 9.0 .
0.6 0.7 0.3 0.2 0.8 0.6 0.6 .
7.1 7.1 2.3 1.0 6.8 7.5 8.6 .
0.4 0.5 0.4 0.2 0.9 0.8 0.8 .
0.1 0.2 0.5 0.8 1.3 1.0 0.5 .
0.5 1.3 6.2 6.5 8.3 7.1 9.2 .
All
0.5
1.6
1.4
6.9
3.4
11.4
7.0
0.6
6.7
0.5
0.3
2.5
2,048
7,121
6,147
30,591
15,328
50,614
31,367
2,683
30,035
2,304
Total N
Alcohol Drug depend. depend. * * . . . * * 0.5 0.9 3.0 2.0 3.6 3.2 4.3 2.8 2.4 1.8 0.7 1.3 0.3 0.7 0.1 0.3 0.1 0.2 0.1
Inability to ambulate 5.6 4.1 2.7 1.5 1.7 2.2 3.2 5.3 6.6 7.8 8.9 10.2 12.5
Toxic neph. * * * 0.4 0.6 0.5 0.6 0.5 0.5 0.5 0.4 0.3 0.2
1,391 11,338
Table C.5 Prescribed therapy for hemodialysis patients (item 23 on ME Form) Incident patients 2005-2009
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
Sessions per week 1-2 3 1.9 85.2 3.9 90.3 4.4 93.1 2.7 95.0 0.8 97.3 0.8 97.5 0.9 97.5 1.0 97.5 1.1 97.6 1.3 97.5 1.7 97.2 2.4 96.8 3.1 96.2
4 6.0 4.9 2.2 1.4 1.3 1.5 1.4 1.3 1.2 1.1 1.0 0.8 0.7
5+ 6.9 1.0 0.3 0.8 0.6 0.3 0.2 0.2 0.1 0.1 0.1 0.0 0.0
Hours per session 1-2 3 8.8 53.3 6.8 65.5 4.4 66.7 1.2 50.1 0.6 34.5 0.4 30.8 0.5 31.1 0.4 31.9 0.4 33.3 0.5 34.7 0.6 38.4 0.7 43.4 1.1 48.8
4 36.3 27.2 28.9 48.2 63.7 67.0 66.9 66.3 65.3 63.9 60.5 55.4 49.8
5+ 1.6 0.5 . 0.5 1.2 1.8 1.5 1.3 1.0 0.9 0.6 0.4 0.3
0-19 20-44 45-64 65-74 75+
3.0 0.8 1.0 1.4 2.3
93.4 97.5 97.5 97.4 96.8
2.3 1.4 1.3 1.1 0.9
1.3 0.3 0.2 0.1 0.1
2.9 0.5 0.4 0.5 0.7
54.5 31.6 32.2 35.7 43.1
42.1 66.3 66.1 62.9 55.7
0.5 1.6 1.2 0.8 0.5
Male Female
1.3 1.6
97.3 97.2
1.2 1.0
0.2 0.1
0.5 0.6
33.4 39.5
64.9 59.2
1.2 0.7
White African American N Am/Alas Native Asian Pacific Islander Other/multiracial Unknown
1.7 0.7 1.2 2.3 1.2 1.0 .
97.1 97.7 97.6 96.6 97.6 97.7 100.0
1.0 1.5 1.1 1.0 1.1 1.1 .
0.2 0.1 0.1 0.2 0.1 0.2 .
0.6 0.4 0.5 0.8 0.8 0.6 .
37.4 30.5 27.3 58.8 42.4 35.3 100.0
61.1 67.7 71.8 40.0 55.7 63.1 .
0.8 1.4 0.5 0.4 1.1 1.0 .
Hispanic, non-spec. Non-Hispanic
1.0 1.5
97.8 97.2
1.1 1.2
0.1 0.2
0.5 0.6
39.3 35.5
59.7 62.9
0.5 1.0
Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing
1.2 1.6 1.5 2.0 2.3 1.5 1.5
97.5 97.1 97.2 96.3 96.7 97.2 97.2
1.2 1.2 1.0 0.9 1.0 1.0 1.1
0.1 0.1 0.4 0.7 0.1 0.2 0.2
0.4 0.7 0.6 1.0 0.7 0.6 0.7
34.2 37.8 35.7 38.1 38.4 37.0 40.5
64.3 60.7 62.4 59.9 60.3 61.5 57.8
1.1 0.8 1.3 1.0 0.6 0.8 0.9
All
1.4
97.3
1.1
0.2
0.6
36.1
62.4
1.0
6,761
456,714
5,389
720
2,633
169,297
293,084
4,568
Total N
Table D.1 Percentages & counts of reported ESRD patients: by treatment modality incident & December 31 point prevalent patients INCIDENT COUNTS Modality Dialysis Started with a transplant Dialysis type Center hemodialysis Center self hemodialysis Home hemodialysis CAPD CCPD Other PD Uncertain dialysis All PERCENTAGES Modality Dialysis Started with a transplant Dialysis type Center hemodialysis Center self hemodialysis Home hemodialysis CAPD CCPD Other PD Uncertain dialysis All POINT PREVALENT COUNTS Modality Dialysis Functioning graft Dialysis type Center hemodialysis Center self hemodialysis Home hemodialysis CAPD CCPD Other PD Uncertain dialysis All PERCENTAGES Modality Dialysis Functioning graft Dialysis type Center hemodialysis Center self hemodialysis Home hemodialysis CAPD CCPD Other PD Uncertain dialysis All
1985
1990
1995
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
29,995 542
49,772 1,100
69,172 1,222
92,804 1,736
95,982 1,820
98,045 1,932
100,683 1,998
102,730 2,247
104,874 2,403
108,489 2,621
108,550 2,643
110,031 2,633
113,636 2,759
24,009 . 398 4,030 139 582 837
40,982 . 576 5,910 610 661 1,033
58,342 51 740 7,288 2,119 172 460
84,689 28 414 5,002 2,447 86 138
87,888 45 384 4,972 2,495 71 127
90,479 53 274 4,676 2,346 103 114
92,954 47 437 4,739 2,325 70 111
94,941 28 477 4,723 2,370 60 131
97,272 31 445 4,703 2,228 46 149
101,081 32 420 4,432 2,307 33 184
101,363 44 444 4,156 2,361 28 154
102,584 50 522 4,148 2,444 33 250
105,712 69 552 4,396 2,698 33 176
30,537
50,872
70,394
94,540
97,802
99,977
102,681
104,977
107,277
111,110
111,193
112,664
116,395
98.2 1.8
97.8 2.2
98.3 1.7
98.2 1.8
98.1 1.9
98.1 1.9
98.1 1.9
97.9 2.1
97.8 2.2
97.6 2.4
97.6 2.4
97.7 2.3
97.6 2.4
80.0 . 1.3 13.4 0.5 1.9 2.8
82.3 . 1.2 11.9 1.2 1.3 2.1
84.3 0.1 1.1 10.5 3.1 0.2 0.7
91.3 0.0 0.4 5.4 2.6 0.1 0.1
91.6 0.0 0.4 5.2 2.6 0.1 0.1
92.3 0.1 0.3 4.8 2.4 0.1 0.1
92.3 0.0 0.4 4.7 2.3 0.1 0.1
92.4 0.0 0.5 4.6 2.3 0.1 0.1
92.8 0.0 0.4 4.5 2.1 0.0 0.1
93.2 0.0 0.4 4.1 2.1 0.0 0.2
93.4 0.0 0.4 3.8 2.2 0.0 0.1
93.2 0.0 0.5 3.8 2.2 0.0 0.2
93.0 0.1 0.5 3.9 2.4 0.0 0.2
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
86,574 26,588
136,105 50,687
209,844 78,100
284,020 108,794
297,095 115,305
309,176 122,167
320,825 128,928
332,263 136,328
343,911 143,734
357,008 151,453
369,990 158,676
383,673 165,592
398,861 172,553
67,572 * 5,824 10,541 542 859 1,235
111,697 . 2,984 16,904 1,976 480 2,064
174,595 506 3,070 22,248 7,794 214 1,417
255,143 267 2,185 13,332 11,892 72 1,129
268,519 316 1,884 12,553 12,738 70 1,015
280,700 271 1,761 11,696 13,702 79 967
291,907 193 1,910 11,404 14,432 57 922
303,223 184 2,052 11,035 14,794 49 926
314,492 138 2,224 10,896 15,176 39 946
327,218 102 2,595 10,535 15,586 36 936
339,361 141 3,224 10,003 16,247 26 988
351,958 153 4,014 9,716 16,755 31 1,046
365,566 197 4,511 9,458 18,064 37 1,028
113,162
186,792
287,944
392,814
412,400
431,343
449,753
468,591
487,645
508,461
528,666
549,265
571,414
76.5 23.5
72.9 27.1
72.9 27.1
72.3 27.7
72.0 28.0
71.7 28.3
71.3 28.7
70.9 29.1
70.5 29.5
70.2 29.8
70.0 30.0
69.9 30.1
69.8 30.2
78.1 0.0 6.7 12.2 0.6 1.0 1.4
82.1 . 2.2 12.4 1.5 0.4 1.5
83.2 0.2 1.5 10.6 3.7 0.1 0.7
89.8 0.1 0.8 4.7 4.2 0.0 0.4
90.4 0.1 0.6 4.2 4.3 0.0 0.3
90.8 0.1 0.6 3.8 4.4 0.0 0.3
91.0 0.1 0.6 3.6 4.5 0.0 0.3
91.3 0.1 0.6 3.3 4.5 0.0 0.3
91.4 0.0 0.6 3.2 4.4 0.0 0.3
91.7 0.0 0.7 3.0 4.4 0.0 0.3
91.7 0.0 0.9 2.7 4.4 0.0 0.3
91.7 0.0 1.0 2.5 4.4 0.0 0.3
91.7 0.0 1.1 2.4 4.5 0.0 0.3
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
Table D.10 Incident ESRD patients, 2009, by treatment modality by age, gender, race, ethnicity, & primary diagnosis
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+ Unknown
Center Center Home hemo self hemo hemo 101 . * 39 . . 129 . . 438 . * 2,483 . 14 5,260 * 24 10,985 * 58 20,484 * 119 12,943 * 69 12,900 * 49 23,756 22 116 9,584 * 53 6,584 * 47 26 . *
CAPD * . * 23 141 355 664 997 583 533 784 213 89 .
CCPD Other PD 141 . 59 * 84 . 87 * 95 * 231 * 384 * 550 * 328 * 243 * 336 * 96 * 63 * * .
0-19 20-44 45-64 65-74 75+ Unknown
707 12,171 39,984 25,066 27,758 26
. 13 17 19 20 .
* 60 224 99 166 *
37 785 1,955 973 646 .
371 505 1,083 423 315 *
* * * * * .
13 38 79 35 11 .
268 723 1,347 376 45 .
1,400 14,300 44,699 26,998 28,970 28
Male Female Unknown
59,961 45,747 *
43 26 .
313 239 .
2,433 1,963 .
1,517 1,181 .
20 13 .
95 79 *
1,614 1,145 .
65,996 50,393 *
White African American Native American Asian Other/unknown
68,945 30,443 1,255 4,558 511
61 * . * .
365 159 . 23 *
3,176 888 48 269 15
1,960 578 25 123 12
21 * . * .
119 18 * 17 16
1,730 214 108 651 56
76,377 32,314 1,442 5,647 615
Hispanic Non-Hispanic
15,031 90,681
* 66
37 515
508 3,888
410 2,288
* 32
13 163
237 16,240 2,522 100,155
Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing cause
47,386 30,413 6,147 1,754 1,430 13,405 3,870 1,307
26 19 * * * * * *
204 199 41 21 * 51 21 13
1,868 1,095 541 279 62 381 134 36
987 581 377 173 32 433 90 25
* * * * . * * *
36 23 18 12 * 32 * 47
105,712
69
552
4,396
2,698
33
176
All
Uncertain dialysis Transplant * 38 * 53 * 74 * 103 * 160 19 321 30 555 47 710 15 324 22 244 19 170 * * * * . .
456 349 478 418 61 494 120 383
All 293 154 294 659 2,900 6,218 12,690 22,917 14,274 14,007 25,207 9,963 6,791 28
50,970 32,688 7,612 2,662 1,590 14,810 4,245 1,818
2,759 116,395
Table D.11 Point prevalent ESRD patients, 2009, by treatment modality December 31 point prevalent patients, by age, gender, race, ethnicity, & primary diagnosis
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+ Unknown
Center hemo 131 73 213 861 8,768 21,501 44,921 78,241 47,395 44,012 74,192 26,798 18,458 *
Center self hemo . . * * * 28 38 42 26 21 18 * * .
Home hemo * . * 19 154 508 824 1,075 530 477 597 192 123 .
CAPD 13 * * 36 332 928 1,621 2,414 1,271 1,014 1,287 362 172 .
CCPD 251 110 174 279 886 1,744 2,902 3,975 2,115 1,869 2,705 695 359 .
Other PD . . * * * * * * * * * * * .
Uncertain dialysis * * 12 35 63 133 181 281 130 72 81 18 * .
Transplant 301 878 1,484 2,828 8,757 19,382 36,260 46,967 22,417 16,487 15,169 1,338 285 .
All 707 1,068 1,902 4,061 18,968 44,227 86,752 133,001 73,886 63,955 94,059 29,413 19,413 *
0-19 20-44 45-64 65-74 75+ Unknown
1,278 48,620 152,206 83,735 79,725 *
* 53 88 33 19 .
31 1,035 2,056 800 589 .
57 1,967 4,599 1,725 1,110 .
814 3,936 7,686 3,373 2,255 .
* * 12 12 * .
61 288 500 124 55 .
5,491 44,127 89,656 26,805 6,474 .
7,738 100,031 256,803 116,607 90,233 *
Male Female Unknown
202,537 163,024 *
124 73 .
2,724 1,787 .
4,842 4,616 .
9,664 8,400 .
21 16 .
588 436 *
102,776 69,775 *
323,276 248,127 11
White African American Native American Asian Other/unknown
201,320 138,573 5,325 17,646 2,702
114 71 * 11 .
2,949 1,350 41 156 15
6,123 2,384 134 751 66
12,057 4,638 212 1,038 119
20 11 . * *
595 263 17 72 81
124,090 33,395 1,952 10,686 2,430
347,268 180,685 7,682 30,365 5,414
Hispanic Non-Hispanic
60,614 304,952
16 181
332 4,179
1,239 8,219
2,608 15,456
* 36
120 908
22,936 149,617
87,866 483,548
Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing cause
164,181 104,905 34,289 8,899 6,549 32,581 12,533 1,629
66 57 29 * * 24 * *
1,371 1,130 871 260 113 597 144 25
3,419 2,399 1,579 516 170 979 345 51
5,897 4,491 3,188 921 405 2,421 685 56
* 11 * * * * . *
223 180 207 62 26 175 26 129
40,079 27,325 44,717 16,590 5,837 25,530 7,822 4,653
215,245 140,498 84,883 27,254 13,108 62,315 21,563 6,548
All
365,566
197
4,511
9,458
18,064
37
1,028
172,553
571,414
Table D.17 Counts of incident ESRD patients, by payor category: all patients by age, gender, race, ethnicity, & primary diagnosis
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+ Unknown
2001 M'care M'care/ FFS Mcaid 37 22 37 19 101 18 230 20 1,206 181 2,374 546 4,445 929 7,177 1,736 4,721 1,185 6,322 2,625 15,020 4,443 5,039 1,219 2,739 770 . .
MSP EGHP Non-EGHP 43 * 30 . 53 . 128 * 537 * 1,215 18 2,654 66 4,278 115 1,972 46 623 96 422 285 44 79 13 39 . .
All 203 151 309 586 2,712 5,754 11,058 17,774 10,481 11,875 24,841 7,770 4,288 .
2005 M'care FFS 53 47 99 214 1,173 2,420 4,933 8,201 5,183 6,537 14,672 6,325 3,591 .
M'care/ Mcaid 24 11 23 25 204 544 1,276 2,254 1,361 2,873 4,848 1,556 899 .
0-19 20-44 45-64 65-74 75+ Unknown
405 5,537 14,386 13,849 15,271 .
79 1,111 3,466 5,071 3,986 .
254 2,817 7,839 939 163 .
507 3,546 7,748 681 383 .
1,249 13,173 34,606 24,760 24,014 .
413 5,711 16,199 13,621 17,504 .
Male Female Unknown
28,310 21,138 .
5,061 8,652 .
4,895 4,114 .
6,711 6,154 .
52,607 45,195 .
White African American Native American Asian Other/unknown
34,781 12,573 585 1,047 462
500 230 11 13 *
6,709 1,879 22 358 41
6,896 4,338 205 748 678
†Hispanic †Non-Hispanic
1,102 10,910
36 719
1,119 7,890
7,624 3,681 606 91 323 921 436 31
5,370 2,162 1,772 693 344 1,267 372 32
353 218 47 15 23 61 37 *
13,713
12,012
755
MSP EGHP Non-EGHP 49 . 34 . 77 . 121 * 411 * 1,193 17 2,540 66 4,639 226 2,279 115 805 126 518 337 55 114 19 66 . .
HMO . . . . * 38 123 435 463 1,446 4,090 1,507 815 .
Other/ unk 83 54 137 263 940 1,692 3,182 4,919 2,552 444 618 180 133 .
All 209 146 336 624 2,737 5,904 12,120 20,674 11,953 12,231 25,083 9,737 5,523 .
83 1,252 4,387 5,439 4,737 .
281 2,659 8,403 1,162 235 .
* 40 389 292 351 .
. 82 981 3,448 4,410 .
537 4,011 9,274 817 558 .
1,315 13,755 39,633 24,779 27,795 .
31,343 22,104 *
6,482 9,415 *
7,768 4,972 .
693 380 .
5,004 3,916 *
8,286 6,910 *
59,576 47,697 *
63,931 27,804 1,175 3,449 1,443
37,691 13,583 589 1,292 293
8,629 5,941 259 938 131
8,358 3,605 107 588 82
777 261 13 18 *
6,458 2,000 32 375 56
8,259 5,100 224 947 667
70,172 30,490 1,224 4,158 1,233
2,368 10,497
11,791 86,011
5,322 48,126
2,838 13,060
1,222 11,518
74 999
1,279 3,158 7,642 12,039
13,893 93,384
4,161 2,883 536 115 240 679 384 11
5,144 2,693 1,561 453 374 1,848 622 170
44,155 26,321 8,640 2,268 2,771 9,323 3,997 327
22,813 16,073 3,795 999 1,158 6,015 2,314 281
8,366 4,298 659 149 271 1,376 656 123
5,595 2,396 1,709 801 238 1,517 399 85
509 287 58 * 33 111 50 16
4,176 2,839 387 91 166 791 426 45
5,976 3,172 1,601 473 303 2,537 809 326
47,435 29,065 8,209 2,522 2,169 12,347 4,654 876
9,009
12,865
97,802
53,448
15,898
12,740
1,073
8,921 15,197
107,277
HMO * . . * * 49 138 446 436 1,817 4,174 1,276 665 .
Other/ unk 99 65 137 206 773 1,552 2,826 4,022 2,121 392 497 113 62 .
* 57 197 236 263 .
* 105 970 3,984 3,948 .
7,138 4,874 .
492 263 .
7,070 5,443 228 809 163
7,975 3,341 124 474 98
4,922 44,526
2,244 11,469
Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing cause
21,503 14,684 4,118 901 1,467 4,547 2,146 82
All
49,448
Table D.17 Counts of incide by age, gender, rac
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+ Unknown
2009 M'care FFS 53 32 87 211 1,227 2,426 4,794 8,352 5,386 6,210 12,677 5,670 3,953 *
M'care/ Mcaid 31 20 26 26 201 574 1,283 2,360 1,426 2,699 4,200 1,413 924 .
EGHP 35 20 52 104 346 965 2,289 4,166 2,441 978 548 64 18 .
MSP Non-EGHP . . . * 11 34 91 217 166 173 317 155 94 .
HMO * . . * 21 117 428 1,364 1,237 3,238 6,625 2,405 1,588 .
Other/ unk 173 82 129 315 1,094 2,102 3,805 6,458 3,618 709 840 256 214 27
All 293 154 294 659 2,900 6,218 12,690 22,917 14,274 14,007 25,207 9,963 6,791 28
0-19 20-44 45-64 65-74 75+ Unknown
383 5,628 16,557 12,444 16,066 *
103 1,293 4,551 4,983 4,253 .
211 2,204 8,003 1,379 229 .
* 78 441 336 403 .
* 297 2,870 6,659 7,197 .
699 4,800 12,277 1,197 822 27
1,400 14,300 44,699 26,998 28,970 28
Male Female Unknown
30,696 20,381 *
6,592 8,591 .
7,397 4,629 .
832 428 .
9,390 7,635 .
11,089 8,729 *
65,996 50,393 *
White African American Native American Asian Other/unknown
36,237 12,671 709 1,382 80
8,530 5,234 249 1,122 48
8,037 3,261 105 589 34
877 355 * 18 *
11,758 4,540 53 645 29
10,938 6,253 318 1,891 422
76,377 32,314 1,442 5,647 615
†Hispanic †Non-Hispanic
5,348 45,731
2,764 12,419
1,297 10,729
102 1,158
2,612 14,413
4,117 15,705
16,240 100,155
Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing cause
21,520 15,694 3,235 936 751 6,376 1,926 641
7,891 4,236 500 160 176 1,464 478 278
5,194 2,451 1,426 760 167 1,539 338 151
551 362 64 27 * 172 56 19
8,007 5,373 691 148 225 1,836 594 151
7,807 4,572 1,696 631 262 3,423 853 578
50,970 32,688 7,612 2,662 1,590 14,810 4,245 1,818
All
51,079
15,183
12,026
1,260
17,025
19,822
116,395
Table D.21 Counts of point prevalent ESRD patients, by payor category: all patients December 31 point prevalent patients, by age, gender, race, ethnicity, & primary diagnosis
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+ Unknown
2001 M'care M'care/ FFS Mcaid 62 137 127 249 292 464 621 904 3,356 6,795 11,071 14,551 22,425 21,196 33,274 23,176 17,921 11,056 22,617 12,046 42,573 16,975 12,627 4,111 6,296 2,101 . .
MSP EGHP Non-EGHP 104 * 114 * 169 12 414 23 1,678 114 4,737 410 9,124 629 11,969 733 4,892 289 1,982 232 730 361 65 73 15 26 . .
HMO * * * 13 180 654 1,542 2,797 2,030 4,191 9,192 2,559 1,218 .
Other/ unk 174 428 884 1,418 4,680 10,660 16,666 17,153 6,701 1,488 1,402 270 163 .
0-19 20-44 45-64 65-74 75+ Unknown
1,102 24,020 64,027 45,380 38,733 .
1,754 31,443 45,331 21,804 13,429 .
801 10,382 22,018 2,530 262 .
44 818 1,357 444 248 .
23 1,469 5,734 9,160 8,000 .
Male Female Unknown
103,135 70,127 .
52,828 60,933 .
21,227 14,766 .
2,040 871 .
White African American Native American Asian Other/unknown
116,593 48,644 1,995 4,907 1,123
52,778 52,472 2,290 5,336 885
25,288 8,753 354 1,421 177
†Hispanic †Non-Hispanic
16,050 157,212
19,126 94,635
62,495 45,860 28,644 8,548 5,179 15,776 6,058 702
Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing cause All
All 484 926 1,825 3,393 16,803 42,083 71,582 89,102 42,889 42,556 71,233 19,705 9,819 .
2005 M'care FFS 73 110 238 551 2,952 10,350 22,573 39,687 22,134 26,292 46,686 16,146 9,161 .
M'care/ Mcaid 177 204 416 975 6,799 15,176 25,206 30,700 13,693 14,806 20,728 5,390 2,953 .
2,904 6,628 23,162 91,294 32,698 171,165 2,339 81,657 984 61,656 . .
972 22,780 74,916 50,985 47,300 .
13,604 10,782 .
1,969 818 40 76 *
3,140 32,853
45,800 30,932 16,506 2,671 3,122 10,714 3,795 221
173,262 113,761
MSP EGHP Non-EGHP 105 * 96 * 204 * 441 21 1,610 150 4,798 492 9,857 902 14,724 1,217 6,296 500 2,812 354 1,152 518 119 107 26 54 . .
Other/ HMO unk * 191 * 594 * 1,005 * 1,925 135 5,817 597 11,578 1,601 19,686 3,338 23,676 2,447 9,664 4,268 1,904 10,474 2,028 3,360 466 1,793 329 . .
All 553 1,015 1,874 3,922 17,463 42,991 79,825 113,342 54,734 50,436 81,586 25,588 14,316 .
1,772 33,437 58,137 26,680 17,197 .
846 10,704 26,581 3,665 444 .
43 1,059 2,202 657 376 .
16 3,715 1,345 26,226 6,773 44,195 9,734 3,123 10,161 1,604 . .
7,364 95,551 212,804 94,844 77,082 .
33,537 226,371 118,502 28,548 186,027 78,450 * * *
66,006 71,217 .
25,508 16,732 .
2,987 1,350 .
15,749 43,303 12,279 35,557 * *
272,055 215,585 *
16,517 5,934 84 1,730 121
39,804 252,949 131,783 15,641 132,262 55,372 947 5,710 2,245 3,554 17,024 6,104 2,141 4,455 1,449
64,802 61,185 2,742 7,007 1,487
29,180 10,555 354 1,883 268
2,913 1,230 69 114 11
18,697 50,596 6,860 19,180 119 1,019 2,166 4,856 187 3,212
297,971 154,382 6,548 22,130 6,614
192 2,719
3,834 20,552
9,406 51,748 19,192 52,681 360,652 177,761
25,780 111,443
3,825 38,415
364 3,973
4,497 14,456 23,532 64,407
68,114 419,531
13,767 5,786 7,391 2,516 1,076 4,177 1,049 231
858 576 657 178 122 387 98 35
10,633 6,925 2,890 871 577 1,596 834 60
14,955 148,508 10,705 100,784 15,276 71,364 4,143 18,927 2,371 12,447 9,105 41,755 3,309 15,143 2,223 3,472
74,616 51,973 29,659 9,521 5,323 18,203 6,682 976
57,250 37,555 18,000 3,199 3,409 12,526 4,906 378
15,613 7,080 8,465 3,173 1,145 5,143 1,264 357
1,365 862 942 255 154 554 155 50
12,511 7,756 3,071 1,041 634 1,966 932 118
19,025 13,850 18,767 5,377 2,915 11,795 4,391 2,743
180,380 119,076 78,904 22,566 13,580 50,187 18,330 4,622
35,993
2,911
24,386
62,087 412,400 196,953
137,223
42,240
4,337
28,029 78,863
487,645
Table D.21 Counts of point December 31 point
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+ Unknown
2009 M'care FFS 61 75 148 454 2,947 10,290 23,856 42,796 28,310 31,044 48,598 16,662 11,377 .
M'care/ Mcaid 190 205 359 896 6,795 14,958 26,069 35,077 16,220 15,790 21,581 5,563 3,520 .
EGHP 99 72 147 397 1,397 4,066 9,339 14,783 7,572 3,517 1,499 106 40 .
MSP Non-EGHP * 14 14 18 196 604 1,210 1,694 1,009 723 784 178 111 .
HMO * * * 18 361 1,276 3,497 7,651 5,920 9,480 18,518 6,176 3,720 .
Other/ unk 351 701 1,225 2,278 7,272 13,033 22,781 31,000 14,855 3,401 3,079 728 645 *
All 707 1,068 1,902 4,061 18,968 44,227 86,752 133,001 73,886 63,955 94,059 29,413 19,413 *
0-19 20-44 45-64 65-74 75+ Unknown
738 23,070 85,129 57,800 49,881 .
1,650 33,193 65,926 28,416 18,038 .
715 9,290 27,867 4,640 522 .
48 1,320 3,393 1,182 614 .
32 2,937 15,768 19,346 18,548 .
4,555 30,221 58,720 5,223 2,630 *
7,738 100,031 256,803 116,607 90,233 *
Male Female Unknown
131,831 84,787 .
72,647 74,575 *
26,303 16,731 .
4,421 2,136 .
31,517 25,113 *
56,557 44,785 *
323,276 248,127 11
White African American Native American Asian Other/unknown
142,436 62,992 2,578 7,650 962
71,373 63,458 2,968 8,469 955
29,355 11,000 419 2,135 125
4,221 2,053 76 179 28
35,966 16,813 227 3,413 212
63,917 24,369 1,414 8,519 3,132
347,268 180,685 7,682 30,365 5,414
†Hispanic †Non-Hispanic
22,455 194,163
29,761 117,462
4,306 38,728
621 5,936
9,756 46,875
20,967 80,384
87,866 483,548
83,335 57,217 30,099 10,729 4,707 21,786 7,211 1,534
62,638 40,153 17,591 3,591 3,030 14,227 5,274 719
15,486 7,674 8,141 3,336 950 5,682 1,332 433
2,202 1,316 1,305 410 182 834 239 69
25,884 15,569 5,459 1,985 967 4,610 1,830 327
25,700 18,569 22,288 7,203 3,272 15,176 5,677 3,466
215,245 140,498 84,883 27,254 13,108 62,315 21,563 6,548
216,618
147,223
43,034
6,557
56,631
101,351
571,414
Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing cause All
Table E.4 Percent of prevalent dialysis patients wait-listed for a kidney by age, gender, race, ethnicity, & primary diagnosis
<1 1-4 5-9 10-17 18-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1980 . 3.7 1.8 1.2 1.0 0.6 0.2 0.0 0.0 . . . .
1985 . 4.4 7.3 6.3 4.9 3.6 2.4 0.8 0.2 0.1 0.0 . .
1990 7.2 19.4 22.0 29.2 23.7 18.2 14.1 7.5 3.3 1.4 0.3 0.0 0.1
1995 4.8 21.3 29.0 28.2 29.0 24.1 19.2 12.5 6.7 3.5 0.6 0.1 .
2000 8.4 22.1 27.5 30.9 32.3 29.7 23.1 17.7 11.8 7.2 1.9 0.2 0.1
2001 3.5 33.6 32.3 34.2 33.3 30.5 24.0 18.7 13.1 8.3 2.2 0.3 0.0
2002 11.2 23.7 30.1 34.8 35.1 32.1 25.4 19.9 14.3 9.4 2.7 0.3 0.1
2003 8.0 27.0 29.0 35.3 36.9 33.7 26.4 20.9 15.3 10.5 3.2 0.3 0.1
2004 10.2 37.5 31.6 37.9 37.2 33.9 26.5 21.3 16.0 11.4 3.6 0.4 0.1
2005 13.3 31.4 30.1 36.9 36.9 34.5 27.3 21.6 16.4 12.1 4.0 0.5 0.1
2006 10.5 33.9 33.8 36.1 36.7 34.6 27.6 22.1 17.1 12.8 4.5 0.6 0.1
2007 17.7 37.0 36.3 37.4 37.1 34.8 28.7 22.3 18.1 13.6 4.9 0.6 0.1
2008 13.9 34.6 43.4 38.6 37.1 34.7 28.7 22.6 18.6 14.2 5.2 0.6 0.1
2009 9.1 40.8 37.4 37.0 37.4 34.0 29.0 22.9 18.8 14.9 5.7 0.8 0.2
0-17 18-44 45-64 65-74 75+
1.3 0.6 0.0 . .
5.9 3.7 0.8 0.0 .
25.8 18.6 7.2 1.0 0.1
26.2 23.9 12.0 2.2 0.1
27.9 28.4 16.9 5.0 0.5
31.6 29.3 17.9 5.8 0.6
31.7 30.8 19.2 6.7 0.7
32.0 32.3 20.2 7.8 0.8
34.7 32.5 20.5 8.4 0.9
33.7 33.1 20.9 9.1 1.1
33.3 33.3 21.3 9.7 1.2
35.4 33.8 22.0 10.4 1.4
36.3 33.5 22.3 10.9 1.5
33.1 33.6 22.5 11.6 1.6
Male Female
0.2 0.2
1.4 1.4
8.2 6.5
11.0 8.8
14.0 11.5
14.6 12.2
15.5 13.1
16.3 13.9
16.7 14.2
17.1 14.5
17.5 14.9
17.9 15.5
18.1 15.7
18.4 15.9
White African American Native American Asian
0.2 0.3 0.3 0.6
1.3 1.5 1.6 1.6
7.6 6.6 7.8 14.0
9.9 9.7 9.6 15.6
12.2 13.1 10.8 20.7
12.7 13.9 11.9 21.7
13.4 14.8 13.3 23.2
14.2 15.5 13.9 24.4
14.5 15.9 13.5 25.1
14.8 16.3 14.2 25.2
15.2 16.7 14.5 25.2
15.7 17.3 15.1 25.6
15.9 17.5 15.4 25.7
16.2 17.7 14.9 25.7
†Hispanic †Non-Hispanic
0.4 0.2
2.3 1.3
12.0 7.1
11.3 9.8
14.7 12.5
15.7 13.2
16.7 14.0
18.0 14.7
18.7 15.0
19.4 15.3
20.0 15.6
20.4 16.1
20.4 16.4
20.9 16.6
Diabetes Hypertension Glomerulonephritis Other cause
0.0 0.2 0.5 0.2
0.4 1.0 2.7 1.4
4.7 5.3 13.2 9.0
6.5 7.7 18.4 13.1
9.1 10.7 23.7 16.5
9.7 11.4 25.0 17.5
10.5 11.9 26.7 18.6
11.3 12.7 28.1 19.8
11.7 13.1 28.6 20.0
12.1 13.5 29.4 20.3
12.6 13.8 30.0 20.6
13.2 14.1 31.0 21.4
13.5 14.2 31.2 21.9
13.9 14.4 31.6 22.0
All
0.2
1.4
7.4
10.0
12.8
13.5
14.4
15.2
15.5
15.9
16.3
16.8
17.0
17.3
Table E.6 Renal transplants: by donor type
1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Deceased 2,580 2,870 3,400 3,965 4,610 4,944 5,778 6,061 7,276 7,104 7,802 7,747 7,694 8,187 8,382 8,609 8,584 8,620 9,005 8,977 9,035 9,116 9,443 9,529 10,236 10,811 11,576 11,450 11,385 11,291
Living donor relation Living Distantly Spouse/ Paired Unrelated Non(Total) Related related life partner exchange directed directed 915 . . . . . . 1,137 . . . . . . 1,551 . . . . . . 1,711 . . . . . . 1,930 . . . . . . 2,325 . . . . . . 2,856 . . . . . . 2,691 . . . . . . 1,838 1,648 37 40 . 30 * 1,919 1,731 31 54 . 31 . 2,098 1,776 46 59 . 30 . 2,402 2,192 48 59 . 47 . 2,544 2,260 71 80 . 78 . 2,873 2,458 100 120 . 69 . 3,009 2,375 127 134 * 76 . 3,395 2,793 181 260 . 155 . 3,687 2,840 214 363 . 223 . 3,940 3,001 233 381 . 274 . 4,422 3,158 296 547 . 362 * 4,728 3,289 348 577 . 476 * 5,497 3,618 411 669 * 774 20 6,042 3,884 468 716 * 926 28 6,236 3,848 494 721 * 1,108 54 6,473 3,848 478 732 19 1,309 75 6,649 3,831 510 803 34 1,383 80 6,570 3,697 506 832 27 1,426 69 6,433 3,510 491 823 74 1,452 58 6,043 3,181 491 798 111 1,286 79 5,968 3,045 464 757 226 1,295 80 6,388 3,146 502 836 277 1,377 119
Living-Dec'd exchange . . . . . . . . . . . . . . . . * * * * * * * * * 11 22 91 99 127
Unk. 915 1,137 1,551 1,711 1,930 2,325 2,856 2,691 82 72 187 56 55 126 296 * 45 48 56 31 * * . * * * * * * *
Unk. 293 226 162 200 202 239 254 190 131 128 141 126 173 116 116 165 132 121 185 152 108 81 74 87 72 77 62 28 63 57
Total 3,788 4,233 5,113 5,876 6,742 7,508 8,888 8,942 9,245 9,151 10,041 10,275 10,411 11,176 11,507 12,169 12,403 12,681 13,612 13,857 14,640 15,239 15,753 16,089 16,957 17,458 18,071 17,521 17,416 17,736
Table E.9 Renal transplant rates, by donor type by age, gender, race, ethnicity, & primary diagnosis, per 100 dialysis patient years ALL <1 1-4 5-9 10-17 18-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1980 77.4 36.6 54.4 31.2 21.5 14.9 9.5 3.5 0.5 0.2 . . 0.8
1985 52.9 68.6 76.8 44.1 26.3 19.5 13.1 5.5 1.7 0.5 0.1 0.1 0.4
1990 34.2 71.3 59.5 41.5 23.9 16.9 12.3 6.8 2.7 1.2 0.2 . 0.2
1995 41.4 43.8 51.5 45.7 18.5 13.8 9.7 6.0 3.2 1.5 0.3 . .
2000 36.1 48.7 42.9 38.1 15.6 11.9 8.6 5.9 3.6 2.2 0.5 0.1 .
2001 48.4 61.5 45.3 39.4 15.2 11.8 8.4 6.0 3.8 2.2 0.6 . .
2002 51.2 53.8 49.9 38.8 14.1 11.6 8.2 6.0 3.8 2.5 0.7 . .
2003 48.3 62.1 51.9 41.9 14.4 10.9 7.9 5.8 4.0 2.7 0.7 0.1 .
2004 42.8 60.7 40.6 37.6 14.8 11.3 8.0 6.0 4.1 2.8 0.8 0.1 .
2005 45.0 56.7 51.3 45.1 14.0 10.4 7.8 5.8 4.3 3.1 1.0 0.1 .
2006 51.0 59.7 47.9 48.9 14.0 10.1 7.6 5.8 4.2 3.2 1.0 0.1 .
2007 42.4 65.6 49.5 42.8 12.1 9.6 7.0 5.5 4.2 3.0 1.0 0.1 .
2008 33.7 46.9 49.2 43.4 12.0 8.6 6.7 5.1 4.2 3.0 1.1 0.1 .
2009 36.1 61.7 60.5 46.3 11.1 8.6 6.6 4.9 4.0 3.0 1.1 0.1 .
0-17 18-44 45-64 65-74 75+
35.0 16.1 3.7 0.2 .
50.7 20.3 5.4 0.3 0.1
46.2 17.9 6.2 0.8 0.1
46.2 13.9 5.7 1.0 0.1
39.5 11.7 5.7 1.5 0.1
42.6 11.5 5.8 1.5 0.2
42.5 11.2 5.7 1.8 0.2
45.1 10.8 5.6 1.9 0.2
40.0 11.0 5.8 2.0 0.2
46.7 10.5 5.6 2.3 0.3
49.8 10.1 5.6 2.4 0.3
45.4 9.4 5.3 2.3 0.3
43.7 8.7 5.0 2.3 0.3
48.7 8.6 4.8 2.3 0.3
Male Female White African American Native American Asian
8.5 6.3 . 8.6 4.8 6.0 11.9
10.0 6.9 . 10.1 5.4 8.4 9.6
8.5 6.1 . 9.1 4.2 5.4 10.0
6.6 4.6 . 7.1 3.5 4.1 5.9
5.6 4.3 . 6.4 3.0 3.6 5.3
5.5 4.3 . 6.2 3.1 3.6 5.4
5.4 4.3 . 6.2 3.1 3.2 5.1
5.3 4.2 . 5.9 3.1 3.3 5.3
5.3 4.2 . 5.9 3.1 3.7 5.5
5.3 4.2 . 5.7 3.2 3.4 5.5
5.3 4.1 . 5.6 3.2 4.5 6.5
4.9 3.8 . 5.1 3.0 4.3 7.4
4.6 3.7 . 4.8 2.9 4.2 7.1
4.5 3.7 . 4.6 2.9 4.9 7.3
†Hispanic †Non-Hispanic
11.1 7.4
14.3 8.3
10.3 7.2
6.0 5.6
4.8 5.0
4.7 5.0
4.7 4.9
4.5 4.8
4.6 4.9
4.5 4.8
4.4 4.8
4.1 4.5
4.0 4.2
3.8 4.2
Diabetes Hypertension Glomerulonephritis Other cause
9.3 5.2 11.4 6.3
9.0 5.1 12.6 8.2
6.2 4.1 11.7 9.2
4.3 3.3 10.0 8.2
3.4 3.0 9.5 7.9
3.4 3.1 9.2 7.9
3.4 3.0 9.5 7.6
3.2 2.8 9.4 7.9
3.3 3.0 9.7 7.7
3.2 3.1 9.4 7.8
3.1 3.1 9.7 7.6
3.0 3.0 8.8 7.0
2.8 2.9 8.5 6.6
2.7 2.8 8.2 6.7
7.5
8.5
7.4
5.7
5.0
4.9
4.9
4.8
4.8
4.8
4.8
4.4
4.2
4.1
All
Table E.9 (continued) Renal transplant rates, by donor type by demographic characteristics, & primary diagnosis, per 100 dialysis patient-years DECEASED DONORS <1 1-4 5-9 10-17 18-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1980 49.2 21.3 29.2 18.2 12.9 10.2 7.2 2.9 0.4 0.2 . . .
1985 34.8 40.9 37.9 24.8 16.3 13.0 9.2 3.8 1.2 0.3 0.1 . 0.4
1990 13.2 39.0 33.2 23.3 16.2 12.9 10.3 5.9 2.5 1.1 0.2 . 0.1
1995 10.1 17.6 21.1 22.2 11.4 9.7 7.2 4.6 2.5 1.2 0.3 . .
2000 9.0 17.6 18.4 17.9 7.9 7.2 5.4 3.9 2.5 1.6 0.4 . .
2001 10.3 17.5 18.9 16.8 7.0 7.0 5.1 3.9 2.4 1.5 0.4 . .
2002 7.4 23.9 21.3 16.8 6.7 6.8 5.0 3.8 2.6 1.6 0.5 . .
2003 12.7 24.8 24.2 20.5 6.2 6.2 4.8 3.6 2.7 1.8 0.5 0.1 .
2004 10.7 21.9 20.1 20.3 6.4 6.6 4.9 3.8 2.7 1.9 0.6 0.1 .
2005 12.8 25.4 26.5 25.4 6.4 6.2 4.8 3.7 2.9 2.2 0.7 0.1 .
2006 20.2 37.1 29.3 33.5 6.5 6.0 4.8 3.9 2.9 2.3 0.8 0.1 .
2007 20.6 35.4 29.4 28.3 5.6 6.0 4.5 3.7 2.9 2.2 0.8 0.1 .
2008 14.9 23.8 31.9 28.1 5.7 5.3 4.3 3.4 3.0 2.2 0.8 0.1 .
2009 20.9 32.0 36.1 29.4 5.0 5.2 4.1 3.2 2.8 2.1 0.8 0.1 .
0-17 18-44 45-64 65-74 75+
20.1 10.6 2.9 0.2 .
28.2 13.4 3.7 0.2 .
25.5 13.3 5.4 0.7 0.1
20.8 9.5 4.4 0.8 .
17.3 6.8 3.7 1.1 0.1
16.8 6.4 3.7 1.1 0.1
17.4 6.3 3.7 1.2 0.1
20.8 5.8 3.6 1.3 0.1
19.7 6.0 3.7 1.4 0.1
24.6 5.9 3.6 1.6 0.2
32.2 5.7 3.8 1.7 0.2
28.4 5.6 3.6 1.7 0.2
27.2 5.2 3.4 1.7 0.2
29.8 4.8 3.2 1.7 0.2
Male Female
5.9 4.1
6.7 4.4
6.7 4.7
4.8 3.2
3.5 2.6
3.3 2.5
3.3 2.5
3.2 2.4
3.2 2.5
3.3 2.6
3.4 2.6
3.3 2.5
3.0 2.4
2.8 2.4
White African American Native American Asian
5.7 3.7 3.9 8.0
6.4 4.1 4.1 6.2
6.9 3.7 3.9 8.2
4.9 2.8 2.6 4.3
3.7 2.2 2.5 3.4
3.5 2.3 1.9 3.4
3.4 2.3 2.1 3.3
3.2 2.3 2.1 3.5
3.2 2.3 2.6 3.9
3.3 2.4 2.4 3.8
3.3 2.5 3.0 4.2
3.1 2.4 2.6 4.4
2.9 2.3 2.8 4.2
2.7 2.3 3.1 4.0
†Hispanic †Non-Hispanic
5.7 5.1
7.9 5.5
7.8 5.6
4.0 4.0
2.8 3.1
2.8 3.0
2.9 2.9
2.7 2.8
2.8 2.9
2.9 3.0
2.9 3.1
2.8 2.9
2.7 2.8
2.4 2.7
Diabetes Hypertension Glomerulonephritis Other cause
6.4 3.8 7.4 4.4
5.9 3.6 8.2 5.4
4.8 3.6 8.7 7.0
3.3 2.5 6.6 5.4
2.3 2.0 5.6 4.4
2.2 2.1 5.1 4.1
2.2 2.0 5.3 4.0
2.2 1.9 5.1 4.1
2.2 2.0 5.5 4.1
2.3 2.1 5.4 4.2
2.2 2.3 5.7 4.4
2.2 2.2 5.2 4.1
2.1 2.1 5.0 3.9
2.0 2.0 4.8 3.8
All
5.1
5.6
5.7
4.0
3.1
3.0
2.9
2.8
2.9
3.0
3.0
2.9
2.8
2.6
Table E.9 (continued) Renal transplant rates, by donor type by demographic characteristics, & primary diagnosis, per 100 dialysis patient-years ALL LIVING DONORS <1 1-4 5-9 10-17 18-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1980 28.1 15.2 19.0 9.4 6.7 3.6 1.8 0.4 . . . . 0.8
1985 18.1 23.2 33.9 17.2 9.2 5.9 3.6 1.6 0.5 0.1 . . .
1990 20.9 31.4 24.7 17.6 7.4 3.7 1.8 0.9 0.2 0.1 . . 0.1
1995 31.2 26.1 29.3 22.6 6.8 4.0 2.3 1.3 0.6 0.3 0.1 . .
2000 27.1 29.5 24.2 19.8 7.5 4.6 3.2 2.0 1.1 0.6 0.1 . .
2001 38.1 44.1 25.7 21.8 8.1 4.7 3.2 2.1 1.4 0.7 0.2 . .
2002 43.7 29.9 28.3 21.5 7.2 4.7 3.2 2.1 1.3 0.9 0.2 . .
2003 35.6 37.2 27.4 21.2 8.2 4.7 3.1 2.2 1.3 0.9 0.2 . .
2004 32.1 38.8 20.1 17.0 8.3 4.7 3.0 2.2 1.4 0.9 0.2 . .
2005 32.3 31.3 24.8 19.5 7.5 4.2 2.9 2.1 1.3 0.9 0.2 . .
2006 30.7 22.7 18.6 15.2 7.4 4.1 2.8 1.9 1.3 0.9 0.3 . .
2007 21.9 30.2 20.1 14.5 6.5 3.6 2.5 1.8 1.2 0.8 0.2 . .
2008 18.8 23.2 17.3 15.2 6.1 3.3 2.4 1.6 1.2 0.8 0.3 . .
2009 15.2 29.7 23.9 16.5 6.1 3.4 2.5 1.7 1.1 0.9 0.3 . .
0-17 18-44 45-64 65-74 75+
11.1 4.3 0.5 . .
19.9 6.3 1.5 0.1 .
20.0 4.3 0.7 0.1 .
24.6 4.2 1.3 0.2 .
21.7 4.8 2.0 0.4 .
25.2 5.0 2.1 0.4 .
24.6 4.8 2.0 0.6 .
24.1 5.0 2.0 0.6 .
20.0 4.9 2.1 0.6 0.1
22.0 4.5 2.0 0.6 0.1
17.3 4.3 1.9 0.7 0.1
17.1 3.8 1.7 0.6 0.1
16.5 3.5 1.6 0.6 0.1
18.6 3.7 1.6 0.7 0.1
Male Female
2.0 1.6
3.0 2.2
1.7 1.4
1.7 1.4
2.0 1.7
2.1 1.8
2.1 1.7
2.1 1.7
2.1 1.7
2.0 1.6
1.9 1.4
1.7 1.3
1.6 1.3
1.6 1.3
White African American Native American Asian
2.3 0.7 1.8 1.9
3.4 1.1 4.2 3.0
2.2 0.5 1.5 1.6
2.2 0.7 1.5 1.5
2.7 0.7 1.0 1.9
2.7 0.8 1.7 1.9
2.7 0.8 1.1 1.8
2.7 0.8 1.2 1.7
2.6 0.8 1.1 1.6
2.5 0.8 1.0 1.6
2.3 0.7 1.6 2.3
2.0 0.6 1.6 3.1
1.9 0.6 1.5 2.9
1.9 0.6 1.8 3.4
†Hispanic †Non-Hispanic
4.0 1.8
5.8 2.5
2.4 1.5
1.9 1.6
1.9 1.9
1.8 2.0
1.8 1.9
1.8 1.9
1.7 1.9
1.6 1.8
1.5 1.7
1.3 1.6
1.2 1.5
1.4 1.5
Diabetes Hypertension Glomerulonephritis Other cause
2.4 1.0 3.0 1.5
2.9 1.4 4.1 2.6
1.3 0.5 2.8 2.1
0.9 0.7 3.2 2.7
1.0 0.9 3.9 3.5
1.1 0.9 4.1 3.8
1.1 1.0 4.1 3.5
1.0 0.9 4.3 3.8
1.0 1.0 4.2 3.6
1.0 0.9 4.0 3.5
0.9 0.9 3.9 3.2
0.8 0.8 3.6 2.9
0.7 0.8 3.4 2.7
0.7 0.8 3.4 2.9
1.3 0.1
1.3 0.3
1.2 0.6
1.3 0.7
1.2 0.7
1.1 0.8
1.1 0.8
1.0 0.8
0.9 0.8
0.8 0.7
0.7 0.7
0.7 0.8
1.5
1.6
1.9
2.0
1.9
1.9
1.9
1.8
1.7
1.5
1.4
1.5
Related donor Unrelated donor All
1.8
2.6
Table F.2 One-year graft survival probabilities: all deceased donor transplants by age, gender, race, ethnicity, primary diagnosis, & transplant number UNADJUSTED <1 1-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1980 * * 71.9 69.4 79.0 68.5 65.1 61.8 60.8 57.7 72.7 * . .
1985 77.3 50.0 76.1 79.6 70.5 75.9 76.2 73.7 68.7 69.5 66.7 * . *
1990 * 60.5 63.9 73.8 78.3 80.6 80.5 79.0 79.3 78.8 76.0 75.0 . *
1995 * 79.2 87.7 83.8 82.4 87.9 87.5 85.8 85.2 83.2 79.8 80.6 * *
1996 * 81.1 85.5 91.8 85.4 87.7 89.0 87.4 86.1 84.9 81.8 83.7 * *
1997 * 78.1 93.6 91.3 90.1 90.2 90.0 89.1 86.7 87.0 82.2 80.0 * .
1998 * 95.8 89.4 91.1 81.4 90.9 90.8 90.7 87.2 84.2 84.0 78.5 * *
1999 * 84.4 79.0 90.7 87.2 89.7 89.1 90.4 86.7 84.1 83.3 80.8 * *
2000 * 79.2 91.1 94.4 87.4 89.6 90.9 89.2 86.5 83.7 82.6 83.5 * *
2001 * 95.8 96.4 88.8 90.8 90.2 91.1 90.5 88.5 85.8 83.0 80.6 * *
2002 * 76.7 91.0 92.9 90.9 89.8 90.3 90.1 88.3 86.9 85.1 81.7 * *
2003 * 92.9 89.7 91.5 90.4 90.4 89.8 91.5 88.9 84.9 86.9 84.0 93.3 .
2004 63.6 96.8 89.3 93.7 92.7 93.0 90.7 91.8 88.7 87.5 84.7 85.6 94.1 *
2005 * 90.5 94.6 86.8 92.5 92.1 91.8 90.9 89.7 89.2 83.4 85.3 73.3 .
2006 88.9 93.9 92.6 93.8 90.8 93.0 92.6 91.4 89.7 88.7 88.5 83.2 85.2 *
2007 90.5 90.0 89.3 95.5 94.3 90.4 93.1 92.7 91.3 88.1 87.8 87.0 71.0 *
2008 75.0 95.2 94.1 94.2 91.3 92.3 93.7 93.3 90.0 89.9 90.2 87.6 83.3 *
Male Female
65.2 66.2
74.0 73.1
79.0 79.4
85.1 86.4
86.6 87.3
88.7 87.3
88.2 89.1
87.9 87.5
87.7 87.8
88.6 89.2
88.2 89.4
88.6 89.8
89.2 90.1
89.3 90.0
89.7 91.0
90.6 91.2
90.9 91.6
White African American Other race
67.6 58.7 61.5
74.6 70.4 78.2
79.6 77.1 82.7
85.4 85.4 89.6
87.4 85.3 87.7
88.6 86.2 93.2
88.9 86.7 92.4
88.6 85.3 89.6
88.8 84.6 90.3
89.5 86.9 90.1
89.5 86.5 89.9
90.1 86.4 90.3
89.8 88.1 93.0
89.8 88.3 92.2
90.5 88.6 92.8
91.5 88.8 92.8
91.7 89.6 93.4
. .
. .
. .
. .
89.0 86.7
90.3 88.0
91.6 88.2
89.6 87.5
89.9 87.4
91.6 88.4
91.9 88.2
91.4 88.7
91.6 89.3
91.1 89.3
91.4 90.0
92.6 90.5
92.7 90.9
Diabetes Hypertension Glomerulonephritis Other cause
62.1 64.8 69.3 64.3
76.0 71.6 75.8 71.5
78.3 79.2 80.0 79.0
86.6 85.9 85.7 84.3
87.5 87.3 86.9 86.0
87.7 86.1 89.6 88.9
88.4 87.8 89.1 88.7
88.1 86.9 87.9 87.9
87.4 84.9 89.3 88.6
89.3 87.1 89.9 88.6
88.0 87.3 89.8 89.4
88.5 87.8 89.7 90.0
88.3 89.7 90.0 90.6
88.7 89.1 90.3 90.3
88.6 90.6 91.0 91.0
90.1 90.6 91.7 91.2
89.5 92.0 93.1 91.2
First transplant Subsequent transplants
66.5 57.8
75.7 63.6
79.9 74.6
86.3 81.2
87.2 84.7
88.5 86.2
88.9 86.2
88.1 85.1
88.1 85.1
89.3 85.4
88.8 87.9
89.5 85.7
90.1 86.1
89.7 88.2
90.3 89.2
91.0 89.5
91.5 88.9
All
65.5
73.7
79.2
85.6
86.9
88.2
88.6
87.8
87.7
88.8
88.7
89.1
89.6
89.6
90.2
90.9
91.2
ADJUSTED 0-19 20-44 45-64 65-74 75+
73.0 64.2 56.0 74.5 .
71.5 75.4 69.3 61.2 *
72.9 79.6 78.7 74.1 *
83.4 87.2 84.9 79.8 64.9
86.3 88.4 86.0 82.0 75.5
89.5 89.8 87.5 81.5 74.7
87.1 91.2 87.3 82.7 73.9
86.7 89.6 87.2 82.9 72.0
88.8 90.3 86.7 83.1 75.5
91.0 90.9 88.6 82.6 75.2
90.3 90.8 88.4 84.2 78.0
90.7 90.9 88.8 86.3 83.0
91.7 91.7 89.4 85.6 80.0
90.4 92.2 89.8 84.7 76.9
91.4 92.6 90.0 87.0 81.0
92.8 92.7 91.0 87.7 83.2
91.8 93.5 90.8 89.4 86.5
Male Female
58.2 59.8
70.1 69.2
76.4 76.5
83.9 85.1
85.5 86.3
88.0 86.2
87.5 88.2
87.2 86.6
87.2 87.1
88.3 88.7
88.0 89.0
88.5 89.6
89.2 89.9
89.4 89.9
89.9 90.8
90.9 91.2
91.2 91.6
White African American Other race
60.3 55.6 52.3
70.1 68.6 72.8
76.8 75.8 79.1
84.1 84.7 87.7
86.4 84.6 86.1
87.7 85.6 92.2
88.2 86.2 91.3
87.8 84.8 88.8
88.3 84.1 89.4
89.1 86.6 89.3
89.3 86.2 89.0
90.1 86.2 89.9
89.8 87.9 92.5
90.0 88.2 91.8
90.8 88.5 92.4
91.8 88.8 92.5
92.0 89.6 93.2
Diabetes Hypertension Glomerulonephritis Other cause
52.8 65.0 65.2 59.3
70.2 72.2 73.0 68.2
73.9 79.9 78.0 76.3
84.6 86.5 84.6 82.7
85.8 88.0 85.8 84.6
86.3 87.0 88.8 87.7
87.3 88.7 88.2 87.6
87.1 87.8 87.1 86.7
86.6 86.2 88.7 87.7
88.8 88.3 89.4 87.6
87.5 88.5 89.4 88.7
88.4 89.0 89.4 89.4
88.3 90.7 89.6 90.0
88.8 90.3 90.0 89.7
88.8 91.6 91.0 90.4
90.5 91.7 91.5 90.7
89.9 93.0 93.1 90.7
First transplant Subsequent transplants
59.5 52.6
71.7 59.4
77.3 71.1
85.2 78.5
86.3 82.5
87.7 84.3
88.3 84.4
87.5 83.3
87.7 83.1
89.1 83.7
88.7 86.5
89.6 84.2
90.1 84.6
89.9 87.1
90.6 88.1
91.3 88.5
91.8 88.0
All
58.7
69.7
76.4
84.3
85.8
87.3
87.8
87.0
87.1
88.4
88.4
88.9
89.4
89.6
90.2
91.0
91.4
†Hispanic †Non-Hispanic
Table F.6 Ten-year graft survival probabilities: all deceased donor transplants by age, gender, race, ethnicity, primary diagnosis, & transplant number UNADJUSTED <1 1-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1980 * * 34.4 26.4 39.1 33.4 25.3 20.2 18.2 11.5 9.1 * . .
1985 54.6 17.7 32.8 28.7 24.6 33.8 31.1 26.2 18.9 15.9 7.7 * . *
1990 * 51.2 34.7 32.0 33.3 39.1 39.1 37.3 33.9 30.0 19.6 21.9 . *
1995 * 62.5 49.1 44.4 33.5 42.0 47.3 45.5 40.2 28.9 27.3 15.1 * *
1996 * 54.1 49.3 39.8 36.0 42.8 48.8 45.8 38.1 34.1 28.3 21.1 * *
1997 * 56.3 59.7 40.8 35.9 45.0 48.7 47.9 40.8 33.1 21.9 16.1 * .
1998 * 75.0 60.6 43.6 35.4 45.5 52.2 49.3 42.3 32.4 30.1 20.5 * *
1999 * 62.5 57.9 47.5 37.6 47.2 51.0 50.9 43.0 35.9 25.0 23.8 * *
Male Female
24.9 27.2
26.8 28.9
35.4 37.2
40.9 42.8
41.3 43.2
42.3 43.7
44.1 45.3
43.7 46.6
White African American Other race
29.4 12.4 25.6
31.2 14.5 42.2
39.2 24.7 45.7
44.3 32.2 55.0
45.0 32.3 51.7
46.4 31.6 53.0
47.9 33.9 53.2
47.9 34.2 55.6
49.4 41.3
48.1 42.3
50.5 43.8
48.1 44.5
†Hispanic †Non-Hispanic Diabetes Hypertension Glomerulonephritis Other cause
20.7 19.3 31.0 25.3
22.9 18.1 33.4 29.7
30.0 31.5 38.4 41.4
38.2 34.3 44.4 47.8
36.0 35.4 46.0 49.5
36.5 36.7 45.3 51.7
39.5 36.3 47.6 52.8
39.3 36.8 48.2 52.8
First transplant Subsequent transplants
27.0 15.1
29.7 17.0
36.6 33.5
42.6 35.5
42.8 36.7
43.3 39.6
45.0 41.4
45.2 42.2
All
25.7
27.6
36.1
41.6
42.0
42.9
44.6
44.9
0-19 20-44 45-64 65-74 75+
31.4 25.3 15.5 7.1 .
26.9 30.5 19.3 5.8 *
34.3 37.9 33.4 18.3 *
40.6 46.4 39.3 24.2 0.0
40.6 47.4 39.1 25.8 26.8
43.0 47.6 41.8 20.3 8.5
45.8 50.1 42.5 27.9 17.1
44.9 50.3 43.7 24.8 19.9
Male Female
18.4 19.9
21.5 23.6
31.5 32.1
38.3 39.6
38.6 40.5
40.1 40.8
42.2 42.6
41.8 43.9
White African American Other race
21.5 10.4 17.9
25.1 12.9 32.6
34.6 23.1 39.0
41.3 30.9 49.8
42.3 31.1 48.3
43.8 30.7 48.7
45.9 33.0 48.8
45.9 33.4 53.7
Diabetes Hypertension Glomerulonephritis Other cause
12.8 20.1 25.6 20.5
15.9 18.8 28.7 25.2
23.9 33.0 34.6 37.0
33.4 36.3 41.5 44.4
31.7 37.8 43.3 46.1
32.8 39.5 42.5 48.3
36.2 39.7 44.8 49.7
36.3 39.6 46.0 49.8
First transplant Subsequent transplants
19.9 11.9
23.9 14.1
32.3 28.9
40.2 30.7
40.6 32.3
41.3 35.4
43.3 37.3
43.5 38.3
All
18.9
22.3
31.7
38.8
39.3
40.4
42.3
42.6
ADJUSTED
Table F.8 One-year graft survival probabilities: all living donor transplants by age, gender, race, ethnicity, primary diagnosis, & transplant number UNADJUSTED <1 1-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1980 * * 91.7 91.5 87.9 88.8 90.1 81.5 78.6 . * . . *
1985 * 85.7 82.4 82.6 91.2 89.7 88.4 91.4 91.6 94.9 91.7 * . .
1990 87.5 71.0 84.8 77.5 83.4 93.1 90.2 89.4 87.4 89.7 86.4 * . *
1995 89.7 97.1 88.9 91.4 91.8 92.8 94.1 93.1 89.3 87.7 82.7 88.5 . .
1996 1997 88.0 100.0 85.4 92.6 90.1 98.3 95.8 92.3 94.0 92.3 95.0 95.3 93.5 95.3 94.8 93.3 92.4 92.7 92.9 91.2 88.2 92.1 92.0 93.9 . . . .
1998 97.0 90.6 97.1 96.9 92.1 93.4 95.1 95.7 94.3 92.8 93.1 78.3 . .
1999 97.1 95.9 94.3 93.0 96.2 93.9 94.6 94.3 93.6 93.4 93.7 91.4 * .
2000 87.0 93.0 98.3 93.0 93.8 93.4 95.7 93.8 93.4 94.8 92.8 88.4 * .
2001 92.1 98.3 93.4 94.8 94.6 94.7 95.1 94.4 93.6 92.5 91.8 92.6 * .
2002 97.5 91.5 97.5 98.5 95.2 95.8 95.4 94.7 94.1 94.3 93.3 92.6 * .
2003 86.7 96.4 96.2 97.1 95.8 95.3 95.1 95.5 95.9 94.6 93.7 91.3 * *
2004 93.6 96.4 98.5 93.1 94.3 96.0 94.0 96.4 95.3 93.5 95.4 89.8 * .
2005 2006 89.2 97.0 98.0 100.0 95.3 93.6 94.3 96.8 92.0 97.9 95.5 95.9 95.1 96.0 95.6 96.1 94.8 95.7 95.9 96.7 95.0 95.0 92.3 94.5 * * * *
2007 96.2 97.6 96.2 94.3 96.2 96.2 97.0 96.6 96.5 95.4 95.6 96.7 * *
2008 84.2 97.9 97.6 98.8 96.4 95.9 97.4 97.5 96.3 95.1 94.5 91.9 * .
Male Female
86.6 88.5
89.9 89.1
89.1 88.9
91.7 92.2
94.6 92.2
94.5 92.9
94.8 93.8
94.9 93.1
94.2 93.6
94.4 93.7
94.9 94.5
95.5 94.9
95.8 94.0
95.3 94.6
96.1 95.7
96.7 95.9
96.6 95.8
White African American Other race
87.9 83.3 85.0
90.4 85.7 87.1
88.8 88.4 94.4
92.0 91.1 94.6
94.0 91.2 96.0
93.9 92.9 96.3
94.5 93.1 95.7
94.3 92.2 97.1
94.3 92.2 93.5
94.3 92.6 95.3
94.9 93.5 96.0
95.3 94.7 95.9
95.1 93.7 97.4
94.9 94.1 97.8
96.1 94.6 96.7
96.4 95.7 97.0
96.4 95.3 96.5
94.5 93.5
95.8 93.6
94.6 94.3
94.7 94.1
94.4 93.9
95.1 94.0
96.0 94.6
96.1 95.1
96.0 94.9
95.2 95.0
96.9 95.8
97.0 96.3
97.5 96.1
†Hispanic †Non-Hispanic Diabetes Hypertension Glomerulonephritis Other cause
84.9 88.2 89.5 86.2
84.7 92.8 90.9 90.1
87.4 89.0 90.3 88.7
91.6 91.2 92.0 92.5
93.0 94.8 93.9 93.2
92.3 94.7 94.1 94.2
93.6 94.0 94.9 94.6
93.9 92.1 94.3 94.8
93.6 92.9 93.8 94.7
93.5 93.8 94.4 94.3
93.5 95.0 95.6 94.8
94.6 95.4 95.3 95.5
94.3 94.7 95.7 95.2
93.7 95.3 95.2 95.5
96.0 96.1 95.9 95.9
96.3 96.4 96.4 96.5
94.9 96.2 96.7 96.7
First transplant Subsequent transplants
87.1 92.0
90.0 85.6
89.5 82.0
91.9 92.5
93.6 93.0
94.0 92.0
94.5 92.8
94.3 91.8
94.2 91.3
94.3 92.0
95.0 93.0
95.3 94.8
95.3 93.3
95.3 92.5
96.2 93.9
96.7 93.8
96.3 95.7
All
87.4
89.6
89.0
92.0
93.6
93.8
94.4
94.1
93.9
94.1
94.8
95.2
95.1
95.0
96.0
96.4
96.3
ADJUSTED 0-19 20-44 45-64 65-74 75+
86.9 87.5 79.2 * *
84.5 89.8 91.3 93.1 *
79.0 91.4 87.8 86.6 *
90.1 93.4 91.0 85.4 *
91.4 94.4 93.6 88.9 *
92.6 94.9 92.7 92.3 *
93.6 94.7 94.8 90.2 *
94.1 94.3 94.0 93.3 *
92.6 94.3 94.2 91.6 83.1
93.5 94.8 93.9 92.8 84.2
95.4 95.2 94.7 93.8 88.2
94.9 95.6 95.4 93.4 88.1
93.7 95.1 95.5 94.5 89.2
92.0 95.3 95.4 94.7 87.0
96.6 96.2 95.9 95.2 94.1
94.8 96.4 96.5 96.0 98.4
95.7 96.7 96.5 94.3 90.9
Male Female
83.6 86.9
88.8 88.4
87.5 88.2
91.1 92.0
94.3 92.0
94.1 92.7
94.5 93.6
94.6 92.9
94.0 93.4
94.3 93.7
94.9 94.5
95.5 94.8
95.9 93.9
95.4 94.5
96.2 95.6
96.8 95.7
96.6 95.7
White African American Other race
85.2 82.6 80.0
89.1 86.0 84.9
87.4 88.8 93.6
91.3 91.3 94.0
93.5 91.4 95.7
93.3 93.1 96.2
94.1 93.3 95.5
93.9 92.4 96.8
94.1 92.4 92.8
94.1 92.8 95.4
94.9 93.7 95.9
95.2 94.9 95.6
95.1 93.8 97.1
94.9 94.3 97.5
96.2 94.7 96.4
96.5 95.8 96.7
96.5 95.4 96.1
Diabetes Hypertension Glomerulonephritis Other cause
81.5 87.3 88.3 84.7
82.1 93.0 90.2 89.4
85.0 88.6 89.5 87.6
91.0 91.5 91.5 92.0
92.6 95.0 93.5 92.8
91.9 94.9 93.7 93.8
93.3 94.2 94.5 94.3
93.8 92.5 93.9 94.5
93.6 93.2 93.4 94.3
93.6 94.2 94.1 94.0
93.7 95.4 95.4 94.6
94.7 95.7 95.2 95.3
94.5 95.2 95.5 95.0
94.0 95.7 95.1 95.3
96.3 96.4 95.7 95.7
96.5 96.7 96.2 96.3
95.3 96.5 96.6 96.6
First transplant Subsequent transplants
84.7 90.3
89.1 83.8
88.4 80.3
91.5 91.7
93.4 92.1
93.7 91.0
94.3 91.9
94.2 90.6
94.1 90.3
94.3 91.2
95.0 92.2
95.3 94.3
95.3 92.5
95.4 91.6
96.3 93.3
96.7 93.1
96.4 95.4
All
84.9
88.6
87.8
91.5
93.3
93.5
94.1
93.9
93.8
94.0
94.8
95.2
95.1
95.0
96.0
96.4
96.3
Table F.12 Ten-year graft survival probabilities: all living donor transplants by age, gender, race, ethnicity, primary diagnosis, & transplant number UNADJUSTED <1 1-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1980 * * 45.8 38.3 45.5 60.2 58.8 45.2 33.3 . * . . *
1985 * 71.4 51.0 37.2 39.5 55.8 52.2 55.4 50.4 64.4 33.3 * . .
1990 75.0 48.4 57.6 52.5 36.9 59.3 61.2 57.3 42.5 28.2 50.0 * . *
1995 69.0 60.0 63.0 47.4 53.6 56.3 62.5 58.0 48.4 37.0 27.2 38.5 . .
1996 76.0 68.8 63.4 51.3 56.0 59.1 61.5 60.4 52.7 45.6 40.2 24.0 . .
1997 78.6 81.5 63.3 54.8 51.4 62.2 65.4 59.0 54.0 43.4 43.0 18.2 . .
1998 81.8 75.0 73.5 62.5 44.6 56.8 65.4 64.5 56.5 47.4 32.4 37.0 . .
1999 74.3 85.7 71.4 60.5 51.0 57.9 69.5 63.3 61.0 45.7 32.9 37.9 * .
Male Female
51.9 54.4
51.2 54.1
55.7 54.1
56.6 53.2
58.7 55.7
59.4 56.9
59.6 58.5
60.6 60.5
White African American Other race
53.6 45.6 60.0
54.3 38.7 60.0
56.5 39.1 64.4
56.4 46.4 63.0
59.7 45.0 63.1
60.7 43.6 63.1
61.0 46.3 66.8
62.2 47.1 76.7
62.1 56.8
65.5 57.3
63.9 58.5
64.0 60.1
†Hispanic †Non-Hispanic Diabetes Hypertension Glomerulonephritis Other cause
46.2 54.0 54.1 53.7
39.6 48.3 55.9 58.2
46.6 49.0 58.0 59.2
45.6 48.3 56.9 61.8
47.3 49.0 60.0 64.8
44.2 51.3 63.3 64.4
48.4 53.3 61.4 66.0
48.1 52.2 62.5 69.0
First transplant Subsequent transplants
52.5 60.0
52.1 54.6
55.6 46.0
55.5 51.2
58.2 48.3
58.7 54.5
59.9 51.4
61.3 52.9
All
52.9
52.3
55.0
55.1
57.4
58.3
59.2
60.6
ADJUSTED 0-19 20-44 45-64 65-74 75+
37.1 56.2 36.4 * *
39.2 55.4 52.8 40.8 *
42.9 60.9 43.8 49.8 *
50.3 60.3 51.9 32.2 *
53.4 60.7 57.1 40.1 *
54.0 62.7 55.4 38.7 *
54.5 62.1 59.6 36.1 *
55.7 64.4 60.1 38.9 *
Male Female
44.5 48.8
48.3 51.4
51.5 50.9
54.2 52.3
57.2 54.5
57.1 55.4
58.1 57.3
59.4 59.3
White African American Other race
46.2 42.4 50.4
50.3 39.6 57.0
52.4 39.4 60.3
53.8 46.7 60.5
57.4 45.5 62.9
58.0 44.7 63.3
58.9 47.3 66.9
60.3 48.0 75.1
Diabetes Hypertension Glomerulonephritis Other cause
37.5 51.4 49.1 49.3
33.6 49.7 52.5 55.6
39.6 47.4 53.8 56.0
42.6 49.8 54.2 59.8
45.5 50.3 57.5 62.9
42.4 52.5 60.5 62.5
47.1 54.8 58.6 64.2
47.9 54.4 59.7 67.5
First transplant Subsequent transplants
46.0 53.6
49.4 51.0
52.0 43.1
53.9 48.4
57.3 44.3
57.1 50.6
58.8 47.6
60.4 49.1
All
46.1
49.3
51.1
53.2
55.9
56.3
57.6
59.2
Table G.1 Total admission rates: ESRD patients per 1,000 patient years, period prevalent patients, by age, gender, race, ethnicity, & primary diagnosis UNADJUSTED 0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1993 2,251 1,595 1,595 1,597 1,677 1,704 1,634 1,734 1,766 1,914 1,933 2,038 2,061
1994 2,058 1,804 1,695 1,616 1,620 1,737 1,633 1,783 1,817 1,950 1,980 2,110 2,123
Male Female
1,681 1,715 1,701 1,711 1,685 1,693 1,739 1,716 1,762 1,777 1,780 1,815 1,818 1,753 1,721 1,733 1,664 1,927 1,965 1,997 2,012 1,983 1,985 2,046 2,039 2,087 2,111 2,082 2,103 2,108 2,062 2,024 2,037 1,951
White African American Native American Asian
1,818 1,801 1,803 1,255
1,841 1,858 1,921 1,260
1995 2,593 1,581 1,741 1,654 1,634 1,731 1,671 1,750 1,839 1,943 2,009 2,085 2,107
1,865 1,842 1,999 1,254
1996 2,373 1,766 1,447 1,579 1,592 1,716 1,670 1,764 1,857 1,959 2,038 2,116 2,162
1,869 1,871 1,913 1,275
1997 2,291 1,864 1,374 1,391 1,556 1,678 1,637 1,751 1,812 1,932 2,006 2,106 2,182
1,840 1,840 1,892 1,319
†Hispanic †Non-Hispanic
1998 2,308 1,761 1,682 1,546 1,551 1,681 1,629 1,729 1,840 1,963 2,007 2,068 2,135
1,856 1,826 1,915 1,351
1999 2,193 1,896 1,416 1,617 1,605 1,724 1,690 1,781 1,877 1,997 2,057 2,142 2,213
1,899 1,896 1,987 1,406
2000 2,191 1,533 1,394 1,658 1,578 1,707 1,715 1,771 1,849 1,959 2,037 2,081 2,151
1,882 1,881 1,962 1,399
2001 2,216 2,247 1,487 1,728 1,612 1,736 1,788 1,809 1,892 1,998 2,069 2,138 2,203
1,921 1,946 1,932 1,383
2002 2,479 1,619 1,649 1,745 1,663 1,779 1,803 1,826 1,937 2,020 2,071 2,112 2,169
1,937 1,966 1,971 1,422
2003 2,103 1,823 1,708 1,707 1,691 1,754 1,805 1,827 1,893 2,005 2,048 2,072 2,199
1,923 1,959 1,960 1,394
2004 2,221 1,633 1,512 1,683 1,748 1,815 1,883 1,840 1,942 1,995 2,065 2,091 2,180
1,937 2,012 1,993 1,396
2005 2,781 1,738 1,709 1,656 1,760 1,814 1,872 1,835 1,912 2,008 2,074 2,147 2,187
1,943 2,015 1,908 1,419
2006 2,576 1,957 1,737 1,858 1,759 1,771 1,831 1,789 1,859 1,928 1,993 2,057 2,138
1,876 1,972 1,825 1,378
2007 2,483 1,943 1,582 1,737 1,837 1,740 1,775 1,766 1,820 1,869 1,965 2,021 2,088
1,843 1,935 1,746 1,354
2008 2,298 1,790 1,417 1,778 1,946 1,747 1,761 1,762 1,812 1,895 1,995 2,062 2,104
1,865 1,933 1,723 1,370
2009 2,484 1,786 1,704 1,837 1,919 1,754 1,713 1,721 1,750 1,786 1,865 1,915 1,956
1,782 1,861 1,747 1,309
1,805 1,846 1,802 1,866 1,892 1,891 1,876 1,865 1,794 1,764 1,771 1,719 1,833 1,888 1,876 1,920 1,937 1,923 1,957 1,963 1,908 1,872 1,884 1,804
Diabetes Hypertension Glomerulonephritis Other cause
2,208 1,750 1,476 1,561
2,233 1,790 1,481 1,593
All
1,798 1,834 1,842 1,853 1,826 1,830 1,884 1,868 1,913 1,931 1,919 1,947 1,950 1,893 1,857 1,869 1,792
ADJUSTED 0-19 20-44 45-64 65-74 75+
1,889 1,872 1,760 1,903 2,039
Male Female
1,768 1,801 1,769 1,781 1,748 1,746 1,789 1,761 1,798 1,804 1,802 1,834 1,836 1,768 1,733 1,747 1,674 1,977 2,004 2,023 2,033 1,997 1,988 2,040 2,030 2,072 2,095 2,065 2,085 2,086 2,041 2,006 2,019 1,936
White African American Native American Asian
1,901 1,859 1,748 1,402
1,882 1,874 1,784 1,943 2,091
1,912 1,920 1,835 1,385
2,210 1,779 1,527 1,609
1,761 1,887 1,770 1,935 2,093
1,916 1,897 1,940 1,365
2,231 1,775 1,488 1,633
1,846 1,874 1,772 1,958 2,120
1,911 1,931 1,885 1,392
2,179 1,746 1,471 1,606
1,652 1,824 1,741 1,932 2,087
1,874 1,895 1,887 1,429
†Hispanic †Non-Hispanic
2,181 1,734 1,464 1,616
1,769 1,818 1,733 1,939 2,066
1,878 1,874 1,950 1,438
2,234 1,791 1,472 1,673
1,822 1,882 1,778 1,981 2,119
1,910 1,945 1,982 1,479
2,205 1,769 1,477 1,650
1,803 1,863 1,776 1,939 2,095
1,889 1,929 1,909 1,464
2,233 1,824 1,505 1,706
1,630 1,921 1,814 1,971 2,134
1,919 1,985 1,904 1,427
2,228 1,847 1,527 1,738
1,372 1,967 1,833 1,977 2,130
1,929 2,001 1,926 1,458
2,208 1,834 1,528 1,711
1,487 1,958 1,821 1,979 2,090
1,912 1,993 1,870 1,426
2,221 1,864 1,551 1,755
1,401 2,021 1,856 1,966 2,126
1,924 2,047 1,904 1,423
2,212 1,863 1,558 1,773
1,379 2,019 1,840 1,976 2,151
1,923 2,052 1,844 1,444
2,140 1,810 1,519 1,716
2,277 1,955 1,799 1,903 2,076
1,858 2,006 1,770 1,392
2,082 1,783 1,481 1,712
2,267 1,914 1,771 1,867 2,031
1,824 1,968 1,697 1,368
2,091 1,788 1,505 1,724
2,609 1,941 1,764 1,885 2,067
1,847 1,971 1,697 1,377
2,010 1,697 1,456 1,651
2,240 1,925 1,717 1,777 1,928
1,769 1,891 1,734 1,308
1,834 1,866 1,800 1,861 1,888 1,877 1,858 1,846 1,776 1,751 1,757 1,700 1,862 1,912 1,897 1,937 1,949 1,932 1,965 1,969 1,913 1,877 1,890 1,810
Diabetes Hypertension Glomerulonephritis Other cause
2,211 1,736 1,566 1,585
2,239 1,763 1,565 1,629
2,207 1,760 1,616 1,629
2,235 1,748 1,577 1,673
2,182 1,726 1,569 1,649
2,183 1,713 1,559 1,650
2,239 1,760 1,563 1,709
2,211 1,743 1,572 1,681
2,240 1,790 1,600 1,732
2,237 1,811 1,611 1,767
2,224 1,798 1,615 1,749
2,245 1,832 1,629 1,800
2,241 1,826 1,643 1,814
2,184 1,773 1,602 1,753
2,128 1,746 1,561 1,750
2,150 2,065 1,756 1,677 1,584 1,526 1,763 1,678
All
1,863 1,893 1,885 1,895 1,862 1,858 1,904 1,884 1,924 1,938 1,922 1,949 1,950 1,892 1,857 1,870 1,792
Table G.2 Total admission rates: dialysis patients per 1,000 patient years, period prevalent patients, by age, gender, race, ethnicity, & primary diagnosis UNADJUSTED 0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1993 2,757 2,036 1,905 1,692 1,800 1,808 1,688 1,782 1,800 1,931 1,937 2,037 2,061
1994 2,587 2,447 2,040 1,745 1,700 1,809 1,685 1,839 1,854 1,969 1,985 2,110 2,123
Male Female
1,726 1,759 1,747 1,768 1,737 1,742 1,787 1,761 1,806 1,824 1,833 1,870 1,874 1,808 1,779 1,792 1,715 1,982 2,019 2,053 2,068 2,039 2,038 2,101 2,093 2,143 2,164 2,144 2,161 2,168 2,120 2,083 2,097 2,003
White African American Native American Asian
1,900 1,808 1,826 1,301
1,922 1,864 1,931 1,296
1995 3,312 2,068 2,163 1,736 1,696 1,826 1,746 1,801 1,877 1,961 2,015 2,085 2,107
1,949 1,853 2,032 1,305
1996 2,668 2,172 1,623 1,711 1,688 1,811 1,748 1,824 1,893 1,982 2,046 2,116 2,162
1,959 1,886 1,955 1,341
1997 2,559 2,391 1,509 1,499 1,636 1,786 1,700 1,805 1,850 1,954 2,012 2,107 2,183
1,928 1,852 1,938 1,366
†Hispanic †Non-Hispanic
1998 2,478 2,104 1,893 1,620 1,604 1,775 1,692 1,786 1,883 1,988 2,013 2,069 2,136
1,940 1,839 1,955 1,392
1999 2,310 2,505 1,655 1,560 1,660 1,814 1,760 1,843 1,920 2,026 2,064 2,142 2,213
1,978 1,915 2,013 1,452
2000 2,075 2,005 1,605 1,736 1,617 1,792 1,786 1,832 1,887 1,990 2,044 2,081 2,151
1,957 1,900 1,987 1,449
2001 2,182 3,192 1,636 1,796 1,677 1,827 1,856 1,865 1,940 2,027 2,077 2,138 2,203
1,995 1,966 1,961 1,428
2002 2,731 1,678 1,819 1,948 1,740 1,865 1,875 1,882 1,991 2,051 2,082 2,112 2,170
2,010 1,986 2,011 1,467
2003 2,416 2,067 1,802 1,725 1,794 1,861 1,896 1,896 1,942 2,045 2,061 2,074 2,199
2,005 1,984 1,996 1,440
2004 2,877 2,185 1,526 1,770 1,860 1,901 1,975 1,905 1,999 2,035 2,083 2,092 2,180
2,016 2,039 2,017 1,431
2005 3,371 2,405 1,637 1,797 1,866 1,899 1,971 1,902 1,969 2,048 2,092 2,148 2,187
2,023 2,042 1,920 1,461
2006 2,906 2,914 1,725 2,019 1,883 1,871 1,927 1,853 1,913 1,974 2,014 2,059 2,138
1,951 2,003 1,851 1,431
2007 2,980 2,444 1,697 1,979 1,990 1,839 1,866 1,830 1,875 1,923 1,989 2,025 2,088
1,922 1,964 1,778 1,408
2008 3,171 1,954 1,556 1,994 2,109 1,846 1,842 1,826 1,866 1,950 2,026 2,065 2,105
1,947 1,964 1,745 1,408
2009 2,792 1,862 1,866 1,971 2,080 1,848 1,785 1,781 1,802 1,838 1,891 1,920 1,957
1,852 1,889 1,764 1,351
1,853 1,904 1,850 1,921 1,954 1,964 1,937 1,922 1,847 1,820 1,821 1,764 1,887 1,942 1,928 1,971 1,987 1,980 2,015 2,022 1,966 1,932 1,947 1,858
Diabetes Hypertension Glomerulonephritis Other cause
2,236 1,773 1,554 1,623
2,261 1,816 1,530 1,671
All
1,850 1,885 1,896 1,913 1,882 1,884 1,938 1,919 1,965 1,983 1,978 2,005 2,009 1,951 1,917 1,930 1,845
ADJUSTED 0-19 20-44 45-64 65-74 75+
2,184 1,987 1,794 1,911 2,038
Male Female
1,790 1,821 1,795 1,815 1,778 1,777 1,820 1,790 1,827 1,838 1,842 1,875 1,878 1,811 1,778 1,792 1,716 2,011 2,039 2,065 2,071 2,034 2,024 2,078 2,069 2,114 2,135 2,115 2,131 2,137 2,090 2,056 2,072 1,983
White African American Native American Asian
1,952 1,864 1,747 1,406
2,220 1,967 1,824 1,949 2,091
1,964 1,921 1,836 1,387
2,246 1,811 1,587 1,678
1,962 2,005 1,816 1,944 2,094
1,974 1,902 1,965 1,378
2,271 1,811 1,553 1,713
2,020 2,002 1,822 1,971 2,121
1,974 1,938 1,913 1,414
2,217 1,774 1,536 1,684
1,815 1,944 1,787 1,943 2,086
1,934 1,900 1,917 1,427
†Hispanic †Non-Hispanic
2,216 1,762 1,523 1,688
2,096 1,925 1,783 1,951 2,065
1,937 1,879 1,973 1,437
2,271 1,820 1,532 1,740
2,011 1,988 1,830 1,996 2,120
1,967 1,955 1,983 1,483
2,239 1,797 1,535 1,718
2,035 1,963 1,825 1,955 2,096
1,943 1,940 1,914 1,470
2,266 1,851 1,562 1,780
1,860 2,029 1,861 1,988 2,133
1,974 1,998 1,922 1,430
2,258 1,873 1,589 1,820
1,395 2,067 1,885 1,997 2,130
1,986 2,015 1,965 1,462
2,244 1,869 1,600 1,801
1,459 2,082 1,883 2,005 2,091
1,981 2,010 1,906 1,430
2,255 1,897 1,619 1,850
1,442 2,143 1,915 1,993 2,128
1,990 2,067 1,924 1,420
2,246 1,899 1,641 1,863
1,403 2,135 1,904 2,004 2,153
1,993 2,072 1,854 1,443
2,176 1,850 1,587 1,805
2,572 2,068 1,859 1,935 2,079
1,923 2,030 1,795 1,403
2,118 1,824 1,559 1,805
2,712 2,021 1,831 1,907 2,035
1,893 1,991 1,736 1,385
2,127 1,830 1,585 1,822
2,831 2,045 1,824 1,930 2,073
1,918 1,995 1,716 1,382
2,042 1,734 1,532 1,728
2,369 2,018 1,772 1,818 1,935
1,832 1,914 1,756 1,324
1,851 1,888 1,815 1,884 1,917 1,917 1,892 1,875 1,805 1,785 1,790 1,730 1,900 1,952 1,936 1,976 1,990 1,981 2,015 2,021 1,966 1,931 1,945 1,860
Diabetes Hypertension Glomerulonephritis Other cause
2,251 1,754 1,605 1,615
2,277 1,785 1,580 1,671
2,253 1,787 1,645 1,667
2,285 1,779 1,610 1,715
2,229 1,749 1,600 1,693
2,231 1,739 1,590 1,690
2,289 1,784 1,597 1,751
2,257 1,769 1,605 1,724
2,284 1,816 1,631 1,781
2,276 1,837 1,652 1,823
2,271 1,835 1,666 1,814
2,293 1,866 1,676 1,865
2,285 1,864 1,705 1,878
2,234 1,814 1,649 1,821
2,178 1,788 1,620 1,823
2,194 2,105 1,800 1,716 1,647 1,590 1,839 1,741
All
1,890 1,919 1,918 1,932 1,895 1,891 1,939 1,917 1,959 1,974 1,967 1,993 1,996 1,938 1,905 1,919 1,836
Table G.5 Total admission rates: transplant patients per 1,000 patient years, period prevalent patients, by age, gender, race, ethnicity, & primary diagnosis UNADJUSTED 0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+ Male Female White African American Native American Asian
1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 1,126 1,085 1,398 1,379 1,515 1,635 1,406 1,755 1,731 1,793 824 1,010 902 1,022 949 1,183 1,299 1,071 1,084 1,283 987 824 857 810 897 1,017 783 908 1,039 1,053 890 804 1,053 988 963 973 1,105 1,235 1,191 1,029 851 854 890 814 817 888 878 904 875 923 890 973 880 919 871 869 914 913 903 979 872 906 823 829 847 844 832 823 902 898 897 849 897 856 890 823 828 839 895 898 850 881 841 867 953 889 898 987 913 906 851 938 990 922 859 903 988 912 1,003 993 980 972 988 846 1,017 954 1,037 960 1,062 994 * * * * * * 917 1,318 1,104 2,133 * * * * * * * * * *
2005 1,760 964 1,158 1,045 939 960 829 847 903 989 965 1,021 *
2006 1,570 1,202 1,367 1,242 853 882 787 811 868 890 962 1,247 *
2007 1,360 1,062 1,105 1,077 871 811 767 812 799 833 916 954 *
2008 1,321 1,238 885 1,170 927 827 759 797 856 825 824 1,038 767
2009 1,562 1,261 1,052 1,259 881 809 759 755 788 810 820 754 1,119
841 826 992 1,021
780 990
751 946
758 939
737 912
839 866 847 834 830 830 854 868 899 911 870 873 870 843 1,070 1,081 1,047 1,049 1,075 1,030 1,013 1,012 1,041 1,069 1,011 1,030 1,050 970 1,060 1,072 1,112 918 941 1,030 1,002 1,067 1,121 929 937 1,145 1,127 1,078 579 534 478 407 573 558 616 543 603 598 552 551 559 549
800 944 936 566
786 963 958 650
767 932 984 573
788 835
802 833
780 809
847 931
857 972
833 957
817 949
818 969
†Hispanic †Non-Hispanic
810 960
886 869
821 979
826 894
838 864 867 974 1,015 1,042
874 896
893 931
905 944
2003 1,328 1,192 1,039 1,165 883 897 834 841 972 932 1,018 597 * 839 972
850 901
2004 1,186 1,061 1,067 1,139 897 924 853 854 921 955 992 960 *
875 908
875 911
856 866
Diabetes 1,313 1,378 1,286 1,283 1,251 1,215 1,232 1,231 1,258 1,259 1,212 1,197 1,208 1,150 1,057 1,062 1,032 Hypertension 875 845 793 767 863 828 807 801 847 914 840 831 790 744 762 759 697 Glomerulonephritis 682 726 721 695 694 680 679 721 759 753 743 756 716 711 671 706 674 Other cause 735 709 736 720 717 759 810 796 812 808 738 780 836 784 775 741 752 All
881
904
883
869
879
871
886
893
926
939
894
903
906
865
828
829
805
ADJUSTED 0-19 20-44 45-64 65+
952 816 1,221 1,061 1,128 916 1,170 740 810 653 908 884 1,061 1,136 1,062 1,078 1,013 1,018 1,023 1,004 1,028 1,020 1,021 1,108 1,003 1,014 1,047 994 1,011 1,018 953 944 973 930 925 939 985 972 937 949 927 875 1,003 1,055 1,141 1,018 1,006 993 1,114 1,024 1,121 1,107 1,063 1,028 1,056 983
704 2,004 1,489 942 970 958 862 862 815 926 878 851
Male Female
1,019 1,044 1,009 962 966 1,027 1,051 1,073 1,007 1,017
947 950 945 995 987 959 958 936 875 993 1,088 1,024 1,099 1,109 1,041 1,022 1,075 1,019
830 990
824 960
799 927
White African American Other race
977 993 956 902 901 896 935 923 985 977 932 931 940 901 1,050 1,129 1,202 1,145 1,124 1,075 1,171 1,104 1,157 1,182 1,129 1,091 1,126 1,014 1,007 831 789 627 786 880 905 782 894 784 740 783 773 799
861 982 747
828 975 762
800 940 727
890 887
854 869
842 838
†Hispanic †Non-Hispanic
961 933
877 999
878 961 924 969 1,030 1,029
894 980
957 961
974 973
965 919
Diabetes 1,323 1,328 1,277 1,245 1,181 1,140 1,231 1,224 1,286 1,258 1,219 1,195 1,232 1,171 1,082 1,088 1,068 Hypertension 877 899 901 808 928 897 896 816 891 939 887 860 840 789 810 787 715 Glomerulonephritis 770 832 855 826 824 773 824 813 887 813 842 860 791 767 744 750 676 Other cause 756 793 856 814 759 832 914 829 861 876 763 834 902 788 739 718 746 All
1,021 1,043 1,035
976
982
962 1,014
978 1,041 1,040
992
981
995
937
900
883
854
Table H.1 Total patient deaths: ESRD patients period prevalent patients, by age, gender, race, ethnicity, primary diagnosis, & patient vintage
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1980 * 15 28 47 345 791 1,125 2,180 1,470 1,730 2,216 383 138
1985 23 15 23 47 411 1,212 1,718 3,458 2,818 3,212 5,269 1,133 452
1990 56 27 34 69 563 1,860 2,859 4,710 4,060 5,398 9,607 2,524 1,162
1995 37 16 26 61 592 2,334 4,530 7,157 5,656 7,755 16,453 5,047 2,626
2000 38 12 17 53 534 2,191 5,488 10,343 7,406 9,632 23,293 8,418 5,420
2001 52 20 17 55 584 2,252 5,822 11,129 7,772 9,999 24,180 9,188 5,934
2002 38 * 28 53 610 2,232 5,965 11,579 7,867 10,006 24,767 9,852 6,646
2003 32 21 32 77 577 2,169 5,985 12,179 8,580 10,376 25,078 10,285 7,206
2004 36 13 24 58 578 2,106 6,030 12,517 8,791 10,506 25,243 10,804 7,507
2005 41 * 29 72 595 2,055 6,097 12,803 8,785 10,599 25,372 11,286 8,237
2006 38 12 20 64 592 2,009 5,965 13,570 9,113 10,656 25,311 11,530 8,829
2007 36 * 19 40 564 2,059 5,833 13,357 9,234 10,849 24,936 11,644 9,287
2008 39 13 * 49 570 1,926 5,558 13,453 9,596 11,181 25,128 11,489 9,657
2009 41 16 20 38 583 1,905 5,675 13,485 10,175 11,551 25,078 11,497 10,054
0-19 20-44 45-64 65-74 75+
100 1,601 4,310 3,061 1,406
108 2,351 7,266 6,250 3,816
186 3,731 10,321 10,589 8,102
140 4,949 15,320 16,652 15,229
120 4,989 20,973 21,221 25,542
144 5,114 22,445 21,889 27,412
129 5,215 23,038 22,248 29,023
162 5,094 24,396 22,510 30,435
131 4,996 25,026 22,758 31,302
151 4,962 25,373 22,838 32,656
134 4,863 26,386 22,755 33,571
105 4,800 26,247 22,871 33,845
110 4,618 26,485 23,384 34,071
115 4,634 27,189 23,938 34,242
Male Female
5,947 4,531
10,977 8,814
17,678 15,251
27,361 24,924
38,002 34,842
40,377 36,626
41,883 37,770
43,925 38,667
45,187 39,026
46,462 39,516
47,579 40,128
48,085 39,783
48,887 39,781
50,212 39,906
White Af Am N Am Asian Other/unk.
7,555 2,654 30 14 225
14,107 5,189 157 187 151
22,874 9,111 364 490 90
35,230 15,068 561 1,180 251
48,406 20,673 903 1,917 946
51,068 22,032 872 2,125 907
53,051 22,492 936 2,240 934
54,763 23,518 964 2,417 935
55,634 24,116 945 2,521 997
57,009 24,363 975 2,684 949
58,640 24,598 956 2,771 744
58,914 24,463 954 2,953 584
59,602 24,547 1,054 2,904 561
60,708 24,799 1,076 3,092 443
7,199 65,646
7,822 69,182
8,211 71,442
8,786 73,811
9,069 75,144
9,401 76,579
9,612 78,097
9,587 78,281
9,969 78,699
10,394 79,724
†Hispanic †Non-Hisp. Diabetes HTN GN Cystic kidney Oth. urologic Other cause Unk. cause Missing
1,239 1,209 983 264 150 784 981 4,868
5,066 4,824 2,404 624 595 1,925 1,481 2,872
10,859 9,923 4,127 900 994 3,158 1,711 1,257
20,495 16,112 5,361 1,167 1,264 5,062 2,008 821
32,365 20,443 6,317 1,323 2,053 6,723 2,746 875
34,799 21,454 6,365 1,457 2,135 7,100 2,949 745
35,874 22,284 6,480 1,423 2,240 7,605 3,015 732
37,350 23,135 6,559 1,419 2,292 7,927 3,131 784
38,178 23,771 6,327 1,427 2,379 8,068 3,271 792
39,005 24,330 6,347 1,444 2,268 8,325 3,385 876
40,068 24,744 6,185 1,466 1,864 9,114 3,385 883
39,917 24,895 6,071 1,499 1,767 9,564 3,393 762
40,342 25,247 5,752 1,397 1,570 10,019 3,449 892
41,055 25,490 5,924 1,522 1,538 10,270 3,429 890
<2 years 2-<5 years 5+ years
6,538 3,228 712
10,861 5,625 3,305
18,065 8,810 6,054
26,059 15,907 10,324
35,629 20,845 16,371
37,235 22,181 17,588
38,012 23,198 18,443
38,871 23,966 19,760
38,878 24,578 20,757
39,358 24,824 21,798
39,802 25,188 22,719
39,430 24,831 23,607
39,190 25,193 24,285
38,782 25,622 25,714
10,478 9,287
19,791 18,170
32,929 31,139
52,290 50,042
72,845 69,181
77,004 73,175
79,653 75,737
82,597 78,565
84,213 79,978
85,980 81,688
87,709 83,601
87,868 83,914
88,668 84,678
90,118 86,262
All All with unknowns dropped
Table H.2 Annual mortality rates: ESRD patients per 1,000 patient years at risk, period prevalent patients, by age, gender, race, ethnicity, primary diagnosis, & patient vintage UNADJUSTED 0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1980 116.7 60.8 40.3 27.8 48.0 79.1 112.3 153.1 228.1 290.3 351.9 498.3 613.0
1985 67.8 33.4 34.2 24.3 39.7 68.1 97.5 162.1 228.2 287.7 371.1 496.8 599.6
1990 69.1 14.1 13.2 16.4 39.8 65.9 92.1 147.3 209.7 276.4 358.6 451.8 565.9
1995 57.5 17.8 13.9 23.0 36.6 61.6 88.8 138.2 196.7 249.7 335.4 453.2 539.9
2000 64.8 13.3 7.0 17.0 30.5 52.7 79.8 128.1 184.3 238.6 331.6 446.5 574.3
2001 81.8 17.0 6.8 17.8 34.3 54.6 82.2 128.3 182.0 235.4 326.8 451.2 559.8
2002 61.7 8.7 14.4 16.1 35.6 52.5 81.2 124.9 173.6 227.0 321.3 440.1 565.2
2003 58.9 18.6 17.1 21.6 34.1 50.0 79.1 123.2 178.4 222.4 313.1 429.9 548.1
2004 51.2 13.5 11.2 16.4 33.0 48.0 76.7 119.2 171.1 215.9 306.3 417.4 531.4
2005 44.0 8.2 15.7 17.0 32.9 47.0 75.7 114.2 160.6 208.8 299.7 419.9 534.4
2006 41.9 8.2 10.4 16.7 32.9 46.2 72.9 114.0 157.7 198.3 288.7 410.0 521.4
2007 45.7 6.0 10.2 10.9 31.1 46.3 68.8 107.7 147.8 189.9 274.9 398.9 517.9
2008 49.1 9.1 4.3 12.5 30.5 42.6 64.4 103.2 142.1 182.4 265.7 382.6 495.9
2009 41.4 15.1 9.7 8.5 30.1 41.8 64.1 100.8 137.4 178.1 256.1 368.1 478.5
Male Female
161.5 159.2
172.3 170.6
171.3 175.9
169.8 182.3
168.2 186.9
169.5 188.1
167.0 185.9
167.1 182.9
164.1 177.5
161.3 173.7
157.9 170.1
152.4 162.7
147.6 156.5
145.7 151.6
White Af Am Other race
164.2 152.1 150.1
179.7 156.3 142.1
182.3 159.9 134.4
186.4 161.5 132.3
188.8 159.4 149.5
189.2 163.6 143.3
187.8 159.4 140.9
185.7 160.0 138.1
180.6 158.2 133.0
178.1 154.0 128.3
175.2 149.5 122.3
169.1 142.8 116.4
163.8 137.0 111.6
160.9 133.3 108.8
148.9 180.4
149.8 181.9
146.8 179.7
145.2 178.6
139.9 174.8
136.4 171.7
130.5 168.7
121.8 162.9
117.8 157.4
116.5 154.0
†Hispanic †Non-Hisp. Diabetes HTN GN Other cause
257.0 135.7 75.7 188.8
266.0 189.2 91.2 169.2
244.8 203.7 100.5 142.5
233.8 204.7 95.0 135.0
232.7 200.5 89.0 134.9
234.2 201.4 87.5 135.3
227.6 200.3 86.2 134.6
225.2 197.9 85.3 133.9
219.4 195.1 79.9 130.3
213.9 193.1 78.6 126.4
209.3 189.8 75.2 123.2
199.1 182.6 72.4 120.3
192.4 176.5 67.3 115.9
187.9 170.3 68.1 113.6
<2 years 2-<5 years 5+ years
194.2 140.4 78.0
222.6 153.7 106.0
224.1 165.5 107.2
217.3 186.6 110.1
224.7 184.0 115.8
227.1 186.0 117.0
224.4 186.3 114.6
224.5 183.7 115.0
218.3 181.6 113.7
215.1 178.8 112.3
210.9 176.7 110.0
202.8 169.0 107.6
196.1 163.9 104.7
190.3 161.4 104.9
All
160.5
171.5
173.4
175.6
176.7
177.9
175.5
174.2
170.1
166.8
163.3
156.9
151.5
148.3
ADJUSTED 0-19 20-44 45-64 65-74 75+
50.9 91.4 170.1 274.1 386.2
50.9 82.4 184.1 312.7 429.8
36.1 75.9 162.6 289.9 410.5
35.5 71.0 144.1 264.7 393.6
30.2 64.4 131.3 254.2 398.3
30.8 64.6 131.1 250.6 398.4
29.6 65.1 127.3 243.8 389.8
34.0 64.1 126.4 238.2 382.8
30.5 62.0 122.9 230.6 375.9
30.2 60.7 119.2 224.7 371.5
27.1 59.4 116.5 214.9 364.3
23.8 57.4 111.1 203.5 353.0
22.2 54.8 106.7 195.0 341.0
20.7 53.6 104.0 190.6 332.6
Male Female
220.8 200.4
236.7 218.0
215.9 200.3
194.5 190.4
182.1 184.7
181.0 184.3
176.2 180.5
174.0 177.2
170.1 171.5
166.8 167.1
162.5 163.0
155.9 156.2
150.3 150.2
147.3 145.6
White Af Am Other race
227.8 180.8 192.8
251.0 190.3 209.9
225.2 187.8 173.5
206.2 179.4 144.6
191.6 174.7 154.1
189.4 177.6 150.1
184.5 173.9 144.2
180.9 173.4 140.4
175.1 170.9 136.0
171.1 168.1 132.0
167.0 163.1 126.3
160.5 155.3 120.3
155.0 148.7 115.0
151.7 144.3 111.7
Diabetes HTN GN Other cause
274.3 161.0 139.9 199.7
292.1 193.3 152.7 210.4
258.8 188.3 153.6 187.5
235.5 180.3 137.8 172.7
224.0 170.6 128.5 167.5
222.3 170.3 127.7 167.9
214.9 167.6 125.0 165.6
210.8 165.3 122.9 164.7
204.3 161.6 117.9 161.8
199.5 159.3 115.0 158.2
194.4 156.2 110.6 152.4
185.7 150.4 105.7 146.2
178.5 145.9 100.0 140.7
173.9 142.4 98.9 137.0
<2 years 2-<5 years 5+ years
256.2 214.4 144.1
256.6 219.9 194.6
228.2 205.9 182.7
202.7 200.7 168.9
193.0 184.3 166.7
192.9 182.6 166.0
188.9 179.0 160.7
187.3 175.2 157.2
182.4 170.4 152.7
179.2 166.0 149.0
175.1 162.1 144.0
168.5 154.9 137.9
162.7 149.1 132.2
158.4 145.6 129.0
All
211.2
228.2
208.7
192.4
183.1
182.3
178.1
175.3
170.5
166.8
162.6
155.9
150.2
146.4
Table H.3 Total patient deaths: dialysis patients period prevalent patients, by age, gender, race, ethnicity, primary diagnosis, & patient vintage
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1980 * * * 22 228 522 823 1,656 1,178 1,364 1,707 277 83
1985 * * * 37 279 878 1,310 2,816 2,401 2,684 4,380 904 323
1990 1995 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 18 21 26 31 21 21 20 18 17 21 22 22 * * * 14 * 14 * * * * * * 13 14 * * 17 24 19 18 * 15 * * 25 39 29 34 31 44 36 30 43 27 27 21 393 435 422 460 470 479 474 468 454 444 460 459 1,358 1,817 1,732 1,778 1,774 1,722 1,667 1,624 1,652 1,667 1,566 1,534 2,110 3,476 4,339 4,630 4,763 4,811 4,865 4,913 4,833 4,705 4,465 4,524 3,757 5,800 8,326 9,036 9,462 9,876 10,221 10,272 10,911 10,819 10,851 10,907 3,372 4,682 6,092 6,352 6,483 7,054 7,233 7,185 7,446 7,538 7,819 8,229 4,576 6,485 8,003 8,321 8,342 8,573 8,644 8,685 8,752 8,854 9,118 9,302 7,996 13,727 19,437 20,074 20,611 20,876 20,995 21,066 20,857 20,468 20,621 20,434 2,022 4,199 6,726 7,469 8,086 8,517 8,920 9,291 9,504 9,598 9,492 9,474 908 2,079 4,330 4,686 5,193 5,605 5,874 6,513 6,990 7,469 7,750 8,121
0-19 20-44 45-64 65-74 75+
42 1,099 3,308 2,390 1,041
66 1,697 5,987 5,207 3,084
62 80 68 85 72 103 84 72 78 69 64 62 2,701 3,810 3,933 4,021 4,171 4,063 4,005 3,938 3,917 3,848 3,722 3,702 8,289 12,400 16,978 18,235 18,781 19,879 20,455 20,524 21,379 21,325 21,439 21,951 8,899 13,993 17,689 18,214 18,535 18,715 18,836 18,858 18,687 18,633 19,099 19,384 6,603 12,497 20,807 22,336 23,697 24,856 25,597 26,697 27,416 27,756 27,882 27,947
Male Female
4,323 3,557
8,710 13,924 21,972 30,581 32,413 33,787 35,455 36,458 37,266 38,204 38,618 39,241 40,175 7,331 12,630 20,808 28,894 30,478 31,469 32,161 32,519 32,823 33,273 33,013 32,965 32,871
White Af Am N Am Asian Other/unk.
5,604 11,197 17,996 28,077 38,336 40,402 42,229 43,475 44,119 45,066 46,313 46,566 47,080 47,645 2,084 4,440 7,764 13,077 17,933 19,174 19,506 20,434 21,074 21,115 21,317 21,255 21,285 21,462 23 134 322 478 784 760 837 833 817 847 829 830 890 915 * 159 419 1,012 1,656 1,816 1,926 2,102 2,174 2,280 2,352 2,468 2,473 2,635 161 111 53 136 766 739 758 772 793 781 666 512 478 389
†Hispanic †Non-Hisp.
6,014 6,632 7,055 7,527 7,770 8,043 8,148 8,181 8,454 8,885 53,461 56,259 58,201 60,089 61,207 62,046 63,329 63,450 63,752 64,161
Diabetes HTN GN Cystic kidney Oth. urologic Other cause Unk. cause Missing
1,069 1,038 831 226 115 696 825 3,080
4,276 4,038 1,981 522 491 1,547 1,224 1,962
9,205 17,435 27,573 29,668 30,730 32,005 32,719 33,424 34,186 34,162 34,617 35,207 8,114 13,615 17,013 17,821 18,532 19,248 19,898 20,323 20,738 20,723 20,972 21,081 3,300 4,324 5,011 5,039 5,179 5,212 5,030 4,968 4,829 4,730 4,436 4,489 722 911 962 1,075 1,042 1,043 1,030 1,016 1,038 1,033 971 1,012 823 978 1,594 1,682 1,756 1,803 1,861 1,812 1,545 1,428 1,250 1,194 2,483 3,859 5,097 5,286 5,651 5,786 5,826 5,875 6,406 6,773 7,117 7,185 1,345 1,535 2,114 2,251 2,312 2,409 2,457 2,518 2,549 2,608 2,631 2,629 562 123 111 69 54 110 156 153 186 174 212 249
<2 years 2-<5 years 5+ years
4,987 2,421 472
9,432 15,514 23,014 31,131 32,527 33,198 34,060 33,943 34,188 34,563 34,325 34,031 33,436 4,192 6,746 12,676 17,039 18,232 19,262 19,932 20,516 20,768 21,253 20,967 21,268 21,863 2,417 4,294 7,090 11,305 12,132 12,796 13,624 14,518 15,133 15,661 16,339 16,907 17,747
All All with unknowns dropped
7,880 16,041 26,554 42,780 59,475 62,891 65,256 67,616 68,977 70,089 71,477 71,631 72,206 73,046 6,907 14,716 25,162 41,116 56,619 59,923 62,213 64,465 65,751 66,825 68,282 68,533 69,110 70,043
Table H.4 Annual mortality rates: dialysis patients per 1,000 patient years at risk, period prevalent patients, by age, gender, race, ethnicity, primary diagnosis, & patient vintage UNADJUSTED 0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1980 111.6 73.5 40.7 36.3 66.6 94.6 120.4 160.3 230.3 291.9 352.5 498.3 613.4
1985 85.0 68.1 46.8 45.0 62.7 99.1 121.5 178.8 235.8 291.0 372.5 496.9 599.5
1990 124.7 34.7 42.6 26.1 70.2 110.6 130.2 180.2 232.7 287.7 362.2 452.6 566.5
1995 104.5 44.8 34.2 42.1 64.0 104.9 130.7 176.0 224.5 269.2 342.8 454.6 540.4
2000 141.8 34.8 17.1 35.8 51.7 89.2 120.1 168.8 219.7 266.8 345.3 448.8 575.5
2001 163.2 61.0 17.4 40.0 56.0 90.9 124.1 170.7 218.0 266.5 342.1 454.6 561.1
2002 114.6 13.9 34.1 33.0 58.7 88.6 123.6 168.6 211.5 259.1 338.6 444.0 566.8
2003 119.9 59.8 51.0 44.7 60.0 84.0 122.7 167.0 218.8 256.6 331.6 434.3 550.3
2004 93.8 59.1 34.1 36.8 56.8 80.1 119.9 164.1 212.3 250.7 328.0 421.8 532.9
2005 84.0 28.8 36.6 27.3 56.5 77.9 118.5 156.7 201.4 244.9 323.8 425.4 536.4
2006 81.2 43.4 25.9 41.9 54.4 77.2 113.8 157.5 200.0 236.6 314.5 416.0 524.2
2007 95.1 32.3 40.7 27.0 51.9 76.3 107.2 149.5 189.5 229.2 301.2 405.9 520.2
2008 95.7 38.8 18.7 29.0 50.8 70.4 99.6 143.1 184.0 222.7 295.5 390.0 499.5
2009 79.9 53.8 28.4 18.2 49.5 67.6 97.8 140.5 178.2 218.9 286.0 376.8 482.8
Male Female
184.2 179.5
217.5 203.9
231.4 222.7
228.0 231.1
226.7 239.3
228.2 241.8
225.8 240.4
226.7 237.2
223.5 231.8
219.6 228.2
215.7 224.3
208.4 215.0
202.4 207.0
199.1 200.0
White Af Am Other race
192.2 160.4 170.5
233.9 171.6 179.2
260.2 179.3 179.8
268.1 181.4 169.1
274.6 181.0 189.2
274.9 186.4 181.2
274.9 182.0 178.3
272.5 183.5 175.6
266.3 182.6 169.4
262.8 178.3 165.5
258.8 173.8 160.7
248.8 167.1 155.9
241.1 160.4 152.8
234.8 156.3 151.8
185.6 239.5
186.6 241.9
185.0 240.1
184.5 239.2
178.1 235.6
173.9 232.2
166.0 229.1
155.9 221.6
150.6 214.7
149.2 209.3
†Hispanic †Non-Hisp. Diabetes HTN GN Other cause
286.1 147.6 92.0 210.5
309.4 211.5 124.1 211.8
294.0 233.1 152.1 204.2
274.6 234.8 148.4 206.8
271.2 233.8 142.0 215.3
272.5 235.0 140.9 217.6
265.5 234.1 142.8 219.3
262.9 232.3 142.3 219.3
256.1 229.9 136.5 216.9
250.7 227.5 133.9 211.6
245.0 225.2 129.7 207.0
233.5 217.4 126.7 200.9
225.8 210.5 117.7 194.9
220.1 203.3 118.6 189.7
<2 years 2-<5 years 5+ years
209.5 162.2 103.8
244.4 200.8 146.3
244.7 231.8 176.1
232.5 249.3 193.6
239.1 236.2 212.2
241.3 237.0 215.3
238.4 236.3 214.3
238.5 232.4 214.6
231.9 228.8 215.7
228.1 224.5 212.7
224.6 220.8 207.9
216.1 209.9 204.1
208.5 203.5 198.0
202.1 199.0 195.4
All
182.1
211.1
227.2
229.5
232.7
234.6
232.6
231.5
227.3
223.6
219.6
211.4
204.5
199.5
ADJUSTED 0-19 20-44 45-64 65-74 75+
66.3 112.5 183.2 288.5 404.8
78.1 112.9 203.2 324.1 444.4
60.6 119.0 198.7 309.3 433.1
64.5 114.0 185.4 292.7 418.9
61.2 104.3 176.9 293.1 431.6
66.2 103.3 177.5 291.6 433.1
58.8 104.6 174.9 287.7 426.7
68.1 103.1 174.3 283.9 419.4
62.3 100.1 171.2 278.2 413.6
56.2 97.7 166.1 273.5 409.5
55.4 94.2 162.9 264.2 402.9
52.1 89.7 155.7 251.6 391.6
49.7 84.8 149.5 243.6 379.7
44.2 81.8 145.4 238.3 370.3
Male Female
234.9 213.2
256.1 232.8
249.0 224.0
229.5 220.1
220.0 218.7
219.4 219.2
215.6 217.0
213.6 214.2
210.1 208.8
206.1 203.6
201.1 199.2
193.1 191.0
186.6 184.1
182.7 177.6
White Af Am Other race
243.9 191.2 202.4
273.5 199.4 223.7
263.1 203.2 194.9
249.5 196.5 165.5
239.5 191.7 179.7
237.9 195.4 175.2
234.8 192.0 168.3
231.5 191.8 164.0
226.1 189.8 158.7
221.1 186.5 154.1
216.2 181.0 148.3
207.7 172.7 141.2
200.7 165.3 136.8
195.7 160.2 133.7
Diabetes HTN GN Other cause
296.1 170.6 147.1 212.7
319.8 206.4 163.7 225.4
300.4 211.1 175.3 215.7
278.1 207.8 164.1 208.6
268.5 200.2 158.2 212.5
266.8 200.1 158.9 214.7
259.6 198.0 158.6 215.0
254.7 196.5 158.2 215.0
247.3 193.2 154.5 213.7
240.8 190.4 151.2 210.3
234.5 186.8 146.8 204.7
223.5 179.7 142.2 197.0
214.4 174.8 135.5 190.7
207.8 170.4 133.9 186.1
<2 years 2-<5 years 5+ years
259.8 224.3 175.7
264.8 242.4 221.2
238.6 243.0 231.3
212.9 236.8 230.9
204.9 215.9 242.2
204.9 213.9 243.7
201.7 210.5 241.1
200.5 206.4 238.2
195.9 201.1 234.9
192.1 195.7 230.5
188.0 191.4 224.5
180.9 182.5 216.0
174.6 175.9 208.4
169.6 171.2 203.3
All
224.6
245.5
237.7
225.1
219.2
219.1
216.1
213.6
209.2
204.8
200.1
192.0
185.2
180.2
Table H.10 Annual mortality rates: transplant patients per 1,000 patient years at risk, period prevalent patients, by age, gender, race, ethnicity, primary diagnosis, & patient vintage UNADJUSTED 0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1980 124.2 48.9 40.0 17.2 15.4 39.9 73.6 66.2 131.2 60.2 91.7 . .
1985 48.3 13.2 26.1 8.7 16.1 27.4 40.3 71.1 90.4 99.6 59.5 403.1 602.7
1990 22.2 6.4 . 9.6 11.9 20.9 36.9 54.1 69.4 100.6 103.3 98.5 297.4
1995 10.0 8.5 5.8 11.5 8.1 16.5 31.0 45.7 70.7 90.4 118.7 136.0 .
2000 4.3 7.1 3.8 6.7 7.0 14.1 24.7 42.4 62.3 83.7 115.1 201.0 190.9
2001 16.4 3.0 3.0 6.9 9.8 16.2 25.8 40.3 62.7 77.3 115.0 153.9 216.3
2002 22.9 7.1 6.9 7.2 9.5 14.0 24.7 36.9 55.0 74.5 108.0 144.1 199.2
2003 15.0 7.0 4.4 9.4 5.6 13.3 21.8 37.7 59.0 73.1 113.3 150.3 110.9
2004 15.6 1.3 2.9 5.9 7.1 12.7 20.2 33.5 55.7 75.2 98.9 163.5 240.3
2005 11.0 2.6 8.1 11.8 7.4 12.8 19.8 35.0 51.3 72.7 95.0 169.9 237.5
2006 10.7 . 5.7 4.6 9.5 10.6 19.6 34.1 48.8 64.3 95.7 173.0 139.2
2007 7.1 . 1.4 3.4 8.2 11.1 17.9 31.5 45.2 61.6 97.4 168.6 237.3
2008 10.0 2.5 . 5.0 7.3 9.5 17.3 30.0 42.9 58.4 85.3 172.4 172.5
2009 3.6 7.3 4.2 4.3 7.6 9.8 18.0 28.5 42.7 59.1 91.1 160.0 143.2
Male Female
48.7 33.9
37.5 31.2
37.9 27.0
36.9 29.3
35.9 32.5
37.6 32.5
35.5 31.5
35.9 32.5
35.0 30.2
36.1 30.2
35.1 30.4
34.5 29.6
32.9 29.2
34.1 30.4
White Af Am Other race
38.2 61.4 66.0
33.8 42.9 27.4
32.1 43.7 22.3
33.0 39.6 27.0
34.2 38.9 24.8
35.4 39.4 25.7
33.2 39.4 25.5
34.3 38.7 23.4
33.0 35.8 25.4
33.9 36.3 23.9
33.4 35.6 23.5
33.4 32.2 23.7
32.0 32.5 22.5
34.0 32.0 21.2
28.0 35.2
28.5 36.4
24.5 35.0
23.5 35.8
23.9 34.2
25.5 34.8
27.9 33.9
24.0 33.7
24.9 32.3
24.5 33.8
†Hispanic †Non-Hisp. Diabetes HTN GN Other cause
77.5 33.2 22.0 54.0
62.7 33.0 21.6 37.9
52.8 38.3 23.7 31.1
54.8 38.3 23.8 28.4
55.6 39.1 25.6 26.5
57.8 40.7 25.9 27.1
54.3 41.4 23.2 26.1
55.6 38.7 24.1 27.4
56.2 35.6 21.8 25.8
53.2 39.8 23.9 26.1
55.3 37.2 23.1 24.6
51.8 37.2 22.5 25.5
50.1 36.9 22.0 23.6
50.9 36.5 23.8 25.3
<2 years 2-<5 years 5+ years
59.3 44.9 14.1
37.2 35.7 33.3
25.8 31.4 37.0
20.4 26.4 39.6
15.5 24.5 40.5
19.1 25.0 41.1
19.3 24.3 38.7
17.9 23.0 40.0
16.9 22.8 37.8
21.3 22.0 38.3
15.1 20.8 38.3
15.1 21.8 37.0
15.7 18.7 36.0
14.7 19.4 37.4
All
42.7
35.0
33.6
33.8
34.5
35.6
33.9
34.5
33.0
33.7
33.2
32.5
31.4
32.6
31.0 35.5 66.9 87.4 147.8
21.7 27.7 54.9 89.1 76.0
16.7 19.4 46.2 90.4 130.5
11.7 15.5 36.7 78.0 112.3
10.2 16.4 36.9 77.0 116.4
12.0 15.7 34.5 73.2 111.2
12.7 14.9 33.8 71.8 115.7
10.4 13.6 30.9 67.5 112.7
13.3 13.5 31.1 67.3 106.6
9.1 12.5 28.8 61.2 101.8
6.5 11.9 26.6 57.9 96.4
5.5 11.0 24.9 52.9 92.0
6.3 10.9 24.6 53.1 91.6
Male Female
81.8 66.2
64.3 49.5
68.3 48.3
52.1 45.2
53.4 45.7
50.6 43.6
50.0 44.2
47.1 41.5
47.6 40.2
43.6 37.8
41.0 35.2
37.2 33.8
36.2 34.1
White Af Am Other race
79.5 72.1 44.0
57.8 58.5 51.4
58.2 62.1 48.0
48.8 51.4 36.7
49.8 52.5 35.8
46.8 50.8 32.9
47.5 49.4 31.5
44.8 45.6 31.8
45.0 44.0 31.8
42.0 40.6 30.6
39.5 37.2 29.4
36.8 34.7 28.6
36.9 33.7 27.9
Diabetes HTN GN Other cause
86.5 60.7 74.2 85.2
69.5 52.3 49.2 55.8
78.8 50.5 41.5 49.4
67.7 41.2 35.6 37.8
69.0 42.2 35.6 37.7
64.6 41.3 33.0 35.3
64.9 40.5 32.9 35.7
62.2 36.8 29.4 34.4
59.4 38.7 30.6 34.3
56.0 35.8 28.2 30.8
51.0 34.8 26.8 29.1
47.1 32.6 25.4 27.4
46.2 32.3 25.9 28.3
<2 years 2-<5 years 5+ years
79.2 74.2 69.4
50.9 55.2 68.2
47.1 52.4 82.4
33.3 45.0 77.3
35.9 44.5 77.0
35.7 41.9 71.0
35.9 41.0 72.1
33.4 39.1 68.2
35.5 36.7 65.6
30.5 34.7 64.3
27.6 33.5 60.5
25.9 30.1 57.1
25.4 29.7 57.1
All
74.7
57.6
58.7
48.9
49.8
47.3
47.3
44.5
44.1
40.9
38.3
35.6
35.3
ADJUSTED 0-19 20-44 45-64 65-74 75+
Table I.2 One-year survival probabilities: incident ESRD patients from day 91 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis UNADJUSTED 0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1980 93.5 93.5 97.7 96.5 91.8 89.5 88.0 83.7 78.6 72.7 67.1 59.5 52.8
1985 88.9 95.0 97.6 95.8 92.3 89.4 88.0 82.2 76.5 71.3 66.9 60.1 51.1
1990 85.2 97.1 96.9 97.4 92.7 90.2 89.0 84.3 78.4 75.6 68.5 61.6 54.1
1995 89.3 97.2 97.5 97.3 92.7 88.7 89.3 85.9 80.2 76.9 70.5 62.7 55.8
1996 92.0 95.7 97.0 96.7 94.3 90.3 89.5 85.3 81.4 77.4 70.4 61.9 53.5
1997 89.3 96.1 97.5 98.3 95.4 91.1 90.1 85.8 81.8 76.7 69.5 61.3 54.1
1998 88.5 100.0 97.8 96.8 95.1 91.3 89.1 85.4 80.0 76.3 69.7 60.0 52.9
1999 87.5 96.7 98.0 98.0 95.5 91.0 89.6 86.0 81.2 76.3 69.3 61.5 52.5
2000 84.0 96.1 97.7 97.9 93.7 91.0 89.6 85.5 80.9 77.0 69.5 60.5 53.2
2001 88.8 98.0 98.0 97.9 95.0 91.5 89.1 85.9 81.8 77.2 70.0 61.0 53.7
2002 90.2 94.4 96.7 97.7 94.1 91.7 88.9 85.9 81.1 77.0 70.2 62.1 53.6
2003 90.9 97.2 97.9 98.3 93.8 91.8 88.9 85.6 82.1 78.0 70.1 62.3 54.2
2004 89.3 98.6 97.5 97.3 94.1 92.2 89.5 86.1 82.2 77.6 70.6 63.5 55.3
2005 93.8 98.6 97.2 97.5 94.4 92.2 89.6 86.1 83.1 78.9 71.1 63.0 55.3
2006 86.4 96.0 97.9 97.5 94.9 93.0 90.1 87.1 83.1 79.5 72.1 63.3 56.0
2007 91.5 98.4 98.4 97.5 94.7 93.1 90.7 87.0 83.2 79.4 72.5 64.0 57.5
2008 93.7 95.7 98.5 98.2 94.8 93.2 91.0 87.5 84.4 80.0 73.3 65.4 59.6
Male Female
81.4 82.2
78.9 79.3
79.5 79.5
79.9 79.9
79.9 79.3
79.6 78.8
79.1 78.0
79.3 78.1
79.0 77.8
79.3 78.0
79.1 77.7
79.2 78.0
79.4 78.7
79.7 79.0
80.6 79.6
80.6 80.1
81.2 81.0
White African American Other race
80.4 85.2 82.1
77.1 83.1 83.9
77.1 83.8 86.5
77.7 83.3 84.6
77.2 84.0 83.2
76.6 83.8 84.3
76.2 82.7 82.9
76.5 82.6 83.0
76.3 82.0 84.1
76.2 82.8 85.2
76.2 82.1 84.2
76.5 81.9 85.2
77.0 82.4 85.5
77.3 82.8 85.9
78.2 83.4 86.4
78.2 83.8 87.3
78.9 84.8 87.1
83.8 79.1
83.1 78.7
83.2 78.0
82.9 78.1
83.7 77.6
84.0 77.9
83.2 77.8
83.8 77.9
84.6 78.2
84.8 78.6
85.8 79.2
86.1 79.5
86.4 80.2
†Hispanic †Non-Hispanic Diabetes Hypertension Glomerulonephritis Other cause
76.1 84.5 91.5 79.4
74.3 79.1 88.1 78.4
77.1 78.2 87.4 80.2
78.9 79.0 87.8 78.1
78.7 78.4 88.3 78.1
78.2 77.5 88.3 78.6
77.4 76.9 88.5 78.1
78.1 77.0 87.6 77.8
78.1 76.7 88.3 76.6
78.4 76.9 88.4 77.1
78.3 77.0 88.2 76.1
78.7 76.9 88.6 76.6
79.2 77.1 89.1 77.1
79.7 77.0 89.8 77.9
80.5 78.1 89.7 78.5
80.7 78.6 90.8 78.4
81.3 79.5 90.8 79.5
All
81.8
79.1
79.5
79.9
79.7
79.2
78.6
78.7
78.4
78.7
78.5
78.7
79.1
79.4
80.1
80.4
81.1
ADJUSTED 0-19 20-44 45-64 65-74 75+
93.6 87.9 80.2 69.7 61.1
91.9 88.9 80.0 69.0 62.1
93.0 89.8 82.9 73.1 63.2
93.9 89.1 85.0 75.2 64.5
93.5 90.5 85.1 75.4 63.9
94.4 91.1 85.8 74.7 63.4
94.0 90.8 84.9 74.8 62.8
94.3 90.9 85.6 74.7 63.1
92.7 90.7 85.3 75.0 63.1
94.3 91.0 85.7 75.4 63.6
93.5 90.8 85.4 75.2 64.0
95.1 90.9 85.4 75.8 64.0
93.8 91.4 85.8 76.1 64.7
95.2 91.6 86.1 76.9 64.7
93.3 92.3 86.7 78.0 65.2
94.7 92.6 86.7 77.9 65.9
95.5 92.8 87.4 78.4 67.3
Male Female
72.3 74.0
72.2 74.4
75.5 77.2
77.2 78.8
77.8 78.7
78.1 78.6
77.8 77.9
78.3 78.1
78.2 78.1
78.6 78.6
78.6 78.4
78.8 78.7
79.0 79.2
79.4 79.5
80.2 80.1
80.2 80.5
80.9 81.4
White African American Other race
70.3 79.5 72.0
70.8 77.9 77.8
74.3 79.7 83.2
76.8 79.8 82.9
76.9 80.9 81.9
76.8 81.1 83.3
76.7 80.0 81.6
77.2 79.8 82.2
77.3 79.5 83.1
77.4 80.4 84.2
77.6 79.8 83.3
78.0 79.4 84.5
78.4 79.9 84.7
78.6 80.4 85.2
79.4 81.1 85.7
79.4 81.6 86.6
80.1 82.7 86.5
Diabetes Hypertension Glomerulonephritis Other cause
68.1 80.4 83.6 73.9
68.4 78.2 81.9 73.6
73.9 79.2 82.0 75.9
77.0 80.6 83.2 74.3
77.3 80.4 84.3 74.5
77.2 80.0 84.4 75.6
76.5 79.6 84.6 75.1
77.3 79.7 84.0 74.9
77.6 79.6 84.6 73.8
78.1 79.8 84.3 74.5
78.1 80.2 84.5 73.5
78.4 80.0 84.8 74.0
79.0 80.2 85.1 74.5
79.4 80.1 86.1 75.5
80.2 80.9 86.0 76.2
80.4 81.2 87.1 76.2
81.0 82.0 87.2 77.4
All
73.1
73.3
76.3
78.0
78.3
78.3
77.9
78.2
78.2
78.6
78.5
78.7
79.1
79.5
80.2
80.4
81.1
Table I.6 Ten-year survival probabilities: incident ESRD patients from day 91 to ten years + 90 days, by age, gender, race, ethnicity, & primary diagnosis UNADJUSTED 0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1980 76.1 80.6 79.7 80.3 64.3 47.1 33.4 16.5 8.8 4.8 2.8 1.8 1.1
1985 73.3 83.2 82.0 76.7 64.1 47.3 35.7 18.1 9.4 6.3 2.9 0.9 0.4
1986 75.6 86.6 85.8 79.1 65.7 49.5 36.2 18.9 9.1 5.2 2.4 1.0 0.3
1987 76.7 83.8 89.8 79.0 65.1 47.6 36.2 19.8 8.9 5.0 2.8 1.0 0.0
1988 67.6 90.1 81.5 80.5 67.0 49.6 36.5 18.1 9.5 5.2 2.6 0.7 0.2
1989 74.1 85.2 80.7 83.1 64.6 50.1 34.7 18.5 9.0 5.0 2.3 0.8 0.8
1990 72.7 87.0 81.7 83.0 66.1 50.7 36.3 18.5 9.0 5.4 2.1 0.4 0.3
1991 72.9 90.0 86.7 79.2 64.8 49.6 34.9 19.6 9.4 4.8 2.0 0.7 0.6
1992 75.9 90.2 82.2 81.0 66.2 50.6 37.2 19.5 10.0 5.1 2.2 0.8 0.4
1993 74.4 80.2 83.0 79.7 69.0 50.9 37.4 19.8 10.3 5.8 2.5 0.8 0.5
1994 77.2 89.1 82.5 82.5 68.7 50.5 37.5 21.3 11.0 5.7 2.3 0.7 0.7
1995 77.4 86.1 87.3 80.7 67.5 52.2 38.1 21.7 11.4 6.1 2.5 1.0 0.4
1996 77.8 82.9 87.3 77.4 69.3 52.5 37.7 21.8 12.3 6.4 2.7 1.0 0.9
1997 78.6 92.2 84.1 80.3 70.9 54.0 39.0 22.7 12.7 6.3 2.7 0.8 0.4
1998 78.2 91.0 85.9 77.2 70.9 54.9 39.7 24.2 12.7 7.5 2.9 0.7 0.5
1999 78.0 92.8 85.4 78.6 72.5 55.0 40.5 25.2 13.7 7.3 3.4 1.1 0.5
Male Female
25.4 25.6
23.3 22.2
23.8 21.4
22.9 20.5
22.4 20.8
21.8 19.4
22.1 18.7
20.7 18.2
21.1 18.3
21.6 18.2
21.1 18.3
22.0 18.4
21.5 17.9
21.0 17.9
21.5 18.2
21.7 18.7
White African American Other race
25.9 24.1 27.0
22.7 22.0 31.9
22.4 22.0 33.4
21.6 21.2 30.8
20.6 22.7 32.2
19.6 21.9 30.3
19.5 21.2 31.2
18.4 20.6 30.0
18.5 21.4 28.0
18.7 21.2 29.1
18.3 21.6 27.6
18.9 22.2 25.6
18.3 22.1 24.6
17.9 21.9 25.7
18.3 21.9 26.9
18.5 22.8 27.4
23.8 19.3
24.6 18.9
25.2 19.3
25.5 19.6
†Hispanic †Non-Hispanic Diabetes Hypertension Glomerulonephritis Other cause
14.3 26.5 47.6 21.5
12.4 17.8 39.9 28.0
12.8 17.6 39.9 28.4
12.2 15.9 39.4 29.1
11.8 17.4 39.8 28.4
11.6 16.2 39.0 29.1
10.8 16.3 39.5 30.7
10.7 15.6 37.3 30.7
10.9 16.5 39.7 30.0
11.2 16.0 40.6 31.2
11.5 16.2 39.5 30.9
11.4 17.6 41.4 30.3
11.3 17.0 40.6 30.5
11.1 16.8 41.7 30.7
11.6 16.6 43.1 31.3
12.2 17.3 42.9 31.4
All
25.5
22.8
22.7
21.8
21.7
20.7
20.5
19.6
19.8
20.0
19.8
20.3
19.9
19.6
19.9
20.3
ADJUSTED 0-19 20-44 45-64 65-74 75+
70.4 43.2 12.7 3.5 1.8
68.3 46.0 15.4 4.7 1.4
72.4 47.4 16.4 3.9 1.3
73.4 46.3 16.8 4.0 1.5
71.3 47.6 16.7 4.0 1.4
73.6 47.9 16.9 4.0 1.3
73.9 48.6 17.1 4.2 0.8
72.7 47.6 18.0 3.8 1.1
73.8 48.7 19.0 4.2 1.1
71.3 49.4 19.6 4.7 1.3
75.1 49.7 20.9 4.6 1.2
74.7 49.9 21.6 4.9 1.4
72.1 50.1 22.3 5.3 1.4
75.1 51.7 23.1 5.2 1.4
73.5 51.6 24.2 6.2 1.4
74.5 52.5 25.3 6.5 1.7
Male Female
13.2 14.2
14.7 15.5
15.2 15.3
15.2 15.5
15.0 15.7
15.3 15.5
15.8 15.3
15.5 15.7
16.2 16.1
16.9 16.4
17.0 16.9
17.6 17.2
18.0 17.3
18.3 17.7
19.0 18.4
19.8 18.9
White African American Other race
13.1 14.0 13.3
14.7 14.3 19.4
14.7 14.7 20.7
15.1 14.4 19.0
14.8 15.0 20.9
15.1 14.6 20.6
15.3 14.6 21.9
15.2 14.8 22.0
16.0 15.2 21.6
16.6 15.4 22.4
16.9 15.9 21.8
17.4 16.4 22.3
17.8 16.6 22.3
18.0 17.0 23.5
18.8 17.4 24.7
19.3 18.1 25.7
Diabetes Hypertension Glomerulonephritis Other cause
9.0 19.4 24.0 14.7
9.3 17.2 23.8 19.5
9.6 17.3 24.3 19.8
9.7 16.9 23.8 20.6
9.5 17.4 24.4 20.1
9.5 17.3 24.5 20.9
9.5 17.5 24.3 21.5
9.6 17.3 24.3 21.9
10.2 18.0 25.8 21.7
10.7 18.1 26.4 22.6
11.2 18.6 26.3 22.5
11.3 19.4 27.8 22.5
11.6 19.4 27.7 23.2
11.7 19.9 28.6 23.9
12.4 20.1 30.2 24.4
13.2 20.8 30.9 24.6
All
13.7
15.1
15.3
15.3
15.3
15.4
15.5
15.6
16.2
16.6
17.0
17.4
17.7
18.0
18.7
19.4
Table J.1 Certified dialysis & transplant facilities: by Medicare certification
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
Certified units Facilities Dialysis patients Transplanted patients
2,148 141,942 9,997
2,292 156,834 10,090
2,456 170,958 10,903
2,624 186,316 11,295
2,876 199,711 11,885
3,083 213,731 12,179
3,344 229,834 12,367
3,576 245,365 13,316
3,833 259,159 13,479
4,013 273,009 14,300
Veterans Administration Facilities Dialysis patients Transplanted patients
12 546 14
12 520 11
13 521 *
13 506 *
12 451 .
12 372 .
11 356 .
11 345 .
10 334 .
10 324 .
2,160
2,304
2,469
2,637
2,888
3,095
3,355
3,587
3,843
4,023
142,488 10,011 10,026 2,382 7,644
157,354 10,101 10,115 2,536 7,579
171,479 10,910 10,934 2,828 8,106
186,822 11,296 11,312 3,000 8,312
200,162 11,885 11,902 3,416 8,486
214,103 12,179 12,198 3,703 8,495
230,190 12,367 12,427 3,915 8,512
245,710 13,316 13,272 4,520 8,752
259,493 13,479 13,483 4,644 8,839
273,333 14,300 14,311 5,427 8,884
Total facilities Total dialysis patients Patients transplanted Total transplants Living donor Deceased donor
2001
2002
2003
2004
2005
2006
2007
2008
2009
Certified units Facilities Dialysis patients Transplanted patients
4,175 285,645 14,608
4,379 296,322 15,055
4,530 307,909 15,661
4,673 318,170 16,488
4,870 330,132 17,146
4,997 342,752 17,712
5,170 355,443 17,254
5,430 368,639 16,961
5,689 384,176 17,209
Veterans Administration Facilities Dialysis patients Transplanted patients
10 337 .
54 2,030 22
61 2,186 51
59 2,234 41
71 2,658 114
70 2,551 106
70 2,652 100
71 2,696 93
71 2,841 123
4,185
4,433
4,591
4,732
4,941
5,067
5,240
5,501
5,760
285,982 14,608 14,628 5,804 8,824
298,352 15,077 15,106 5,893 9,213
310,095 15,712 15,738 6,244 9,494
320,404 16,529 16,568 6,506 10,062
332,790 17,260 17,295 6,480 10,815
345,303 17,818 17,870 6,361 11,509
358,095 17,354 17,380 5,987 11,393
371,335 17,054 17,098 5,858 11,240
387,017 17,332 17,370 6,250 11,120
Total facilities Total dialysis patients Patients transplanted Total transplants Living donor Deceased donor
Table K.1 Total Medicare costs ($) of reported ESRD per calendar year all ESRD patients with at least one Medicare claim, by age, gender, race, ethnicity, & primary diagnosis
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+ Unknown
1995 11,017,802 9,329,908 19,553,000 46,984,535 335,029,480 812,178,535 1,174,801,235 1,463,009,832 925,086,177 1,318,941,768 2,129,277,386 413,966,562 188,892,637 591,046
2000 7,923,570 9,255,019 16,705,656 47,232,049 354,453,475 893,667,112 1,595,939,939 2,177,927,344 1,269,790,025 1,663,926,987 3,119,080,743 670,136,245 380,438,728 676,464
2005 16,686,572 11,604,067 28,920,458 64,847,437 451,768,286 1,216,147,728 2,437,145,242 3,730,923,000 2,126,505,207 2,643,304,172 4,673,239,966 1,271,304,035 773,083,731 121,636
2006* 16,636,902 14,003,853 32,109,604 78,209,626 521,952,861 1,372,726,168 2,722,566,728 4,265,905,372 2,355,179,577 2,850,505,926 4,933,509,838 1,357,707,579 868,591,359 1,132,237
2007* 16,420,327 15,687,077 30,106,587 72,974,296 540,109,800 1,415,020,085 2,828,281,501 4,533,352,198 2,513,571,458 2,972,339,266 5,100,017,822 1,410,466,880 949,684,441 366,485
2008* 21,622,616 16,200,674 29,706,738 82,176,293 587,101,712 1,521,168,414 3,073,540,070 5,064,924,275 2,858,114,253 3,332,601,323 5,572,290,098 1,567,275,404 1,097,776,073 319,872
2009 19,863,334 14,611,638 29,522,825 77,057,460 580,874,419 1,487,585,654 3,008,551,299 5,017,568,032 2,933,785,497 3,319,750,812 5,502,083,808 1,556,879,961 1,154,664,092 1,179,886
0-19 20-44 45-64 65-74 75+ Unknown
86,885,245 1,695,193,922 3,014,911,338 2,571,022,552 1,480,055,801 591,046
81,116,294 1,957,696,884 4,334,081,011 3,364,876,398 2,468,706,305 676,464
122,058,533 2,725,308,455 7,237,181,008 5,124,472,130 4,236,459,774 121,636
140,959,984 3,075,888,256 8,162,442,450 5,471,716,242 4,538,598,460 1,132,237
135,188,287 3,168,714,361 8,661,620,682 5,718,412,229 4,714,096,180 366,485
149,706,321 3,429,999,297 9,674,849,427 6,351,422,345 5,218,520,552 319,872
141,055,257 3,349,781,283 9,678,583,618 6,328,986,368 5,204,392,305 1,179,886
Male Female Unknown
4,450,661,058 4,397,888,325 110,522
6,224,065,721 5,983,087,635 .
10,269,118,218 9,176,396,891 86,426
11,311,341,955 10,079,387,565 8,109
11,890,099,041 10,508,294,814 4,368
13,247,472,827 11,577,342,995 1,992
13,272,202,678 11,431,646,479 129,560
White African American Native American Asian Other/unknown
5,231,134,650 3,268,048,325 112,390,807 219,771,675 17,314,448
6,946,880,710 4,630,049,398 171,171,218 366,529,342 92,522,687
11,075,365,987 7,295,328,445 261,378,481 630,988,138 182,540,485
12,111,499,628 8,091,176,980 280,399,543 735,554,370 172,107,109
12,703,670,049 8,452,204,576 293,603,957 795,097,647 153,821,994
14,114,738,650 9,331,169,033 325,747,161 910,720,054 142,442,916
14,071,169,043 9,252,050,007 335,446,480 920,198,614 125,114,573
1,405,680,877 10,068,848,207 732,624,272
2,533,152,068 16,594,242,843 318,206,624
2,854,991,545 18,235,943,294 299,802,790
3,060,943,904 19,055,732,453 281,721,865
3,466,354,114 21,044,113,792 314,349,908
3,498,841,181 20,898,747,310 306,390,225
†Hispanic †Non-Hispanic Unknown Diabetes Hypertension Glomerulonephritis Other cause Unknown
3,343,620,576 2,618,713,417 1,266,339,693 1,322,388,646 297,597,573
5,229,157,965 3,317,945,828 1,519,020,730 1,732,715,110 408,313,724
8,839,528,235 5,212,517,069 2,065,687,430 2,651,760,657 676,108,145
9,754,286,216 5,668,240,760 2,246,599,286 2,961,092,178 760,519,189
10,233,846,534 5,942,668,518 2,278,982,144 3,135,182,603 807,718,424
11,351,253,738 6,567,359,320 2,459,867,876 3,531,686,509 914,650,372
11,355,415,581 6,542,921,440 2,390,302,849 3,510,836,238 904,502,609
All
8,848,659,905
12,207,153,356
19,445,601,536
21,390,737,629
22,398,398,223
24,824,817,814
24,703,978,717
Table K.6 Per person per year costs ($): dialysis patients, with unknowns dropped (model 1) period prevalent patients, as-treated model, primary payor only, by age, gender, race, ethnicity, & primary diagnosis
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1995 60,998 39,653 43,686 42,149 41,313 44,183 44,674 46,861 48,746 53,244 54,258 55,196 55,751
2000 54,661 49,218 40,867 43,801 44,479 48,057 49,835 52,899 54,741 58,605 60,072 59,647 60,155
2001 55,287 50,141 42,956 46,453 46,520 50,706 52,777 56,153 58,612 61,892 63,612 63,605 63,429
2002 59,243 47,542 45,512 50,217 48,786 52,737 55,514 58,576 61,758 65,275 66,120 66,299 65,626
2003 65,670 48,506 49,155 49,090 51,063 54,142 57,387 60,572 63,519 67,724 68,212 68,370 69,245
2004 78,695 52,402 48,235 50,186 53,782 56,520 60,780 63,774 67,138 70,791 71,447 70,759 70,403
2005 89,355 56,957 55,580 57,129 56,096 59,848 63,439 65,981 68,968 73,061 74,266 74,619 74,564
2006* 82,414 78,655 67,129 63,044 63,537 66,732 69,226 71,217 73,048 76,654 78,003 78,150 77,970
2007* 83,202 76,129 68,652 61,003 66,383 68,855 71,025 72,791 74,822 78,271 80,142 80,469 79,955
2008* 128,148 81,189 68,797 71,444 71,600 73,420 76,118 78,234 79,928 84,793 86,978 87,348 86,561
2009 101,482 71,658 73,767 69,073 70,758 72,312 74,226 77,428 79,815 84,551 87,920 89,390 89,403
0-19 20-44 45-64 65-74 75+
44,043 43,801 46,970 53,599 54,964
44,421 47,698 52,955 59,373 59,920
46,701 50,472 56,268 62,756 63,589
49,633 52,914 58,933 65,602 66,215
50,356 54,544 60,889 67,938 68,461
52,307 57,310 64,277 70,946 71,230
59,359 60,584 66,336 73,546 74,551
66,801 67,392 71,267 77,168 78,198
65,583 69,329 73,021 79,278 80,098
76,921 74,201 78,323 85,877 86,971
73,629 72,748 77,563 86,070 88,818
Male Female
47,435 51,883
52,988 57,656
56,160 61,316
58,889 64,095
61,067 66,103
64,086 69,242
67,150 71,498
71,452 76,411
73,188 78,427
78,821 84,671
79,056 84,160
White African American Native American Asian Other/unknown
50,238 49,246 45,521 43,284 56,627
55,765 54,994 49,843 50,849 57,537
59,059 58,745 52,115 52,719 59,056
61,668 61,633 56,139 55,746 60,323
63,981 63,723 56,605 56,021 59,567
66,703 67,359 59,198 58,393 62,903
69,533 69,974 59,785 60,469 65,567
73,735 75,193 62,961 64,961 68,738
75,600 76,986 64,639 66,872 72,840
81,702 82,790 68,309 72,377 76,808
82,013 82,051 69,931 71,666 78,351
54,241 55,210
57,252 58,798
60,462 61,515
62,393 63,641
65,062 66,768
67,510 69,480
72,477 73,992
74,887 75,730
80,842 81,568
80,079 81,511
†Hispanic †Non-Hispanic Diabetes Hypertension Glomerulonephritis Other cause Unknown cause
55,251 48,174 43,209 46,602 48,086
60,408 52,966 47,228 53,294 52,875
64,132 56,266 49,671 56,489 54,946
66,586 58,970 52,301 59,445 58,358
68,499 61,072 54,015 61,992 59,525
72,169 63,567 56,336 64,370 63,778
75,016 66,017 58,254 67,032 67,028
79,785 70,269 62,674 71,362 71,495
81,497 72,098 64,251 73,536 73,395
87,865 77,686 68,939 79,079 80,057
87,911 77,402 68,505 78,869 79,587
All
49,600
55,220
58,614
61,347
63,435
66,495
69,168
73,743
75,592
81,489
81,375
Table K.7 Per person per year costs ($): hemodialysis patients, with unknowns dropped (model 1) period prevalent patients, as-treated model, primary payor only, by age, gender, race, ethnicity, & primary diagnosis
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1995 82,293 49,528 46,099 44,841 42,491 45,685 45,814 47,698 49,549 53,836 54,651 55,216 55,449
2000 85,654 50,442 45,444 45,810 45,681 49,174 50,872 53,600 55,182 59,120 60,060 59,254 59,449
2001 95,906 62,380 51,533 48,908 48,173 52,166 53,899 56,985 59,229 62,190 63,627 63,184 62,733
2002 80,083 59,505 54,285 52,917 50,511 54,319 56,547 59,467 62,444 65,803 66,337 65,887 64,814
2003 65,607 64,605 55,223 51,488 52,865 55,841 58,590 61,617 64,402 68,359 68,476 67,940 68,406
2004 89,134 66,255 51,490 53,657 55,752 58,339 62,246 64,871 68,168 71,510 71,918 70,458 69,698
2005 131,536 70,184 58,962 59,647 57,789 61,505 65,028 67,125 69,895 73,827 74,684 74,327 73,987
2006* 106,722 99,420 67,665 66,376 65,218 68,512 70,694 72,340 74,064 77,336 78,489 77,893 77,522
2007* 107,899 76,642 76,070 64,537 68,099 70,650 72,435 73,950 75,886 79,027 80,615 80,235 79,345
2008* 203,113 106,690 75,031 73,589 73,214 75,096 77,480 79,374 80,981 85,597 87,448 87,260 86,054
2009 135,312 89,494 81,449 73,222 72,447 74,135 75,464 78,538 80,671 85,278 88,319 89,258 88,821
0-19 20-44 45-64 65-74 75+
47,150 45,146 47,881 54,162 55,050
47,032 48,852 53,651 59,708 59,586
51,219 51,858 57,126 63,006 63,247
54,303 54,410 59,797 66,077 65,945
53,091 56,163 61,918 68,483 68,213
54,768 59,101 65,428 71,659 71,106
61,881 62,303 67,506 74,233 74,454
69,254 69,064 72,440 77,817 78,189
68,150 71,003 74,204 79,978 80,037
80,471 75,764 79,491 86,613 86,954
77,869 74,360 78,626 86,725 88,743
Male Female
48,193 53,033
53,424 58,466
56,639 62,220
59,431 65,097
61,742 67,151
64,840 70,487
67,871 72,742
72,199 77,569
73,826 79,753
79,490 85,993
79,742 85,363
White African American Native American Asian Other/unknown
51,513 49,825 45,844 44,532 58,097
56,490 55,411 50,319 51,924 58,747
59,848 59,210 52,622 53,806 60,597
62,543 62,151 56,863 56,907 61,755
64,990 64,297 57,086 57,249 60,629
67,786 68,124 59,844 59,744 64,090
70,616 70,675 60,305 62,044 66,886
74,756 75,891 63,442 66,495 70,041
76,686 77,656 65,047 68,189 74,141
82,849 83,436 68,445 73,552 78,031
83,107 82,667 70,188 72,993 79,282
55,191 55,759
58,148 59,418
61,426 62,225
63,444 64,450
66,100 67,744
68,657 70,412
73,499 74,909
75,900 76,664
81,904 82,521
81,035 82,423
†Hispanic †Non-Hispanic Diabetes Hypertension Glomerulonephritis Other cause Unknown cause
55,950 48,822 44,736 47,687 49,200
60,733 53,338 48,433 54,089 53,426
64,494 56,638 50,991 57,530 55,415
67,023 59,494 53,742 60,488 58,785
69,063 61,607 55,484 63,192 60,350
72,797 64,300 58,112 65,721 64,209
75,633 66,744 59,983 68,305 67,494
80,354 71,016 64,207 72,610 72,339
82,100 72,862 65,989 74,674 74,026
88,417 78,465 70,757 80,292 80,684
88,467 78,100 70,162 80,017 80,207
All
50,554
55,825
59,286
62,097
64,275
67,469
70,123
74,671
76,534
82,442
82,285
Table K.8 Per person per year costs ($): CAPD/CCPD patients, with unknowns dropped (model 1) period prevalent patients, as-treated model, primary payor only, by age, gender, race, ethnicity, & primary diagnosis
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1995 53,296 37,186 41,101 37,426 37,483 38,553 39,760 42,090 42,651 45,512 43,905 44,273 42,182
2000 41,091 47,077 34,526 38,301 38,133 41,234 41,818 45,273 47,638 47,329 49,453 45,354 47,237
2001 46,426 41,277 32,898 40,253 38,426 41,453 43,409 46,449 48,552 51,421 50,865 48,040 45,527
2002 53,158 40,376 36,586 42,326 39,777 42,523 45,851 48,137 49,575 51,936 49,836 50,940 46,789
2003 65,506 39,849 43,263 42,088 41,276 42,556 46,097 48,026 49,073 52,645 51,042 52,306 51,367
2004 70,517 45,330 44,904 39,476 43,386 43,438 46,847 50,111 50,743 53,699 51,547 52,520 48,479
2005 79,763 50,035 52,667 48,369 46,023 47,281 47,396 51,053 52,522 54,208 54,496 56,319 52,066
2006* 75,664 65,164 66,122 52,376 52,989 53,468 54,464 56,168 55,233 58,887 57,208 58,800 55,452
2007* 75,386 76,421 60,476 51,041 55,277 55,237 55,683 56,984 56,315 58,488 58,516 60,052 56,240
2008* 101,639 63,182 63,216 64,301 61,435 59,602 61,431 61,876 61,535 63,563 63,772 63,151 56,842
2009 90,794 61,991 66,462 57,879 59,320 56,930 60,015 60,502 63,568 62,520 65,018 63,154 61,146
0-19 20-44 45-64 65-74 75+
40,571 38,691 41,670 44,959 43,424
38,796 40,425 45,229 48,420 47,941
39,355 41,465 46,182 51,124 49,631
42,079 42,741 48,051 50,697 50,351
46,106 42,996 48,054 52,172 50,954
47,019 44,604 49,480 52,443 51,889
55,018 47,298 50,452 54,269 54,857
62,172 54,413 55,157 58,320 57,134
61,313 55,768 56,333 58,607 58,564
70,836 61,077 61,438 63,560 62,742
67,399 58,397 61,244 63,530 64,067
Male Female
40,847 42,754
43,775 45,872
45,301 47,248
46,760 48,151
47,119 49,016
48,766 49,676
51,280 51,152
55,539 56,687
57,630 56,496
62,056 62,282
61,194 62,011
White African American Native American Asian Other/unknown
41,782 42,500 42,651 34,924 39,377
44,695 45,776 42,208 41,427 44,681
46,199 47,447 45,218 41,475 40,850
47,340 48,860 45,400 42,019 44,421
47,791 49,858 48,404 41,719 44,678
49,492 50,065 48,143 41,959 43,902
51,435 52,749 49,770 42,126 43,157
56,250 57,741 53,249 46,836 52,570
56,642 59,577 55,615 50,629 54,475
61,331 65,331 61,932 57,323 57,949
61,069 64,506 62,616 53,620 60,041
41,555 44,867
43,861 46,578
45,462 47,696
45,621 48,416
48,476 49,370
47,829 51,724
53,724 56,484
55,294 57,326
60,942 62,314
60,291 61,773
†Hispanic †Non-Hispanic Diabetes Hypertension Glomerulonephritis Other cause Unknown cause
48,234 40,167 36,331 39,478 38,894
51,687 42,611 38,788 42,628 41,122
53,329 44,614 39,908 43,583 41,286
54,407 44,745 41,281 45,536 43,779
54,398 45,956 42,819 45,898 41,675
56,878 46,177 42,858 46,951 44,146
58,574 48,479 44,996 48,957 46,552
63,955 52,569 50,327 53,923 49,754
64,655 53,529 49,843 55,920 54,632
71,216 58,456 54,279 60,201 56,303
70,252 58,136 54,642 58,960 57,424
All
41,768
44,821
46,266
47,445
48,054
49,212
51,217
56,095
57,078
62,166
61,588
Table K.9 Per person per year costs ($): transplant patients, with unknowns dropped (model 1) period prevalent patients, as-treated model, primary payor only, by age, gender, race, ethnicity, & primary diagnosis
0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-84 85+
1995 23,486 16,429 15,481 19,005 18,531 17,919 18,173 19,864 19,538 19,637 18,494 18,333 10,425
2000 26,817 13,619 12,960 16,058 17,179 17,205 17,371 19,479 20,485 21,207 21,044 18,734 17,349
2001 26,603 16,101 14,363 19,608 19,277 18,760 19,268 20,511 21,506 22,461 24,151 20,455 18,003
2002 32,850 16,796 17,061 20,300 20,386 19,944 20,212 21,574 21,855 24,361 23,990 19,146 18,311
2003 37,578 20,675 21,349 23,160 20,777 20,255 20,335 21,717 24,307 24,642 24,684 20,684 14,426
2004 36,241 19,022 26,759 26,331 22,997 22,674 22,680 23,606 24,307 26,354 25,449 23,659 32,810
2005 50,823 24,221 33,748 28,022 24,936 23,890 23,906 24,324 25,711 27,179 26,798 26,060 21,309
2006* 49,358 32,998 37,896 35,899 31,408 27,779 27,637 27,619 28,246 28,356 27,260 25,248 27,079
2007* 47,136 43,562 38,787 32,333 29,984 27,578 27,448 27,637 27,698 27,955 27,894 24,416 25,062
2008* 54,204 45,839 38,928 37,328 31,557 28,953 28,766 30,130 29,857 30,857 30,529 32,665 28,988
2009 60,925 46,005 43,107 41,734 31,590 29,418 28,818 29,608 29,572 30,382 30,518 29,029 24,049
0-19 20-44 45-64 65-74 75+
18,035 18,062 19,360 19,379 17,400
15,392 17,056 19,294 21,391 18,593
17,934 18,874 20,514 22,891 24,760
19,729 20,090 21,299 24,038 24,540
23,460 20,374 21,960 24,608 24,141
26,336 22,567 23,650 25,930 25,859
31,116 24,271 24,441 27,034 26,546
37,408 28,307 27,825 28,058 26,256
36,853 27,806 27,708 28,083 26,435
40,604 29,269 29,812 30,812 30,505
44,653 29,429 29,512 30,629 29,173
Male Female
18,550 18,951
18,259 19,082
20,185 20,372
20,881 21,989
21,835 22,173
23,654 24,127
24,891 25,374
27,815 28,637
27,443 28,681
29,610 30,913
29,323 30,976
White African American Native American Asian Other/unknown
17,733 22,918 18,301 14,819 15,729
17,383 23,154 18,380 15,442 26,003
18,923 25,152 19,964 17,940 15,460
20,026 26,259 19,875 18,446 18,810
20,697 26,894 21,237 17,813 35,155
22,602 28,201 23,845 20,385 46,925
23,653 30,093 25,840 21,442 35,312
26,397 34,000 28,550 25,088 37,540
26,290 33,579 27,602 24,945 31,107
28,490 35,641 31,652 27,358 30,650
28,233 35,962 30,649 26,538 29,938
18,730 19,425
20,345 21,076
21,138 22,164
21,740 22,722
23,862 24,330
25,210 25,492
29,831 28,385
28,928 28,301
31,642 30,226
31,068 30,215
†Hispanic †Non-Hispanic Diabetes Hypertension Glomerulonephritis Other cause Unknown cause
25,515 19,527 15,524 15,958 13,997
25,138 18,919 15,391 15,675 15,468
27,092 21,575 16,447 16,984 16,509
29,007 22,295 17,243 17,686 17,148
29,537 22,786 17,827 18,777 16,055
31,411 24,257 19,650 20,468 19,263
32,727 25,483 20,383 21,959 21,032
35,779 27,996 23,554 25,198 24,338
35,455 28,123 23,089 25,185 23,199
38,161 30,356 24,695 27,125 25,346
37,556 30,325 24,591 27,232 24,991
All
18,709
18,591
20,260
21,330
21,972
23,846
25,086
28,147
27,942
30,132
29,983
Table K.b Medicare payments ($) per person per year: 2009, by claim type (model 1) period prevalent patients, as-treated model; Medicare primary payor only
Patient years at risk
All ESRD 340,587
All dialysis Hemodialysis 266,634 248,047
CAPD/CCPD Other dialysis 17,470 1,118
Transplant 73,952
Total Medicare
70,216
81,375
82,285
61,588
188,628
29,983
Total inpatient Medical DRG Surgical DRG Other DRG Rehabilitation Transplant DRG Non-transplant pass-throughs Transplant pass-throughs
26,433 13,436 10,618 130 788 760 663 39
29,501 15,429 12,337 143 912 0 681 0
29,436 15,427 12,279 146 905 0 679 0
24,892 12,202 11,240 76 789 0 585 0
115,997 66,419 42,353 493 4,177 0 2,555 0
15,373 6,249 4,419 83 341 3,499 601 181
Total outpatient Outpatient hemodialysis Outpatient peritoneal dialysis Outpatient other dialysis Outpatient ESA Outpatient vitamin D hormones Outpatient iron Outpatient other injectables Radiology Pharmacy Ambulance Laboratory/pathology Outpatient other
24,877 13,021 972 14 4,864 1,068 620 236 399 111 71 440 3,064
30,955 16,596 1,237 18 6,175 1,361 789 224 445 129 83 331 3,567
31,415 17,761 68 19 6,350 1,460 835 228 456 130 84 330 3,693
24,924 724 17,493 4 3,815 31 147 141 299 103 54 318 1,797
23,191 6,255 6,493 48 4,261 195 553 464 392 276 275 570 3,411
2,966 131 16 1 136 9 11 278 233 44 25 833 1,251
2,516 1,693 219
3,061 1,971 268
3,161 2,030 270
866 1,074 148
14,998 2,900 1,825
554 692 42
14,476 71 448 700 436 68 1,609 750 1,773 217 30 1,244 8 31 1 1,079 292 446 1,275 2,579 1,419
15,619 5 484 755 486 23 1,870 790 2,258 273 37 1,575 9 10 0 19 338 488 1,482 3,245 1,470
15,973 5 481 773 486 23 1,883 797 2,289 268 10 1,674 5 8 0 18 348 495 1,486 3,435 1,490
9,684 8 444 512 373 33 1,231 672 1,868 288 396 185 60 31 2 14 196 375 1,384 436 1,177
29,717 19 1,622 582 2,199 66 9,124 1,037 1,384 1,238 434 1,475 107 58 3 305 421 877 2,182 4,817 1,767
10,356 306 320 501 255 229 668 605 24 17 4 50 5 108 2 4,901 125 293 531 180 1,235
N/A
N/A
N/A
N/A
N/A
N/A
Skilled nursing facility Home health agency Hospice Total physician/supplier Transplant surgery Inpatient surgery Outpatient surgery ~E&M nephrology inpatient ~E&M nephrology outpatient ~E&M non-nephrology inpatient ~E&M non-nephrology outpatient Dialysis capitation Inpatient dialysis Home dialysis Vascular access Peritoneal access Physician/supplier ESA Physician/supplier iron Immunosuppressive drugs Durable medical equipment Physician/supplier radiology Physician/supplier lab/pathology Physician/supplier ambulance Other physician/supplier Part D
2011 USRDS ANNUAL DATA REPORT
volume TWO
esrd
paGe
e370